Cloning	O
of	O
the	O
novel	B-protein
human	I-protein
myeloid-cell-specific	I-protein
C/EBP-epsilon	I-protein
transcription	I-protein
factor	I-protein
.	O

Chicken	B-protein
NF-M	I-protein
transcription	I-protein
factor	I-protein
,	O
in	O
cooperation	O
with	O
either	O
c-Myb	B-protein
or	O
v-Myb	B-protein
,	O
is	O
active	O
in	O
the	O
combinatorial	O
activation	O
of	O
myeloid-cell-specific	B-DNA
genes	I-DNA
in	O
heterologous	B-cell_type
cell	I-cell_type
types	I-cell_type
,	O
such	O
as	O
embryonic	B-cell_type
fibroblasts	I-cell_type
.	O

In	O
humans	O
,	O
similar	O
effects	O
were	O
observed	O
with	O
homologous	O
members	O
of	O
the	O
CCAAT/enhancer-binding	B-protein
protein	I-protein
(	I-protein
C/EBP	I-protein
)	I-protein
family	I-protein
of	O
transcriptional	B-protein
regulators	I-protein
,	O
especially	O
the	O
human	O
homolog	O
of	O
chicken	B-protein
NF-M	I-protein
,	O
C/EBP-beta	B-protein
(	O
NF-IL6	B-protein
)	O
.	O

However	O
,	O
the	O
NF-IL6	B-DNA
gene	I-DNA
is	O
expressed	O
in	O
a	O
variety	O
of	O
nonmyeloid	O
cell	O
types	O
and	O
is	O
strongly	O
inducible	O
in	O
response	O
to	O
inflammatory	O
stimuli	O
,	O
making	O
it	O
an	O
unlikely	O
candidate	O
to	O
have	O
an	O
exclusive	O
role	O
as	O
a	O
combinatorial	O
differentiation	O
switch	O
during	O
myelopoiesis	O
in	O
human	B-cell_type
cells	I-cell_type
.	O

By	O
using	O
a	O
reverse	O
transcription-PCR-based	O
approach	O
and	O
a	O
set	O
of	O
primers	O
specific	O
for	O
the	O
DNA-binding	B-DNA
domains	I-DNA
of	O
highly	O
homologous	O
members	O
of	O
the	O
C/EBP	B-protein
family	I-protein
of	O
transcriptional	B-protein
regulators	I-protein
,	O
we	O
have	O
cloned	O
a	O
novel	B-DNA
human	I-DNA
gene	I-DNA
encoding	O
a	O
member	O
of	O
the	O
C/EBP	B-DNA
gene	I-DNA
family	I-DNA
,	O
identified	O
as	O
the	O
human	O
homolog	O
of	O
CRP1	B-protein
,	O
C/EBP-epsilon	B-protein
.	O

A	O
1.2-kb	B-DNA
cDNA	I-DNA
encoding	O
full-length	O
human	B-DNA
C/EBP-epsilon	I-DNA
was	O
cloned	O
from	O
a	O
promyelocyte-late	B-DNA
myeloblast-derived	I-DNA
lambda	I-DNA
gt11	I-DNA
library	I-DNA
.	O

Molecular	O
analysis	O
of	O
the	O
cDNA	O
and	O
genomic	O
clones	O
indicated	O
the	O
presence	O
of	O
two	O
exons	B-DNA
encoding	O
a	O
protein	O
with	O
an	O
apparent	O
molecular	O
mass	O
of	O
32	O
kDa	O
and	O
a	O
pI	O
of	O
9.5	O
.	O

Primer	O
extension	O
analysis	O
of	O
C/EBP-epsilon	B-RNA
mRNA	I-RNA
detected	O
a	O
single	O
major	O
transcription	B-DNA
start	I-DNA
site	I-DNA
approximately	O
200	O
bp	O
upstream	O
of	O
the	O
start	B-DNA
codon	I-DNA
.	O

The	O
putative	O
promoter	O
area	O
is	O
similar	O
to	O
those	O
of	O
several	O
other	O
myeloid-cell-specific	O
genes	O
in	O
that	O
it	O
contains	O
no	O
TATAAA	B-DNA
box	I-DNA
but	O
has	O
a	O
number	O
of	O
purine-rich	B-DNA
stretches	I-DNA
with	O
multiple	O
sites	O
for	O
the	O
factors	O
of	O
the	O
Ets	B-protein
family	I-protein
of	O
transcriptional	B-protein
regulators	I-protein
.	O

Northern	O
blot	O
analyses	O
indicated	O
a	O
highly	O
restricted	O
mRNA	O
expression	O
pattern	O
,	O
with	O
the	O
strongest	O
expression	O
occurring	O
in	O
promyelocyte	B-cell_line
and	I-cell_line
late-myeloblast-like	I-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

Western	O
blot	O
and	O
immunoprecipitation	O
studies	O
using	O
rabbit	B-protein
anti-C/EBP-epsilon	I-protein
antibodies	I-protein
raised	O
against	O
the	O
N-terminal	B-protein
portion	I-protein
of	O
C/EBP-epsilon	B-protein
(	O
amino	B-protein
acids	I-protein
1	I-protein
to	I-protein
115	I-protein
)	O
showed	O
that	O
C/EBP-epsilon	B-protein
is	O
a	O
32-kDa	B-protein
nuclear	I-protein
phosphoprotein	I-protein
.	O

The	O
human	O
C/EBP-epsilon	B-protein
protein	O
exhibited	O
strong	O
and	O
specific	O
binding	O
to	O
double-stranded	B-DNA
DNA	I-DNA
containing	I-DNA
consensus	I-DNA
C/EBP	I-DNA
sites	I-DNA
.	O

Cotransfection	O
of	O
the	O
C/EBP-epsilon	B-protein
sense	O
and	O
antisense	O
expression	O
constructs	O
together	O
with	O
chloramphenicol	B-DNA
acetyltransferase	I-DNA
reporter	I-DNA
vectors	I-DNA
containing	O
myeloid-cell-specific	B-DNA
c-mim	I-DNA
and	I-DNA
human	I-DNA
myeloperoxidase	I-DNA
promoters	I-DNA
suggested	O
a	O
role	O
for	O
C/EBP-epsilon	B-protein
transcription	B-protein
factor	I-protein
in	O
the	O
regulation	O
of	O
a	O
subset	O
of	O
myeloid-cell-specific	B-DNA
genes	I-DNA
.	O

Transient	O
tranfection	O
of	O
a	O
promyelocyte	B-cell_line
cell	I-cell_line
line	I-cell_line
(	O
NB4	B-cell_line
)	O
with	O
a	O
C/EBP-epsilon	B-DNA
expression	I-DNA
plasmid	I-DNA
increased	O
cell	O
growth	O
by	O
sevenfold	O
,	O
while	O
antisense	O
C/EBP-epsilon	B-protein
caused	O
a	O
fivefold	O
decrease	O
in	O
clonal	O
growth	O
of	O
these	O
cells	O
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLoGYy	NULL
,	NULL
Mar	NULL
.	NULL

1997	NULL
,	NULL
p.	NULL
1375-1386	NULL
0270-7306/97/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1997	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

17	NULL
,	NULL
No	NULL
.	NULL

3	NULL
Cloning	NULL
of	NULL
the	NULL
Novel	NULL
Human	NULL
Myeloid-Cell-Specific	NULL
C/EBP	NULL
-g	NULL
Transcription	NULL
Factor	NULL
ALEXEY	NULL
M.	NULL
CHUMAKOV	NULL
,	NULL
*	NULL
ISABELLE	NULL
GRILLIER	NULL
,	NULL
EKATERINA	NULL
CHUMAKOVA	NULL
,	NULL
DORIS	NULL
CHIH	NULL
,	NULL
JAMES	NULL
SLATER	NULL
,	NULL
anp	NULL
H.	NULL
PHILLIP	NULL
KOEFFLER	NULL
Division	NULL
of	NULL
Hematology/Oncology	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Cedars-Sinai	NULL
Medical	NULL
Center	NULL
,	NULL
UCLA	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
California	NULL
90048	NULL
Received	NULL
24	NULL
July	NULL
1996/Returned	NULL
for	NULL
modification	NULL
4	NULL
September	NULL
1996/Accepted	NULL
23	NULL
December	NULL
1996	NULL
Chicken	NULL
NF-M	NULL
transcription	NULL
factor	NULL
,	NULL
in	NULL
cooperation	NULL
with	NULL
either	NULL
c-Myb	NULL
or	NULL
v-Myb	NULL
,	NULL
is	NULL
active	NULL
in	NULL
the	NULL
combinatorial	NULL
activation	NULL
of	NULL
myeloid-cell-specific	NULL
genes	NULL
in	NULL
heterologous	NULL
cell	NULL
types	NULL
,	NULL
such	NULL
as	NULL
embryonic	NULL
fibroblasts	NULL
.	NULL

In	NULL
humans	NULL
,	NULL
similar	NULL
effects	NULL
were	NULL
observed	NULL
with	NULL
homologous	NULL
members	NULL
of	NULL
the	NULL
CCAAT/enhancer-binding	NULL
protein	NULL
(	NULL
C/EBP	NULL
)	NULL
family	NULL
of	NULL
transcriptional	NULL
regulators	NULL
,	NULL
especially	NULL
the	NULL
human	NULL
homolog	NULL
of	NULL
chicken	NULL
NF-M	NULL
,	NULL
C/EBP	NULL
-B	NULL
(	NULL
NF-IL6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
NF-IL6	NULL
gene	NULL
is	NULL
expressed	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
nonmyeloid	NULL
cell	NULL
types	NULL
and	NULL
is	NULL
strongly	NULL
inducible	NULL
in	NULL
response	NULL
to	NULL
inflammatory	NULL
stimuli	NULL
,	NULL
making	NULL
it	NULL
an	NULL
unlikely	NULL
candidate	NULL
to	NULL
have	NULL
an	NULL
exclusive	NULL
role	NULL
as	NULL
a	NULL
combinatorial	NULL
differentiation	NULL
switch	NULL
during	NULL
myelopoiesis	NULL
in	NULL
human	NULL
cells	NULL
.	NULL

By	NULL
using	NULL
a	NULL
reverse	NULL
transcription-PCR-based	NULL
approach	NULL
and	NULL
a	NULL
set	NULL
of	NULL
primers	NULL
specific	NULL
for	NULL
the	NULL
DNA-binding	NULL
domains	NULL
of	NULL
highly	NULL
homologous	NULL
members	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
of	NULL
transcriptional	NULL
regulators	NULL
,	NULL
we	NULL
have	NULL
cloned	NULL
a	NULL
novel	NULL
human	NULL
gene	NULL
encoding	NULL
a	NULL
member	NULL
of	NULL
the	NULL
C/EBP	NULL
gene	NULL
family	NULL
,	NULL
identified	NULL
as	NULL
the	NULL
human	NULL
homolog	NULL
of	NULL
CRP1	NULL
,	NULL
C/EBP-s.	NULL
A	NULL
1.2-kb	NULL
cDNA	NULL
encoding	NULL
full-length	NULL
human	NULL
C/EBP-s	NULL
was	NULL
cloned	NULL
from	NULL
a	NULL
promyelocyte-late	NULL
myeloblast-derived	NULL
Agt11	NULL
library	NULL
.	NULL

Molecular	NULL
analysis	NULL
of	NULL
the	NULL
cDNA	NULL
and	NULL
genomic	NULL
clones	NULL
indicated	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
exons	NULL
encoding	NULL
a	NULL
protein	NULL
with	NULL
an	NULL
apparent	NULL
molecular	NULL
mass	NULL
of	NULL
32	NULL
kDa	NULL
and	NULL
a	NULL
pI	NULL
of	NULL
9.5	NULL
.	NULL

Primer	NULL
extension	NULL
analysis	NULL
of	NULL
C/EBP-s	NULL
mRNA	NULL
detected	NULL
a	NULL
single	NULL
major	NULL
transcription	NULL
start	NULL
site	NULL
approximately	NULL
200	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
start	NULL
codon	NULL
.	NULL

The	NULL
putative	NULL
promoter	NULL
area	NULL
is	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
several	NULL
other	NULL
myeloid-cell-specific	NULL
genes	NULL
in	NULL
that	NULL
it	NULL
contains	NULL
no	NULL
TATAAA	NULL
box	NULL
but	NULL
has	NULL
a	NULL
number	NULL
of	NULL
purine-rich	NULL
stretches	NULL
with	NULL
multiple	NULL
sites	NULL
for	NULL
the	NULL
factors	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
of	NULL
transcriptional	NULL
regulators	NULL
.	NULL

Northern	NULL
blot	NULL
analyses	NULL
indicated	NULL
a	NULL
highly	NULL
restricted	NULL
mRNA	NULL
expression	NULL
pattern	NULL
,	NULL
with	NULL
the	NULL
strongest	NULL
expression	NULL
occurring	NULL
in	NULL
promyelocyte	NULL
and	NULL
late-myeloblast-like	NULL
cell	NULL
lines	NULL
.	NULL

Western	NULL
blot	NULL
and	NULL
immunoprecipitation	NULL
studies	NULL
using	NULL
rabbit	NULL
antibodies	NULL
raised	NULL
against	NULL
the	NULL
N-terminal	NULL
portion	NULL
of	NULL
C/EBP	NULL
-£	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
115	NULL
)	NULL
showed	NULL
that	NULL
C/EBP-s	NULL
is	NULL
a	NULL
32-kDa	NULL
nuclear	NULL
phosphoprotein	NULL
.	NULL

The	NULL
human	NULL
C/EBP-g	NULL
protein	NULL
exhibited	NULL
strong	NULL
and	NULL
specific	NULL
binding	NULL
to	NULL
double-stranded	NULL
DNA	NULL
containing	NULL
consensus	NULL
C/EBP	NULL
sites	NULL
.	NULL

Cotransfection	NULL
of	NULL
the	NULL
C/EBP	NULL
-£	NULL
sense	NULL
and	NULL
antisense	NULL
expression	NULL
constructs	NULL
together	NULL
with	NULL
chloramphenicol	NULL
acetyltransferase	NULL
reporter	NULL
vectors	NULL
containing	NULL
myeloid-cell-specific	NULL
c-mim	NULL
and	NULL
human	NULL
myeloperoxidase	NULL
promoters	NULL
suggested	NULL
a	NULL
role	NULL
for	NULL
C/EBP	NULL
-£	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
myeloid-cell-specific	NULL
genes	NULL
.	NULL

Transient	NULL
tranfection	NULL
of	NULL
a	NULL
promyelocyte	NULL
cell	NULL
line	NULL
(	NULL
NB4	NULL
)	NULL
with	NULL
a	NULL
C/EBP-e	NULL
expression	NULL
plasmid	NULL
increased	NULL
cell	NULL
growth	NULL
by	NULL
sevenfold	NULL
,	NULL
while	NULL
antisense	NULL
C/EBP	NULL
-s	NULL
caused	NULL
a	NULL
fivefold	NULL
decrease	NULL
in	NULL
clonal	NULL
growth	NULL
of	NULL
these	NULL
cells	NULL
.	NULL

A	NULL
family	NULL
of	NULL
transcriptional	NULL
regulators	NULL
known	NULL
as	NULL
CCAAT/	NULL
enhancer-binding	NULL
proteins	NULL
(	NULL
C/EBP	NULL
)	NULL
currently	NULL
includes	NULL
C/EBP-	NULL
«	NULL
,	NULL
C/EBP-B	NULL
(	NULL
NF-IL6	NULL
,	NULL
CRP2	NULL
)	NULL
,	NULL
C/EBP-8	NULL
(	NULL
NF-IL6-B	NULL
,	NULL
CRP3	NULL
)	NULL
,	NULL
Ig-C/EBP	NULL
,	NULL
GADD15S3	NULL
(	NULL
CHOP	NULL
)	NULL
proteins	NULL
,	NULL
as	NULL
well	NULL
as	NULL
two	NULL
homologous	NULL
genes	NULL
whose	NULL
expression	NULL
has	NULL
not	NULL
been	NULL
detected	NULL
,	NULL
CRP1	NULL
and	NULL
HS8	NULL
(	NULL
1	NULL
,	NULL
15	NULL
,	NULL
17	NULL
,	NULL
25	NULL
,	NULL
37	NULL
,	NULL
67	NULL
,	NULL
68	NULL
,	NULL
84	NULL
,	NULL
86	NULL
)	NULL
.	NULL

These	NULL
proteins	NULL
have	NULL
highly	NULL
homologous	NULL
C-terminal	NULL
basic	NULL
DNA-binding	NULL
and	NULL
dimerization	NULL
domains	NULL
and	NULL
much	NULL
less	NULL
conserved	NULL
N-terminal	NULL
regulatory	NULL
and	NULL
transactivation	NULL
domains	NULL
.	NULL

C/EBP-B	NULL
and	NULL
C/EBP-8	NULL
are	NULL
important	NULL
for	NULL
signal	NULL
transduction	NULL
,	NULL
being	NULL
nuclear	NULL
effectors	NULL
of	NULL
cytokine-induced	NULL
gene	NULL
expression	NULL
in	NULL
cells	NULL
of	NULL
various	NULL
stages	NULL
and	NULL
directions	NULL
of	NULL
differentiation	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
39	NULL
,	NULL
66	NULL
)	NULL
.	NULL

C/EBP	NULL
-	NULL
«	NULL
is	NULL
predominantly	NULL
expressed	NULL
in	NULL
adipocytes	NULL
and	NULL
hepa-tocytes	NULL
,	NULL
but	NULL
it	NULL
is	NULL
also	NULL
expressed	NULL
in	NULL
numerous	NULL
other	NULL
cell	NULL
types	NULL
and	NULL
is	NULL
important	NULL
for	NULL
adipocyte	NULL
differentiation	NULL
(	NULL
13	NULL
,	NULL
15	NULL
,	NULL
19	NULL
,	NULL
28	NULL
,	NULL
38	NULL
,	NULL
40	NULL
,	NULL
50	NULL
,	NULL
51	NULL
,	NULL
65	NULL
,	NULL
69	NULL
,	NULL
81	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
C/EBP-	NULL
«	NULL
has	NULL
also	NULL
been	NULL
implicated	NULL
in	NULL
monocytes	NULL
,	NULL
where	NULL
it	NULL
can	NULL
cooperate	NULL
with	NULL
the	NULL
transcription	NULL
factor	NULL
AML1	NULL
to	NULL
form	NULL
a	NULL
heterodimer	NULL
which	NULL
mediates	NULL
activation	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
macrophage	NULL
colony-stimulat-	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Cedars-Sinai	NULL
Research	NULL
Institute	NULL
,	NULL
UCLA	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
8700	NULL
Beverly	NULL
Blvd	NULL
.	NULL

,	NULL
B121	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
90048	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
310	NULL
)	NULL
855-4609	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
310	NULL
)	NULL
652-8411	NULL
.	NULL

1375	NULL
ing	NULL
factor	NULL
(	NULL
M-CSF	NULL
)	NULL
receptor	NULL
(	NULL
61	NULL
,	NULL
70	NULL
,	NULL
89	NULL
)	NULL
.	NULL

So	NULL
far	NULL
,	NULL
C/EBP	NULL
-like	NULL
proteins	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
have	NULL
clear	NULL
differences	NULL
in	NULL
their	NULL
DNA-binding	NULL
preferences	NULL
,	NULL
and	NULL
possibly	NULL
the	NULL
context	NULL
of	NULL
any	NULL
given	NULL
DNA-binding	NULL
site	NULL
and	NULL
combinatorial	NULL
interaction	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
Myb	NULL
or	NULL
AML-1	NULL
,	NULL
may	NULL
determine	NULL
the	NULL
subset	NULL
of	NULL
genes	NULL
that	NULL
are	NULL
regulated	NULL
by	NULL
each	NULL
individual	NULL
C/EBP	NULL
protein	NULL
(	NULL
14	NULL
,	NULL
89	NULL
)	NULL
.	NULL

In	NULL
the	NULL
past	NULL
few	NULL
years	NULL
,	NULL
studies	NULL
of	NULL
chicken	NULL
myelomonocyte-specific	NULL
c-mim	NULL
and	NULL
c-MGF	NULL
gene	NULL
regulation	NULL
has	NULL
led	NULL
to	NULL
identification	NULL
of	NULL
chicken	NULL
NF-M	NULL
(	NULL
C/EBP-B	NULL
)	NULL
as	NULL
a	NULL
component	NULL
of	NULL
the	NULL
combinatorial	NULL
switch	NULL
,	NULL
which	NULL
is	NULL
involved	NULL
in	NULL
regulation	NULL
of	NULL
myeloid	NULL
genes	NULL
in	NULL
cooperation	NULL
with	NULL
the	NULL
c-Myb	NULL
protein	NULL
(	NULL
14	NULL
,	NULL
61	NULL
,	NULL
70	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
mammalian	NULL
system	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
protein	NULL
most	NULL
closely	NULL
homologous	NULL
to	NULL
chicken	NULL
NF-M	NULL
at	NULL
the	NULL
amino	NULL
acid	NULL
level	NULL
is	NULL
NF-IL6	NULL
(	NULL
CRP2	NULL
,	NULL
C/EBP	NULL
-B	NULL
)	NULL
,	NULL
but	NULL
it	NULL
is	NULL
not	NULL
restricted	NULL
to	NULL
cells	NULL
of	NULL
the	NULL
myelomonocytic	NULL
lineage	NULL
,	NULL
as	NULL
this	NULL
factor	NULL
is	NULL
drastically	NULL
and	NULL
abundantly	NULL
induced	NULL
in	NULL
all	NULL
tissues	NULL
after	NULL
stimulation	NULL
with	NULL
either	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
or	NULL
other	NULL
inflammatory	NULL
signals	NULL
(	NULL
1	NULL
,	NULL
4	NULL
,	NULL
5	NULL
,	NULL
7	NULL
,	NULL
10	NULL
,	NULL
11	NULL
,	NULL
15	NULL
,	NULL
16	NULL
,	NULL
87	NULL
,	NULL
88	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
NF-IL6	NULL
,	NULL
like	NULL
another	NULL
member	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
of	NULL
transcriptional	NULL
regulators	NULL
,	NULL
GADD153	NULL
,	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
functional	NULL
activation	NULL
of	NULL
cells	NULL
of	NULL
diverse	NULL
lineages	NULL
by	NULL
induction	NULL
of	NULL
a	NULL
certain	NULL
subset	NULL
of	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
acute-phase	NULL
proteins	NULL
and	NULL
various	NULL
LPS-induc-ible	NULL
cytokines	NULL
.	NULL

1376	NULL
CHUMAKOV	NULL
ET	NULL
AL	NULL
.	NULL

This	NULL
hypothesis	NULL
prompted	NULL
us	NULL
to	NULL
look	NULL
for	NULL
a	NULL
member	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
of	NULL
proteins	NULL
that	NULL
is	NULL
functionally	NULL
,	NULL
rather	NULL
than	NULL
struc-turally	NULL
,	NULL
homologous	NULL
to	NULL
avian	NULL
NF-M	NULL
and	NULL
whose	NULL
expression	NULL
is	NULL
limited	NULL
to	NULL
cells	NULL
of	NULL
the	NULL
myeloid	NULL
lineage	NULL
.	NULL

In	NULL
this	NULL
investigation	NULL
,	NULL
we	NULL
have	NULL
reported	NULL
the	NULL
cloning	NULL
of	NULL
a	NULL
novel	NULL
human	NULL
myeloid-cell-specific	NULL
C/EBP	NULL
family	NULL
member	NULL
that	NULL
can	NULL
cooperate	NULL
with	NULL
c-Myb	NULL
in	NULL
transactivation	NULL
and	NULL
is	NULL
important	NULL
for	NULL
growth	NULL
and	NULL
differentiation	NULL
of	NULL
myeloid	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reverse	NULL
transcription	NULL
(	NULL
RT	NULL
)	NULL
-PCR	NULL
and	NULL
cloning	NULL
of	NULL
a	NULL
myeloid-cell-specific	NULL
C/EBP-related	NULL
gene	NULL
.	NULL

To	NULL
make	NULL
cDNA	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
prepared	NULL
by	NULL
using	NULL
a	NULL
Pharmacia	NULL
RNA	NULL
purification	NULL
kit	NULL
;	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
from	NULL
the	NULL
promyelocyte-like	NULL
HL60	NULL
cells	NULL
was	NULL
purified	NULL
by	NULL
two	NULL
rounds	NULL
of	NULL
selection	NULL
on	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
-Sepharose	NULL
(	NULL
Pharmacia	NULL
)	NULL
as	NULL
specified	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Five	NULL
micrograms	NULL
of	NULL
polyadenylated	NULL
RNA	NULL
was	NULL
annealed	NULL
to	NULL
a	NULL
universal	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
-tailed	NULL
primer	NULL
(	NULL
5'-TAGGAATTCTCGAGCG	NULL
GCCGCTTTTITTTTTITITTTTT-3	NULL
'	NULL
[	NULL
T-AMP	NULL
]	NULL
)	NULL
at	NULL
70°C	NULL
.	NULL

The	NULL
first	NULL
strand	NULL
of	NULL
cDNA	NULL
was	NULL
synthesized	NULL
by	NULL
using	NULL
Superscript	NULL
II	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
essentially	NULL
as	NULL
described	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Between	NULL
40	NULL
and	NULL
200	NULL
ng	NULL
of	NULL
single-stranded	NULL
cDNA	NULL
was	NULL
then	NULL
amplified	NULL
by	NULL
using	NULL
one	NULL
of	NULL
two	NULL
gene-specific	NULL
primers	NULL
designed	NULL
to	NULL
anneal	NULL
in	NULL
the	NULL
area	NULL
of	NULL
maximal	NULL
homology	NULL
of	NULL
the	NULL
C/EBP	NULL
-like	NULL
genes	NULL
[	NULL
5'-TGCGC	NULL
(	NULL
G/T	NULL
)	NULL
CCTACCTGGGCTACCAG	NULL
(	NULL
G/T	NULL
)	NULL
CG-3	NULL
'	NULL
(	NULL
MS-1	NULL
)	NULL
and	NULL
5'.CG	NULL
(	NULL
C/G	NULL
)	NULL
AACAACATCGC	NULL
(	NULL
G/T	NULL
)	NULL
GTGCGCAAGAGCCG-3	NULL
'	NULL
(	NULL
MS-2	NULL
)	NULL
]	NULL
and	NULL
a	NULL
universal	NULL
-	NULL
downstream	NULL
-	NULL
primer	NULL
(	NULL
5'-TAGGAATTCTCGAGCGGCCGC-3	NULL
'	NULL
[	NULL
AMP	NULL
]	NULL
)	NULL
for	NULL
35	NULL
cycles	NULL
consisting	NULL
of	NULL
94°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
50°C	NULL
for	NULL
1.5	NULL
min	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
1.5	NULL
min	NULL
.	NULL

The	NULL
PCR	NULL
amplification	NULL
products	NULL
were	NULL
analyzed	NULL
by	NULL
gel	NULL
electrophoresis	NULL
;	NULL
candidate	NULL
bands	NULL
were	NULL
excised	NULL
and	NULL
used	NULL
as	NULL
probes	NULL
in	NULL
Northern	NULL
blot	NULL
hybridizations	NULL
with	NULL
total	NULL
RNA	NULL
prepared	NULL
from	NULL
numerous	NULL
hematopoietic	NULL
and	NULL
nonhematopoietic	NULL
cells	NULL
.	NULL

Fragments	NULL
showing	NULL
a	NULL
tissue-specific	NULL
expression	NULL
pattern	NULL
were	NULL
cloned	NULL
into	NULL
an	NULL
Smal	NULL
site	NULL
of	NULL
the	NULL
pTZ19R	NULL
vector	NULL
(	NULL
Pharmacia	NULL
)	NULL
and	NULL
sequenced	NULL
by	NULL
the	NULL
dideoxy	NULL
chain	NULL
termination	NULL
method	NULL
(	NULL
Sequenase	NULL
II	NULL
kit	NULL
;	NULL
U.S.	NULL
Biochemicals	NULL
)	NULL
.	NULL

cDNA	NULL
and	NULL
genomic	NULL
DNA	NULL
library	NULL
screening	NULL
and	NULL
isolation	NULL
of	NULL
C/EBP-£	NULL
clones	NULL
.	NULL

A	NULL
partial	NULL
cDNA	NULL
fragment	NULL
of	NULL
C/EBP	NULL
-e	NULL
obtained	NULL
by	NULL
RT-PCR	NULL
was	NULL
used	NULL
to	NULL
probe	NULL
an	NULL
HL60	NULL
cell	NULL
line-derived	NULL
Agtll	NULL
cDNA	NULL
library	NULL
(	NULL
Clontech	NULL
)	NULL
under	NULL
high-stringency	NULL
conditions	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
53	NULL
)	NULL
except	NULL
that	NULL
a	NULL
Hybond	NULL
N-Plus	NULL
membrane	NULL
(	NULL
Amersham	NULL
)	NULL
was	NULL
used	NULL
.	NULL

Eleven	NULL
positive	NULL
clones	NULL
were	NULL
plaque	NULL
purified	NULL
and	NULL
se-quenced	NULL
,	NULL
with	NULL
10	NULL
of	NULL
them	NULL
representing	NULL
C/EBP-e£	NULL
cDNA	NULL
fragments	NULL
of	NULL
variable	NULL
length	NULL
and	NULL
1	NULL
representing	NULL
human	NULL
C/EBP-a	NULL
,	NULL
which	NULL
is	NULL
also	NULL
expressed	NULL
in	NULL
HL60	NULL
cells	NULL
.	NULL

Similarly	NULL
,	NULL
human	NULL
and	NULL
murine	NULL
genes	NULL
for	NULL
C/EBP	NULL
-£	NULL
were	NULL
cloned	NULL
using	NULL
genomic	NULL
ADASH	NULL
(	NULL
Stratagene	NULL
)	NULL
libraries	NULL
according	NULL
to	NULL
the	NULL
protocol	NULL
of	NULL
the	NULL
provider	NULL
and	NULL
mapped	NULL
by	NULL
partial	NULL
digestion	NULL
with	NULL
restriction	NULL
enzymes	NULL
and	NULL
hybridization	NULL
with	NULL
arm-specific	NULL
probes	NULL
(	NULL
derived	NULL
against	NULL
the	NULL
T7	NULL
and	NULL
T3	NULL
promoters	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Primer	NULL
extension	NULL
.	NULL

The	NULL
human	NULL
C/EBP	NULL
-£	NULL
gene-specific	NULL
primer	NULL
used	NULL
in	NULL
this	NULL
study	NULL
was	NULL
CTCGATGTAGGCGGAGAGGTC	NULL
(	NULL
2UP	NULL
)	NULL
.	NULL

Fifty	NULL
nanograms	NULL
of	NULL
primer	NULL
was	NULL
labelled	NULL
by	NULL
using	NULL
T4	NULL
phage	NULL
polynucleotide	NULL
kinase	NULL
,	NULL
and	NULL
approximately	NULL
10°	NULL
cpm	NULL
of	NULL
labelled	NULL
primer	NULL
was	NULL
annealed	NULL
to	NULL
20	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
which	NULL
was	NULL
prepared	NULL
by	NULL
using	NULL
two	NULL
rounds	NULL
of	NULL
selection	NULL
on	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
-Sepharose	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
manufacturer	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

Primer	NULL
extension	NULL
was	NULL
performed	NULL
with	NULL
Superscript	NULL
RTII	NULL
reverse	NULL
transcriptase	NULL
at	NULL
42°C	NULL
according	NULL
to	NULL
the	NULL
directions	NULL
of	NULL
the	NULL
manufacturer	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
.	NULL

Primer	NULL
extension	NULL
products	NULL
were	NULL
separated	NULL
in	NULL
6	NULL
%	NULL
polyacrylamide	NULL
sequencing	NULL
gels	NULL
by	NULL
the	NULL
dideoxy	NULL
sequencing	NULL
reaction	NULL
performed	NULL
with	NULL
the	NULL
same	NULL
primer	NULL
and	NULL
plasmid	NULL
DNA	NULL
as	NULL
size	NULL
markers	NULL
.	NULL

Plasmid	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
constructs	NULL
.	NULL

The	NULL
c-mim	NULL
promoter	NULL
,	NULL
representing	NULL
the	NULL
0.7-kb	NULL
5	NULL
'	NULL
region	NULL
,	NULL
was	NULL
obtained	NULL
by	NULL
Pfu	NULL
PCR	NULL
amplification	NULL
of	NULL
chicken	NULL
genomic	NULL
DNA	NULL
and	NULL
mim-specific	NULL
primers	NULL
(	NULL
GGCCTCG	NULL
AGAACTGTGGCTITTGGCACCATCCATTTC	NULL
[	NULL
CMIMS	NULL
]	NULL
and	NULL
GGCTCTAGAG	NULL
CGAGTCAAAGACGTCCTCAAGTAG	NULL
[	NULL
CMIM3	NULL
]	NULL
)	NULL
cut	NULL
with	NULL
XhoI	NULL
and	NULL
Xbel	NULL
,	NULL
inserted	NULL
into	NULL
Sall	NULL
and	NULL
Xbel	NULL
sites	NULL
of	NULL
the	NULL
pCATBasic	NULL
promoterless	NULL
reporter	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
and	NULL
sequenced	NULL
.	NULL

To	NULL
make	NULL
the	NULL
human	NULL
myeloperoxidase	NULL
(	NULL
hMPO	NULL
)	NULL
promoter	NULL
construct	NULL
,	NULL
an	NULL
3.8-kb	NULL
Pvull	NULL
fragment	NULL
of	NULL
the	NULL
cloned	NULL
hMPO	NULL
gene	NULL
(	NULL
courtesy	NULL
of	NULL
Giovanni	NULL
Rovera	NULL
,	NULL
Wistar	NULL
Institute	NULL
)	NULL
was	NULL
cloned	NULL
into	NULL
plasmid	NULL
pBL2CAT	NULL
(	NULL
52	NULL
)	NULL
.	NULL

The	NULL
structures	NULL
and	NULL
orientations	NULL
of	NULL
the	NULL
inserts	NULL
were	NULL
in	NULL
all	NULL
cases	NULL
verified	NULL
by	NULL
dideoxy	NULL
sequencing	NULL
with	NULL
the	NULL
Sequenase	NULL
kit	NULL
(	NULL
U.S.	NULL
Biochemicals	NULL
)	NULL
.	NULL

Transfection	NULL
and	NULL
CAT	NULL
and	NULL
clonogenic	NULL
assays	NULL
.	NULL

Transient	NULL
transfection	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
HL60	NULL
cells	NULL
,	NULL
a	NULL
human	NULL
promyelocytic	NULL
cell	NULL
line	NULL
(	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
)	NULL
which	NULL
expresses	NULL
C/EBP-£	NULL
mRNA	NULL
and	NULL
protein	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
alpha	NULL
modified	NULL
Eagle	NULL
medium	NULL
(	NULL
Gibco	NULL
)	NULL
with	NULL
20	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
penicillin-streptomycin	NULL
.	NULL

NB4	NULL
promyelocytes	NULL
,	NULL
Kel22	NULL
myeloblasts	NULL
,	NULL
myelomonocytic	NULL
U937	NULL
cells	NULL
,	NULL
carly	NULL
myeloblast	NULL
KG1	NULL
cells	NULL
,	NULL
T-lymphoblast	NULL
CEM	NULL
cells	NULL
,	NULL
and	NULL
MCF-7	NULL
breast	NULL
cancer	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
same	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

All	NULL
other	NULL
cell	NULL
lines	NULL
used	NULL
in	NULL
transfection	NULL
experiments	NULL
were	NULL
maintained	NULL
according	NULL
to	NULL
the	NULL
directions	NULL
of	NULL
the	NULL
supplier	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
fed	NULL
the	NULL
day	NULL
before	NULL
transfection	NULL
and	NULL
were	NULL
grown	NULL
to	NULL
a	NULL
density	NULL
of	NULL
10°	NULL
ml~	NULL
'	NULL
.	NULL

Thirty	NULL
micrograms	NULL
of	NULL
the	NULL
reporter	NULL
plasmids	NULL
and	NULL
30	NULL
ug	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
-luciferase	NULL
controls	NULL
were	NULL
cotransfected	NULL
by	NULL
electroporation	NULL
(	NULL
250	NULL
V	NULL
,	NULL
960	NULL
mF	NULL
;	NULL
Bio-Rad	NULL
)	NULL
,	NULL
using	NULL
2.5	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
per	NULL
sample	NULL
.	NULL

The	NULL
CMV-luciferase	NULL
plasmid	NULL
(	NULL
1	NULL
pg	NULL
)	NULL
was	NULL
cotransfected	NULL
as	NULL
a	NULL
marker	NULL
of	NULL
transfection	NULL
efficiency	NULL
(	NULL
252	NULL
)	NULL
.	NULL

MCF-7	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
lipofection	NULL
(	NULL
Lipofectin	NULL
;	NULL
Gibco-BRL	NULL
)	NULL
with	NULL
3	NULL
pg	NULL
of	NULL
plasmid	NULL
DNA	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
for	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

performance	NULL
of	NULL
the	NULL
CAT	NULL
assay	NULL
.	NULL

After	NULL
measuring	NULL
production	NULL
of	NULL
light	NULL
by	NULL
luciferase	NULL
,	NULL
the	NULL
CAT	NULL
assay	NULL
was	NULL
carried	NULL
out	NULL
and	NULL
quantified	NULL
by	NULL
scintillation	NULL
counting	NULL
of	NULL
isolated	NULL
thin-layer	NULL
chromatography	NULL
plates	NULL
after	NULL
autoradiography	NULL
.	NULL

For	NULL
clonogenic	NULL
assays	NULL
at	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
G418	NULL
(	NULL
800	NULL
ug/ml	NULL
for	NULL
NB4	NULL
and	NULL
450	NULL
pg/ml	NULL
for	NULL
MCF-7	NULL
)	NULL
in	NULL
a	NULL
two-layer	NULL
soft-agar	NULL
system	NULL
for	NULL
8	NULL
days	NULL
(	NULL
MCF-7	NULL
cells	NULL
)	NULL
and	NULL
15	NULL
days	NULL
(	NULL
NBA	NULL
cells	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
58	NULL
)	NULL
.	NULL

Eukaryotic	NULL
expression	NULL
vectors	NULL
.	NULL

c-Myb	NULL
and	NULL
dominant-negative	NULL
Myb	NULL
mutant-encoding	NULL
vectors	NULL
(	NULL
pCt	NULL
[	NULL
26	NULL
]	NULL
and	NULL
pSCDMSMEnT	NULL
[	NULL
9	NULL
]	NULL
,	NULL
respectively	NULL
)	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Linda	NULL
Shapiro	NULL
(	NULL
St.	NULL
Jude	NULL
's	NULL
Hospital	NULL
,	NULL
Memphis	NULL
,	NULL
Tenn.	NULL
)	NULL
.	NULL

c-Jun	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
CREB	NULL
expression	NULL
plasmids	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Richard	NULL
Gaynor	NULL
(	NULL
South-western	NULL
University	NULL
,	NULL
Dallas	NULL
,	NULL
Tex	NULL
.	NULL
)	NULL

.	NULL

To	NULL
make	NULL
C/EBP-g	NULL
expression	NULL
vectors	NULL
,	NULL
an	NULL
EcoRI	NULL
fragment	NULL
of	NULL
1.2	NULL
kb	NULL
containing	NULL
the	NULL
full-length	NULL
cDNA	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
pcDNAI	NULL
CMV	NULL
promoter-containing	NULL
vector	NULL
(	NULL
Invitrogen	NULL
Corp.	NULL
)	NULL
or	NULL
the	NULL
murine	NULL
sarcoma	NULL
virus-derived	NULL
pSRaTKNeo	NULL
retroviral	NULL
vector	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
Charles	NULL
Sawyers	NULL
,	NULL
University	NULL
of	NULL
Califor-nia-Los	NULL
Angeles	NULL
)	NULL
in	NULL
the	NULL
sense	NULL
and	NULL
antisense	NULL
orientations	NULL
.	NULL

Bacterial	NULL
expression	NULL
,	NULL
antibodies	NULL
,	NULL
and	NULL
in	NULL
vitro	NULL
translation	NULL
.	NULL

The	NULL
pGEX-5X-1	NULL
plasmid	NULL
(	NULL
Pharmacia	NULL
)	NULL
was	NULL
used	NULL
to	NULL
produce	NULL
the	NULL
fusion	NULL
of	NULL
the	NULL
fragment	NULL
encoding	NULL
the	NULL
first	NULL
115	NULL
amino	NULL
acids	NULL
of	NULL
with	NULL
the	NULL
gene	NULL
for	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
.	NULL

The	NULL
fusion	NULL
protein	NULL
was	NULL
purified	NULL
from	NULL
isopropyl-B-p-thiogalactopyranc-side	NULL
(	NULL
IPTG	NULL
)	NULL
-induced	NULL
Escherichia	NULL
coli	NULL
BL-1	NULL
culture	NULL
by	NULL
the	NULL
standard	NULL
protocol	NULL
provided	NULL
by	NULL
Pharmacia	NULL
and	NULL
used	NULL
to	NULL
raise	NULL
polyclonal	NULL
anti-C/EBP-¢	NULL
rabbit	NULL
antiserum	NULL
(	NULL
BabCo	NULL
,	NULL
Berkeley	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
protein	NULL
gel	NULL
electrophoresis	NULL
and	NULL
immunostaining	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
the	NULL
manufacturer	NULL
of	NULL
the	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
)	NULL
detection	NULL
system	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

pCDMEF	NULL
(	NULL
S	NULL
)	NULL
contains	NULL
the	NULL
full-length	NULL
C/EBP	NULL
-£	NULL
cDNA	NULL
cloned	NULL
3	NULL
'	NULL
of	NULL
the	NULL
T7	NULL
promoter	NULL
.	NULL

In	NULL
vitro	NULL
translation	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
standard	NULL
protocols	NULL
with	NULL
the	NULL
TNT	NULL
reticulocyte	NULL
lysate	NULL
system	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Cell	NULL
fractionation	NULL
and	NULL
Western	NULL
blotting	NULL
.	NULL

Kel22	NULL
cells	NULL
(	NULL
10°	NULL
m1l~	NULL
'	NULL
)	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
once	NULL
in	NULL
ice-cold	NULL
RSB	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-Cl	NULL
[	NULL
pH	NULL
7.4	NULL
]	NULL
,	NULL
10	NULL
mM	NULL
NaCl	NULL
,	NULL
25	NULL
mM	NULL
EDTA	NULL
)	NULL
,	NULL
resuspended	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
ice-cold	NULL
RSB	NULL
buffer	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycle	NULL
protease	NULL
inhibitors	NULL
(	NULL
1	NULL
mM	NULL
phenylmethylsul-fonyl	NULL
fluoride	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
pepstatin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
100	NULL
ug	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
)	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
chilled	NULL
Dounce	NULL
homogenizer	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
by	NULL
10	NULL
strokes	NULL
of	NULL
a	NULL
type	NULL
B	NULL
pestle	NULL
following	NULL
the	NULL
addition	NULL
of	NULL
Nonidet	NULL
P-40	NULL
detergent	NULL
to	NULL
0.5	NULL
%	NULL
.	NULL

Nuclei	NULL
were	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
at	NULL
2,000	NULL
rpm	NULL
in	NULL
a	NULL
benchtop	NULL
centrifuge	NULL
and	NULL
washed	NULL
once	NULL
with	NULL
ice-cold	NULL
RBS	NULL
buffer	NULL
.	NULL

Nuclear	NULL
and	NULL
cytoplasmic	NULL
fractions	NULL
(	NULL
30	NULL
g	NULL
)	NULL
were	NULL
denatured	NULL
by	NULL
addition	NULL
of	NULL
2	NULL
%	NULL
electrophoresis	NULL
sample	NULL
buffer	NULL
(	NULL
120	NULL
mM	NULL
Tris-Cl	NULL
[	NULL
pH	NULL
6.8	NULL
]	NULL
,	NULL
4	NULL
%	NULL
SDS	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
3	NULL
%	NULL
B-mercap-toethanol	NULL
]	NULL
,	NULL
incubated	NULL
for	NULL
10	NULL
min	NULL
at	NULL
90°C	NULL
,	NULL
and	NULL
separated	NULL
on	NULL
a	NULL
12.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Western	NULL
blotting	NULL
and	NULL
immunodetection	NULL
were	NULL
done	NULL
by	NULL
standard	NULL
meth-ods	NULL
,	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
supplier	NULL
of	NULL
the	NULL
ECL	NULL
detection	NULL
system	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Purified	NULL
rabbit	NULL
polyclonal	NULL
anti-C/EBP-£	NULL
antibody	NULL
(	NULL
18	NULL
g/m	NULL
!	NULL
)	NULL

was	NULL
incubated	NULL
with	NULL
the	NULL
blocked	NULL
membrane	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
and	NULL
bound	NULL
antibody	NULL
was	NULL
detected	NULL
with	NULL
an	NULL
anti-rabbit	NULL
antibody-horseradish	NULL
peroxidase	NULL
conjugate	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Following	NULL
cell	NULL
washing	NULL
and	NULL
lysis	NULL
,	NULL
immunoprecipitation	NULL
was	NULL
done	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
,	NULL
with	NULL
protein	NULL
A-Sepharose	NULL
and	NULL
1	NULL
pl	NULL
of	NULL
anti-C/EBP-e	NULL
rabbit	NULL
polyclonal	NULL
antiserum	NULL
or	NULL
control	NULL
preimmune	NULL
antiserum	NULL
.	NULL

Following	NULL
separation	NULL
on	NULL
a	NULL
12.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
proteins	NULL
were	NULL
transferred	NULL
by	NULL
electroblotting	NULL
to	NULL
a	NULL
polyvinylidene	NULL
difluoride	NULL
membrane	NULL
(	NULL
Immobilon-P	NULL
;	NULL
Millipore	NULL
)	NULL
and	NULL
exposed	NULL
without	NULL
drying	NULL
to	NULL
X-ray	NULL
film	NULL
overnight	NULL
.	NULL

The	NULL
C/EBP-e-specific	NULL
band	NULL
was	NULL
then	NULL
detected	NULL
by	NULL
Western	NULL
blot	NULL
hybridization	NULL
with	NULL
purified	NULL
antibody	NULL
and	NULL
detection	NULL
of	NULL
the	NULL
signal	NULL
with	NULL
the	NULL
ECL	NULL
system	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

For	NULL
gel	NULL
retardation	NULL
assays	NULL
,	NULL
the	NULL
oligonucleotide	NULL
probe	NULL
was	NULL
end	NULL
labelled	NULL
with	NULL
[	NULL
y-P	NULL
]	NULL
ATP	NULL
,	NULL
annealed	NULL
,	NULL
and	NULL
used	NULL
as	NULL
a	NULL
binding	NULL
probe	NULL
.	NULL

The	NULL
gel	NULL
retardation	NULL
assay	NULL
was	NULL
performed	NULL
with	NULL
approximately	NULL
1	NULL
ng	NULL
of	NULL
the	NULL
double-stranded	NULL
probe	NULL
containing	NULL
an	NULL
optimal	NULL
C/EBP	NULL
binding	NULL
site	NULL
in	NULL
a	NULL
self-complementary	NULL
-	NULL
oligonucleotide	NULL
5'-TGCAGATTGCGCAATCTGCA-3	NULL
'	NULL
(	NULL
73	NULL
,	NULL
83	NULL
)	NULL
,	NULL
3	NULL
ul	NULL
of	NULL
programmed	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
(	NULL
~10	NULL
ug	NULL
of	NULL
protein	NULL
}	NULL
,	NULL
and	NULL
0.5	NULL
mg	NULL
of	NULL
salmon	NULL
sperm	NULL
DNA	NULL
(	NULL
as	NULL
a	NULL
nonspecific	NULL
competitor	NULL
)	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
12	NULL
pl	NULL
of	NULL
the	NULL
binding	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
125	NULL
mM	NULL
NaCl	NULL
,	NULL
1.5	NULL
mM	NULL
MgC	NULL
]	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfony	NULL
]	NULL
fluoride	NULL
,	NULL
10	NULL
pg	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
10	NULL
mg	NULL
of	NULL
pepstatin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
100	NULL
pg	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
)	NULL
(	NULL
22	NULL
)	NULL
.	NULL

After	NULL
30	NULL
min	NULL
of	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
the	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
native	NULL
polyacrylamide	NULL
gels	NULL
(	NULL
4.5	NULL
%	NULL
in	NULL
1	NULL
%	NULL
Tris-borate-EDTA	NULL
)	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
(	NULL
22	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Oligonucleotide	NULL
5'-TGCAGAGACTAGTCTCTGCA-3	NULL
'	NULL
containing	NULL
a	NULL
mutated	NULL
C/EBP	NULL
binding	NULL
motif	NULL
was	NULL
added	NULL
as	NULL
a	NULL
control	NULL
probe	NULL
in	NULL
the	NULL
competition	NULL
assay	NULL
.	NULL

Nuclear	NULL
extracts	NULL
for	NULL
detection	NULL
of	NULL
in	NULL
vivo-expressed	NULL
C/EBP	NULL
-s	NULL
were	NULL
prepared	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
gel	NULL
retardation	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
,	NULL
except	NULL
that	NULL
complementary	NULL
oligonucleotides	NULL
contained	NULL
C/EBP-binding	NULL
sites	NULL
found	NULL
in	NULL
the	NULL
M-CSF	NULL
receptor	NULL
promoter	NULL
(	NULL
89	NULL
)	NULL
:	NULL
CAAGATT	NULL
TCCAAACTCT	NULL
(	NULL
88-73A	NULL
)	NULL
and	NULL
AGAGTTTGGAAATCTTG	NULL
(	NULL
88-73B	NULL
)	NULL
,	NULL
and	NULL
CAAGATTITTCCAAACTCTGTGGTTGCCTTGC	NULL
(	NULL
CAMLA	NULL
)	NULL
and	NULL
GCAAGGC	NULL
AACCACAGAGTTTGGAAATCTTG	NULL
(	NULL
CAMLB	NULL
)	NULL
.	NULL

The	NULL
shorter	NULL
pair	NULL
of	NULL
oligonu-cleotides	NULL
,	NULL
88-73A	NULL
and	NULL
-B	NULL
,	NULL
lacks	NULL
the	NULL
neighboring	NULL
AML-1	NULL
binding	NULL
site	NULL
present	NULL
in	NULL
the	NULL
CAML	NULL
pair	NULL
.	NULL

A	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
CCAAT	NULL
site	NULL
was	NULL
created	NULL
by	NULL
annealing	NULL
CAGGTACCATAAACTCT	NULL
(	NULL
CMUT	NULL
A	NULL
)	NULL
and	NULL
AGAGTTTATGGTACCTG	NULL
(	NULL
CMUT	NULL
B	NULL
)	NULL
.	NULL

The	NULL
C/EBP-binding	NULL
site	NULL
found	NULL
in	NULL
the	NULL
promoter	NULL
area	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
was	NULL
created	NULL
by	NULL
annealing	NULL
of	NULL
the	NULL
ACGT	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
NOVEL	NULL
PROMYELOCYTE-SPECIFIC	NULL
C/EBP	NULL
FACTOR	NULL
-	NULL
1377	NULL
Late	NULL
myeloblast	NULL
--	NULL
promyelocyte	NULL
cell	NULL
line	NULL
HL~-60	NULL
PCRi	NULL
,	NULL
MS-1	NULL
,	NULL
MS-2	NULL
\t	NULL
7	NULL
:	NULL
C/EBP	NULL
-	NULL
specific	NULL
primers	NULL
AMP	NULL
AAAMARAAA	NULL
)	NULL
Northern	NULL
blot	NULL
hybridization	NULL
cDNA	NULL
library	NULL
screening	NULL
+1	NULL
ggagactgcagagggcaggtctagggcagaagatcgagagagchaggcccaggtcaggt	NULL
18	NULL
E3	NULL
ggtqgtagagagaggqcageoggagcaccccaagqqqtqectcaagagcaggtga999¢q	NULL
78	NULL
gggaqccgagggggcgggccggccatgtcccacggggacccactacgagtgtgagccccg	NULL
138	NULL
gggtggccagcaqccactcgagttctcagggggccgagcnggcccggggagctagggga	NULL
198	NULL
catgtgtgagcatgaggcctccattgacctctccgcctacatcgagtctggggaagagca	NULL
258	NULL
1	NULL
M	NULL
E	NULL
A	NULL
S	NULL
I	NULL
D	NULL
L	NULL
§	NULL
A	NULL
¥	NULL
I	NULL
S	NULL
E	NULL
Q	NULL
gcttctctccgatctccttgccgtgaagccagcgtctgaggccagaggcctcaagggccc	NULL
318	NULL
21	NULL
LOL	NULL
S	NULL
b	NULL
FOA	NULL
V	NULL
K	NULL
B	NULL
A	NULL
S	NULL
oE	NULL
R	NULL
L	NULL
K	NULL
Po-M	NULL
8	NULL
cggaacccctgccttcccccactacttgccgcctgaccctcggccctttgcctaccctcc	NULL
378	NULL
41	NULL
G	NULL
T	NULL
P	NULL
A	NULL
F	NULL
P	NULL
H	NULL
L	NULL
P	NULL
P	NULL
D	NULL
RoR	NULL
POF	NULL
¥	NULL
BoP	NULL
acataccttcggcccagacaggaaggcgctggggcctggcatctacagcagcccaqggag	NULL
438	NULL
61	NULL
HoT	NULL
F	NULL
G	NULL
P	NULL
D	NULL
¥	NULL
S	NULL
P	NULL
N	NULL
ctacqaccccagggctqtqqgcqqtgaaggaggageccoggqgggccagagqqcaqgccgage	NULL
-	NULL
498	NULL
81	NULL
¥	NULL
D	NULL
P	NULL
R	NULL
A	NULL
V	NULL
A	NULL
V	NULL
K	NULL
B	NULL
E	NULL
B	NULL
R	NULL
G	NULL
P	NULL
E	NULL
G	NULL
S	NULL
R	NULL
A	NULL
N	NULL
G	NULL
tgccagccgaggcagctacaatcccctgcagtaccaagtggcacactgtgggcagacagc	NULL
558	NULL
101	NULL
A	NULL
S	NULL
R	NULL
G	NULL
¥	NULL
N	NULL
POL	NULL
q	NULL
V	NULL
A	NULL
HOC	NULL
Q	NULL
TI	NULL
A	NULL
T	NULL
618	NULL
121	NULL
MoH	NULL
L	NULL
BoP	NULL
T	NULL
L	NULL
POL	NULL
ROV	NULL
L	NULL
K	NULL
(	NULL
138	NULL
)	NULL
agcagqccagccoctoctcoctcctgccoegqqqctagagaggctqgtgtqgacaggaccct	NULL
678	NULL
gtgcocoqqctcatgetgctgagectgtgettggtgtcgctctgtgaaatggacccaace	NULL
738	NULL
cacagtcctctgtgttcacaccccaccatgacctcoctttecttctctgtgaattcatte	NULL
798	NULL
ccaccctgaatcoccacccaaagcooctgtgqcaagetgacctacttgatctcaggecec	NULL
858	NULL
caccgccagectctctgctqctcaccatgeccoctectcttgtttetctgecqgectgett	NULL
918	NULL
ctgtgagaaatgtctactqgtcatagaacnggagactcaaggcagattgagggaaagtgt	NULL
978	NULL
actcagaaagtqtqagagcattgqctqqqgtqtcqtqgctcatyctqgtaatgccagegctt	NULL
1038	NULL
tqggaggccaaagcaggaggttcgcttaaggccagqqogttggagaccagcctqgacaaca	NULL
1098	NULL
tagcaaggctccatctttacaaaaaaaagaaagaaagaaagtgtgagaacatgaaaggqa	NULL
1158	NULL
gttttggtctcaagcagaggaccctqgtgcatctgqgqtcaccatctcccagaagcagageq	NULL
1218	NULL
atgatagttttgacctgagagacagqgagctgqctctgagtcctgtattcctttgacgcat	NULL
1278	NULL
caagtgtgeectggntgecgagttccoegeconcctcogntctectcctggecagcectca	NULL
1338	NULL
1398	NULL
139	NULL
A	NULL
BOL	NULL
A	NULL
TI	NULL
A	NULL
A	NULL
P	NULL
P	NULL
C	NULL
v	NULL
A	NULL
agtcccctcctgaaggcgccctccccggctggccccttacacaagggcaaqaaggcagtg	NULL
1458	NULL
149	NULL
$	NULL
PB	NULL
L	NULL
L	NULL
K	NULL
A	NULL
B	NULL
Ss	NULL
P	NULL
A	NULL
HOK	NULL
G	NULL
K	NULL
K	NULL
8	NULL
aacaaagatagccttgagtaccggctgagchggagcgcaacaacaccgccgtgcgcaag	NULL
1518	NULL
169	NULL
N	NULL
K	NULL
D	NULL
Ss	NULL
L	NULL
E	NULL
Y	NULL
R	NULL
No	NULL
N	NULL
R	NULL
K	NULL
agccgagacaaqgqccaagagqcqcattctggagacgcagcagaaqqgtqctggagtacatg	NULL
1578	NULL
189	NULL
§	NULL
R	NULL
D	NULL
K	NULL
A	NULL
KOR	NULL
ROI	NULL
L	NULL
E	NULL
T	NULL
Q	NULL
Q	NULL
K	NULL
V	NULL
L	NULL
E	NULL
¥	NULL
M	NULL
L	NULL
gcagagaacgageqgectccqcagcogeqtqgaggagctcacccaggagctagacacectc	NULL
1638	NULL
209	NULL
A	NULL
E	NULL
N	NULL
E	NULL
R	NULL
p	NULL
OR	NULL
S	NULL
R	NULL
V	NULL
E	NULL
E	NULL
LOT	NULL
Q	NULL
E	NULL
L	NULL
D	NULL
T	NULL
L	NULL
N	NULL
D	NULL
o	NULL
cgcaacctcttccgccagattcctgaggcggccaacctcatcaagqgcgtggggggttgc	NULL
1698	NULL
229	NULL
R	NULL
N	NULL
L	NULL
F	NULL
R	NULL
Q	NULL
I	NULL
BoB	NULL
A	NULL
A	NULL
N	NULL
L	NULL
I	NULL
K	NULL
8	NULL
agctgagqgctqqctagtqqattgtqgqcaccagqctcoctggcacqqcctaactctgegqg	NULL
1758	NULL
249	NULL
50+	NULL
accoccatcctgctqqqqqgcctaggaacccctgagacatagaccatggataaatqgcaac	NULL
1618	NULL
CqgogtqgcaaagagqqcaqgacccagcataatggttatatggctgAATAAAqttqcact	NULL
1678	NULL
gtc	NULL
(	NULL
a	NULL
)	NULL
go	NULL
CATTGCACAATCTTAATAAG	NULL
(	NULL
163-139	NULL
)	NULL
and	NULL
ACGTCTITTATTAAGATTG	NULL
TGCAATGTG	NULL
(	NULL
163-139B	NULL
)	NULL
oligonucleotides	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
accession	NULL
number	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
C/EBP-e	NULL
gene	NULL
determined	NULL
in	NULL
this	NULL
study	NULL
has	NULL
been	NULL
deposited	NULL
in	NULL
the	NULL
GenBank/EMBL	NULL
Data	NULL
Library	NULL
under	NULL
accession	NULL
number	NULL
U80982	NULL
.	NULL

Sequencing	NULL
Human	NULL
genomic	NULL
library	NULL
screening	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
C/EBP-e	NULL
RT-PCR	NULL
and	NULL
cloning	NULL
strategy	NULL
.	NULL

Primers	NULL
MS-1	NULL
and	NULL
MS-2	NULL
were	NULL
used	NULL
together	NULL
with	NULL
primer	NULL
AMP	NULL
to	NULL
amplify	NULL
the	NULL
promyelocyte-derived	NULL
cDNA	NULL
encoding	NULL
the	NULL
highly	NULL
conserved	NULL
C-terminal	NULL
domain	NULL
of	NULL
C/EBP-like	NULL
proteins	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
for	NULL
details	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Sequence	NULL
of	NULL
the	NULL
C/EBP	NULL
-£	NULL
gene	NULL
.	NULL

The	NULL
location	NULL
of	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
C/EBP	NULL
-e	NULL
transcript	NULL
is	NULL
indicated	NULL
(	NULL
+1	NULL
)	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

The	NULL
exon	NULL
structure	NULL
was	NULL
determined	NULL
by	NULL
comparison	NULL
of	NULL
the	NULL
cDNA	NULL
and	NULL
genomic	NULL
sequences	NULL
of	NULL
C/EBP-e.	NULL
Amino	NULL
acid	NULL
residues	NULL
that	NULL
differ	NULL
in	NULL
murine	NULL
C/EBP	NULL
-£	NULL
protein	NULL
are	NULL
shown	NULL
(	NULL
in	NULL
boldface	NULL
)	NULL
under	NULL
the	NULL
amino	NULL
acid	NULL
reading	NULL
frame	NULL
for	NULL
human	NULL
C/EBP-e	NULL
.	NULL

The	NULL
residues	NULL
of	NULL
the	NULL
predicted	NULL
leucine	NULL
zipper	NULL
are	NULL
indicated	NULL
in	NULL
boldface	NULL
type	NULL
and	NULL
underlined	NULL
.	NULL

The	NULL
mRNA	NULL
polyadenylation	NULL
signal	NULL
AATAAA	NULL
is	NULL
underlined	NULL
.	NULL

The	NULL
asterisk	NULL
indicates	NULL
the	NULL
stop	NULL
codon	NULL
.	NULL

RESULTS	NULL
Cloning	NULL
of	NULL
cDNA	NULL
encoding	NULL
the	NULL
promyelocyte-specific	NULL
human	NULL
C/EBP	NULL
-like	NULL
protein	NULL
.	NULL

Sequence	NULL
alignment	NULL
of	NULL
previously	NULL
cloned	NULL
members	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
revealed	NULL
a	NULL
highly	NULL
homologous	NULL
stretch	NULL
of	NULL
basic	NULL
amino	NULL
acid	NULL
residues	NULL
in	NULL
the	NULL
DNA-binding	NULL
domain	NULL
.	NULL

This	NULL
sequence	NULL
was	NULL
used	NULL
to	NULL
prepare	NULL
a	NULL
29-mer	NULL
oligonucleotide	NULL
primer	NULL
degenerate	NULL
in	NULL
the	NULL
second	NULL
position	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
for	NULL
details	NULL
)	NULL
.	NULL

Polyadenylated	NULL
mRNA	NULL
was	NULL
prepared	NULL
from	NULL
the	NULL
human	NULL
leukemic	NULL
cell	NULL
line	NULL
HL60	NULL
,	NULL
arrested	NULL
at	NULL
the	NULL
promyelocyte-late	NULL
myeloblast	NULL
stage	NULL
of	NULL
differentiation	NULL
(	NULL
53	NULL
)	NULL
.	NULL

An	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
-tailed	NULL
oligonucleotide	NULL
primer	NULL
was	NULL
used	NULL
to	NULL
reverse-transcribe	NULL
mRNA	NULL
;	NULL
the	NULL
second	NULL
strand	NULL
of	NULL
cDNA	NULL
was	NULL
synthesized	NULL
by	NULL
using	NULL
C/EBP	NULL
-specific	NULL
primers	NULL
,	NULL
and	NULL
PCR	NULL
was	NULL
used	NULL
to	NULL
amplify	NULL
potential	NULL
C/EBP	NULL
-like	NULL
cDNAs	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
RT-PCR	NULL
products	NULL
were	NULL
then	NULL
analyzed	NULL
by	NULL
Northern	NULL
hybridization	NULL
with	NULL
a	NULL
panel	NULL
of	NULL
RNAs	NULL
representing	NULL
cell	NULL
lines	NULL
of	NULL
hematopoietic	NULL
(	NULL
myeloid	NULL
,	NULL
B-	NULL
and	NULL
T-lymphocyte	NULL
,	NULL
erythroid	NULL
,	NULL
mast	NULL
,	NULL
megakaryocyte	NULL
)	NULL
and	NULL
nonhematopoietic	NULL
lineage	NULL
.	NULL

One	NULL
of	NULL
the	NULL
candidate	NULL
RT-PCR	NULL
products	NULL
was	NULL
found	NULL
to	NULL
be	NULL
specifically	NULL
expressed	NULL
only	NULL
in	NULL
the	NULL
HL60	NULL
and	NULL
PLB985	NULL
cell	NULL
lines	NULL
,	NULL
not	NULL
in	NULL
other	NULL
myeloid	NULL
cell	NULL
lines	NULL
arrested	NULL
at	NULL
either	NULL
earlier	NULL
(	NULL
KG1	NULL
)	NULL
or	NULL
later	NULL
(	NULL
U937	NULL
)	NULL
stages	NULL
of	NULL
differentiation	NULL
and	NULL
not	NULL
in	NULL
any	NULL
nonmyeloid	NULL
cells	NULL
.	NULL

Cloning	NULL
and	NULL
sequencing	NULL
of	NULL
this	NULL
RT-PCR	NULL
product	NULL
confirmed	NULL
its	NULL
homology	NULL
to	NULL
other	NULL
C/EBPs	NULL
.	NULL

This	NULL
cDNA	NULL
fragment	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
to	NULL
clone	NULL
a	NULL
full-length	NULL
C/EBP	NULL
-g	NULL
cDNA	NULL
from	NULL
a	NULL
random-primed	NULL
Agt11	NULL
HL60	NULL
cDNA	NULL
library	NULL
(	NULL
Clontech	NULL
)	NULL
.	NULL

Out	NULL
of	NULL
11	NULL
positive	NULL
independent	NULL
phage	NULL
clones	NULL
,	NULL
10	NULL
represented	NULL
human	NULL
C/EBP	NULL
-£	NULL
cDNAs	NULL
of	NULL
different	NULL
lengths	NULL
and	NULL
least	NULL
one	NULL
represented	NULL
human	NULL
C/EBP	NULL
-	NULL
«	NULL
that	NULL
was	NULL
also	NULL
expressed	NULL
in	NULL
HL6O	NULL
cells	NULL
.	NULL

The	NULL
longest	NULL
cDNA	NULL
fragment	NULL
found	NULL
in	NULL
one	NULL
of	NULL
these	NULL
clones	NULL
,	NULL
A9.2	NULL
,	NULL
was	NULL
subcloned	NULL
into	NULL
a	NULL
plasmid	NULL
and	NULL
sequenced	NULL
.	NULL

This	NULL
cDNA	NULL
of	NULL
1.2	NULL
kb	NULL
has	NULL
a	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tail	NULL
of	NULL
approximately	NULL
80	NULL
nucleotides	NULL
,	NULL
with	NULL
the	NULL
polyadenylation	NULL
signal	NULL
sequence	NULL
AATAAA	NULL
163	NULL
nucleotides	NULL
3	NULL
'	NULL
of	NULL
the	NULL
TGA	NULL
stop	NULL
codon	NULL
,	NULL
and	NULL
encodes	NULL
a	NULL
protein	NULL
with	NULL
a	NULL
predicted	NULL
1378	NULL
CHUMAKOV	NULL
ET	NULL
AL	NULL
.	NULL

I\	NULL
Ho	NULL
SX	NULL
E	NULL
BE	NULL
KK	NULL
EE	NULL
F	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

CEM	NULL
HL60	NULL
Marker	NULL
KG1	NULL
U937	NULL
5.2kb	NULL
E	NULL
6.3kb	NULL
E	NULL
5.5	NULL
kb	NULL
6.8	NULL
kb	NULL
E	NULL
5.9kb	NULL
0.3	NULL
1.5kb	NULL
--	NULL
1kb	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
structure	NULL
of	NULL
human	NULL
(	NULL
h	NULL
)	NULL
and	NULL
murine	NULL
(	NULL
m	NULL
)	NULL
genomic	NULL
C/EBP-e	NULL
clones	NULL
(	NULL
XA1l	NULL
and	NULL
ANI	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

A	NULL
partial	NULL
restriction	NULL
map	NULL
of	NULL
the	NULL
human	NULL
C/EBP-e	NULL
gene	NULL
is	NULL
shown	NULL
.	NULL

Positions	NULL
of	NULL
restriction	NULL
enzyme	NULL
recognition	NULL
sites	NULL
are	NULL
indicated	NULL
as	NULL
follows	NULL
:	NULL
H	NULL
,	NULL
HindIII	NULL
;	NULL
S	NULL
,	NULL
Smal	NULL
,	NULL
X	NULL
,	NULL
Xhol	NULL
;	NULL
Bm	NULL
,	NULL
BamHI	NULL
;	NULL
K	NULL
,	NULL
KpnI	NULL
;	NULL
and	NULL
E	NULL
,	NULL
EcoRI	NULL
.	NULL

Some	NULL
of	NULL
the	NULL
indicated	NULL
enzymes	NULL
have	NULL
sites	NULL
that	NULL
are	NULL
not	NULL
shown	NULL
on	NULL
this	NULL
map	NULL
.	NULL

(	NULL
B	NULL
)	NULL
human	NULL
C/EBP-£	NULL
primer	NULL
extension	NULL
analysis	NULL
.	NULL

The	NULL
analysis	NULL
used	NULL
mRNA	NULL
prepared	NULL
from	NULL
the	NULL
C/EBP	NULL
early	NULL
myeloblast	NULL
cell	NULL
line	NULL
KG1	NULL
,	NULL
a	NULL
myelomonocytic	NULL
cell	NULL
line	NULL
(	NULL
U937	NULL
)	NULL
,	NULL
T-lymphoblast	NULL
CEM	NULL
,	NULL
and	NULL
C/EBP-g-positive	NULL
promyelocytic	NULL
cells	NULL
(	NULL
HL60	NULL
)	NULL
.	NULL

The	NULL
size	NULL
of	NULL
the	NULL
single	NULL
primer	NULL
extension	NULL
product	NULL
(	NULL
200	NULL
nucleotides	NULL
[	NULL
nt	NULL
]	NULL
upstream	NULL
from	NULL
the	NULL
ATG	NULL
codon	NULL
)	NULL
is	NULL
indicated	NULL
by	NULL
a	NULL
horizontal	NULL
arrow	NULL
.	NULL

Reverse	NULL
transcriptase	NULL
(	NULL
Superscript	NULL
II	NULL
;	NULL
Gibco-BRL	NULL
)	NULL
was	NULL
used	NULL
to	NULL
extend	NULL
the	NULL
C/EBP-e-specific	NULL
primer	NULL
(	NULL
2UP	NULL
;	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
for	NULL
details	NULL
)	NULL
at	NULL
42°C	NULL
.	NULL

The	NULL
sequencing	NULL
reaction	NULL
,	NULL
using	NULL
the	NULL
same	NULL
primer	NULL
and	NULL
the	NULL
C/EBP	NULL
-£	NULL
promoter-containing	NULL
plasmid	NULL
DNA	NULL
,	NULL
was	NULL
run	NULL
on	NULL
the	NULL
same	NULL
gel	NULL
as	NULL
a	NULL
size	NULL
marker	NULL
(	NULL
the	NULL
C-specific	NULL
termination	NULL
reaction	NULL
is	NULL
shown	NULL
in	NULL
the	NULL
lane	NULL
on	NULL
the	NULL
right	NULL
)	NULL
.	NULL

molecular	NULL
mass	NULL
of	NULL
32	NULL
kDa	NULL
having	NULL
a	NULL
characteristic	NULL
C/EBP	NULL
-like	NULL
basic	NULL
DNA-binding	NULL
domain	NULL
and	NULL
leucine	NULL
zipper	NULL
dimerization	NULL
domain	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Sequence	NULL
analysis	NULL
using	NULL
the	NULL
BLAST	NULL
algorithm	NULL
and	NULL
the	NULL
GCG	NULL
program	NULL
(	NULL
6	NULL
,	NULL
29	NULL
)	NULL
revealed	NULL
its	NULL
significant	NULL
degree	NULL
of	NULL
homology	NULL
to	NULL
other	NULL
previously	NULL
cloned	NULL
C/EBP	NULL
proteins	NULL
,	NULL
especially	NULL
to	NULL
a	NULL
putative	NULL
product	NULL
of	NULL
the	NULL
rat	NULL
C/EBP	NULL
-like	NULL
sequence	NULL
,	NULL
CRP1	NULL
,	NULL
previously	NULL
identified	NULL
by	NULL
Williams	NULL
et	NULL
al	NULL
.	NULL

(	NULL
84	NULL
)	NULL
.	NULL

Low-stringency	NULL
hybridization	NULL
with	NULL
the	NULL
Zoo-blot	NULL
(	NULL
Clontech	NULL
)	NULL
,	NULL
representing	NULL
genomic	NULL
DNA	NULL
of	NULL
several	NULL
vertebrate	NULL
species	NULL
,	NULL
revealed	NULL
two	NULL
bands	NULL
of	NULL
5.5	NULL
and	NULL
6.3	NULL
kb	NULL
for	NULL
human	NULL
DNA	NULL
digested	NULL
with	NULL
EcoRI	NULL
and	NULL
two	NULL
bands	NULL
of	NULL
approximately	NULL
7.2	NULL
and	NULL
6	NULL
kb	NULL
in	NULL
murine	NULL
EcoRI-digested	NULL
genomic	NULL
DNA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Cloning	NULL
of	NULL
human	NULL
and	NULL
murine	NULL
genes	NULL
encoding	NULL
C/EBP-s	NULL
.	NULL

Using	NULL
human	NULL
C/EBP-g	NULL
cDNA	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
we	NULL
have	NULL
screened	NULL
human	NULL
and	NULL
murine	NULL
lambda	NULL
genomic	NULL
DNA	NULL
libraries	NULL
(	NULL
Stratagene	NULL
)	NULL
under	NULL
high-stringency	NULL
conditions	NULL
.	NULL

Positive	NULL
clones	NULL
were	NULL
plaque	NULL
purified	NULL
and	NULL
subjected	NULL
to	NULL
restriction	NULL
mapping	NULL
by	NULL
partial	NULL
digestion	NULL
(	NULL
Fig	NULL
.	NULL

ZA	NULL
)	NULL
.	NULL

An	NULL
18-kb	NULL
human	NULL
genomic	NULL
insert	NULL
and	NULL
a	NULL
13-kb	NULL
murine	NULL
genomic	NULL
fragment	NULL
were	NULL
then	NULL
subcloned	NULL
into	NULL
pTZ19R	NULL
vectors	NULL
and	NULL
partially	NULL
sequenced	NULL
.	NULL

Both	NULL
the	NULL
human	NULL
and	NULL
the	NULL
murine	NULL
genes	NULL
contained	NULL
two	NULL
exons	NULL
,	NULL
interrupted	NULL
by	NULL
a	NULL
short	NULL
intron	NULL
of	NULL
less	NULL
than	NULL
1	NULL
kb	NULL
,	NULL
and	NULL
encoded	NULL
highly	NULL
conserved	NULL
proteins	NULL
(	NULL
94.4	NULL
%	NULL
identical	NULL
and	NULL
96.8	NULL
%	NULL
homologous	NULL
)	NULL
.	NULL

Primer	NULL
extension	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
C/EBP	NULL
-£	NULL
gene	NULL
transcription	NULL
start	NULL
site	NULL
was	NULL
performed	NULL
with	NULL
an	NULL
antisense	NULL
oligonucleotide	NULL
that	NULL
bound	NULL
to	NULL
DNA	NULL
approximately	NULL
40	NULL
bp	NULL
downstream	NULL
of	NULL
the	NULL
ATG	NULL
codon	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
in	NULL
HL60	NULL
cells	NULL
,	NULL
C/EBP	NULL
-£	NULL
has	NULL
a	NULL
single	NULL
transcriptional	NULL
start	NULL
site	NULL
,	NULL
located	NULL
200	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
ATG	NULL
codon	NULL
.	NULL

No	NULL
transcripts	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
myeloid	NULL
cell	NULL
lines	NULL
KG1	NULL
and	NULL
U937	NULL
or	NULL
in	NULL
the	NULL
T-lymphoblast	NULL
CEM	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Promyelocyte-specific	NULL
expression	NULL
of	NULL
C/EBP	NULL
-e.	NULL
To	NULL
study	NULL
further	NULL
the	NULL
expression	NULL
pattern	NULL
of	NULL
the	NULL
C/EBP-£	NULL
gene	NULL
,	NULL
we	NULL
have	NULL
analyzed	NULL
RNA	NULL
from	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
lines	NULL
and	NULL
also	NULL
primary	NULL
cell	NULL
cultures	NULL
.	NULL

The	NULL
results	NULL
of	NULL
this	NULL
analysis	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
1	NULL
and	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

At	NULL
the	NULL
mRNA	NULL
level	NULL
,	NULL
the	NULL
human	NULL
C/EBP-£	NULL
gene	NULL
produced	NULL
a	NULL
single	NULL
transcript	NULL
of	NULL
approximately	NULL
1.2	NULL
to	NULL
1.3	NULL
kb	NULL
that	NULL
is	NULL
exclusively	NULL
expressed	NULL
in	NULL
cell	NULL
lines	NULL
arrested	NULL
at	NULL
or	NULL
near	NULL
the	NULL
promyelocyte	NULL
stage	NULL
of	NULL
myeloid	NULL
differentiation	NULL
(	NULL
HL60	NULL
,	NULL
Kel22	NULL
,	NULL
NB4	NULL
,	NULL
SKM1	NULL
,	NULL
and	NULL
PLB985	NULL
)	NULL
.	NULL

In	NULL
primary	NULL
cells	NULL
,	NULL
C/EBP	NULL
-£	NULL
expression	NULL
is	NULL
detectable	NULL
by	NULL
Northern	NULL
blotting	NULL
only	NULL
at	NULL
a	NULL
low	NULL
level	NULL
in	NULL
E	NULL
hC/EBP-€	NULL
(	NULL
18	NULL
kb	NULL
)	NULL
0.9kb	NULL
B	NULL
mC/EBP-e	NULL
(	NULL
13kb	NULL
)	NULL
|	NULL
99900L9D0D0DLOL0109	NULL
D00OOVDDDOUOUOUOD	NULL
we	NULL
€-200nt	NULL
/	NULL
.	NULL

unfractionated	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
and	NULL
in	NULL
fractionated	NULL
granulocytes	NULL
but	NULL
not	NULL
in	NULL
RNA	NULL
prepared	NULL
from	NULL
any	NULL
other	NULL
normal	NULL
human	NULL
tissues	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

C/EBP-s	NULL
cDNA	NULL
encodes	NULL
a	NULL
32-kDa	NULL
nuclear	NULL
phosphoprotein	NULL
.	NULL

To	NULL
obtain	NULL
antibodies	NULL
against	NULL
C/EBP	NULL
-g	NULL
,	NULL
a	NULL
fragment	NULL
representing	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
C/EBP	NULL
-g	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
GST	NULL
expression	NULL
vector	NULL
pGEXSX-1	NULL
and	NULL
the	NULL
fusion	NULL
protein	NULL
was	NULL
expressed	NULL
and	NULL
purified	NULL
in	NULL
E.	NULL
coli	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Rabbit	NULL
polyclonal	NULL
antiserum	NULL
was	NULL
prepared	NULL
,	NULL
and	NULL
its	NULL
specificity	NULL
was	NULL
tested	NULL
by	NULL
immunoprecipitation	NULL
of	NULL
the	NULL
[	NULL
°°SJmethionine-labelled	NULL
C/EBP	NULL
-£	NULL
which	NULL
had	NULL
been	NULL
produced	NULL
in	NULL
rabbit	NULL
reticulocyte	NULL
lysates	NULL
and	NULL
mixed	NULL
with	NULL
radioactively	NULL
labelled	NULL
brome	NULL
mosaic	NULL
virus	NULL
protein	NULL
controls	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Transient	NULL
transfection	NULL
of	NULL
the	NULL
full-length	NULL
C/EBP-£	NULL
cDNA	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
CMV	NULL
promoter	NULL
in	NULL
the	NULL
peDNAI	NULL
expression	NULL
vector	NULL
,	NULL
metabolic	NULL
labelling	NULL
of	NULL
transfected	NULL
cells	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
[	NULL
**S	NULL
)	NULL
methionine	NULL
and	NULL
[	NULL
°°SJcysteine	NULL
,	NULL
and	NULL
immunoprecipitation	NULL
were	NULL
done	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Transfected	NULL
cells	NULL
expressed	NULL
a	NULL
C/EBP	NULL
-g	NULL
protein	NULL
of	NULL
32	NULL
kDa	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
predicted	NULL
molecular	NULL
mass	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

To	NULL
test	NULL
the	NULL
subcellular	NULL
localization	NULL
of	NULL
the	NULL
C/EBP	NULL
-g	NULL
protein	NULL
,	NULL
Kel22	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
NOVEL	NULL
PROMYELOCYTE-SPECIFIC	NULL
C/EBP	NULL
FACTOR	NULL
-	NULL
1379	NULL
TABLE	NULL
1	NULL
.	NULL

Promyelocyte-specific	NULL
expression	NULL
of	NULL
human	NULL
C/EBP	NULL
-£	NULL
mRNA	NULL
Expression	NULL
of	NULL
C/EBP-£	NULL
mRNA	NULL
in	NULL
normal	NULL
human	NULL
tissues	NULL
``	NULL
Expression	NULL
of	NULL
C/EBP	NULL
-£	NULL
mRNA	NULL
in	NULL
human	NULL
cell	NULL
lines	NULL
``	NULL
Tissue	NULL
type	NULL
Expression	NULL
Cell	NULL
line	NULL
Cell	NULL
type	NULL
Expression	NULL
Spleen	NULL
-	NULL
WI-38	NULL
Embryonic	NULL
fibroblast	NULL
Thymus	NULL
-	NULL
Raji	NULL
Immortalized	NULL
B	NULL
cell	NULL
Prostate	NULL
-	NULL
CEM	NULL
T	NULL
lymphoblast	NULL
Testis	NULL
-	NULL
K562	NULL
Erythroleukemia	NULL
Ovary	NULL
-	NULL
HEL	NULL
Erythroleukemia	NULL
Small	NULL
intestine	NULL
-	NULL
TF-1	NULL
Myeloid	NULL
leukemia	NULL
Colon	NULL
-	NULL
Meg-01	NULL
Megakaryocyte	NULL
Peripheral	NULL
blood	NULL
leukocytes	NULL
+°	NULL
KG1	NULL
Early	NULL
myeloblast	NULL
Heart	NULL
-	NULL
ML-1	NULL
Early	NULL
myeloblast	NULL
Brain	NULL
-	NULL
HL6O	NULL
Promyelocyte	NULL
+++++	NULL
Placenta	NULL
-	NULL
NB4	NULL
Promyelocyte	NULL
+	NULL
Lung	NULL
-	NULL
THPL	NULL
Monoblast	NULL
Liver	NULL
-	NULL
U937	NULL
Myelomonocyte	NULL
Skeletal	NULL
muscle	NULL
-	NULL
Kcl22	NULL
Promyelocyte	NULL
++	NULL
Kidney	NULL
-	NULL
PLB985	NULL
Myelomonoblast	NULL
++	NULL
Pancreas	NULL
-	NULL
KU812	NULL
Mast	NULL
cell	NULL
``	NULL
Expression	NULL
of	NULL
C/EBP-£	NULL
mRNA	NULL
was	NULL
determined	NULL
by	NULL
Northern	NULL
hybridization	NULL
with	NULL
a	NULL
C/EBP	NULL
-e-specific	NULL
cDNA	NULL
probe	NULL
.	NULL

Human	NULL
multiple	NULL
tissue	NULL
Northern	NULL
blots	NULL
(	NULL
MTN	NULL
and	NULL
MTN-II	NULL
;	NULL
Clontech	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
Calif.	NULL
)	NULL
containing	NULL
2	NULL
mg	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
from	NULL
each	NULL
tissue	NULL
were	NULL
hybridized	NULL
and	NULL
washed	NULL
under	NULL
conditions	NULL
of	NULL
high	NULL
stringency	NULL
,	NULL
according	NULL
to	NULL
the	NULL
protocol	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
,	NULL
in	NULL
ExpressHyb	NULL
(	NULL
Clontech	NULL
)	NULL
hybridization	NULL
solution	NULL
.	NULL

Blots	NULL
were	NULL
exposed	NULL
for	NULL
4	NULL
to	NULL
7	NULL
days	NULL
at	NULL
-70°C	NULL
.	NULL

-	NULL
,	NULL
no	NULL
C/EBP-e	NULL
mRNA	NULL
expressed	NULL
;	NULL
+	NULL
,	NULL
C/EBP-e	NULL
mRNA	NULL
expressed	NULL
.	NULL

*	NULL
Expression	NULL
of	NULL
C/EBP	NULL
-£	NULL
mRNA	NULL
in	NULL
human	NULL
cell	NULL
lines	NULL
was	NULL
determined	NULL
by	NULL
Northern	NULL
blot	NULL
hybridization	NULL
with	NULL
20	NULL
pg	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
per	NULL
lane	NULL
.	NULL

Following	NULL
hybridization	NULL
and	NULL
washing	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
as	NULL
used	NULL
for	NULL
MTN	NULL
blots	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
exposed	NULL
for	NULL
24	NULL
h	NULL
at	NULL
-70°C	NULL
(	NULL
to	NULL
detect	NULL
C/EBP	NULL
-g	NULL
expression	NULL
in	NULL
promyelocytes	NULL
)	NULL
and	NULL
for	NULL
7	NULL
days	NULL
(	NULL
to	NULL
confirm	NULL
the	NULL
lack	NULL
of	NULL
C/EBP-£	NULL
expression	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
)	NULL
.	NULL

-	NULL
,	NULL
no	NULL
C/EBP	NULL
-£	NULL
mRNA	NULL
expression	NULL
;	NULL
+	NULL
,	NULL
weak	NULL
expression	NULL
;	NULL
++	NULL
,	NULL
somewhat	NULL
stronger	NULL
expression	NULL
;	NULL
+++++	NULL
,	NULL
very	NULL
strong	NULL
expression	NULL
.	NULL

©	NULL
Poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
derived	NULL
from	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
contains	NULL
a	NULL
2.2-	NULL
to	NULL
2.4-kb	NULL
transcript	NULL
,	NULL
which	NULL
is	NULL
detected	NULL
by	NULL
the	NULL
C/EBP	NULL
-g	NULL
probe	NULL
,	NULL
but	NULL
the	NULL
1.3-kb	NULL
transcript	NULL
is	NULL
not	NULL
detected	NULL
.	NULL

myeloblasts	NULL
which	NULL
expressed	NULL
high	NULL
levels	NULL
of	NULL
C/EBP-g	NULL
protein	NULL
were	NULL
fractionated	NULL
by	NULL
gentle	NULL
lysis	NULL
into	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
fractions	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
a	NULL
1:200	NULL
dilution	NULL
of	NULL
rabbit	NULL
polyclonal	NULL
anti-C/EBP	NULL
-£	NULL
antiserum	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

All	NULL
detectable	NULL
C/EBP	NULL
-£	NULL
protein	NULL
was	NULL
found	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
the	NULL
murine	NULL
and	NULL
human	NULL
C/EBP	NULL
-£	NULL
genes	NULL
predicted	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
conserved	NULL
site	NULL
for	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
(	NULL
MAP	NULL
)	NULL
kinase	NULL
at	NULL
positions	NULL
41	NULL
to	NULL
44	NULL
(	NULL
PGTP	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
C/EBP	NULL
-g	NULL
can	NULL
be	NULL
phosphorylated	NULL
.	NULL

Phosphorylation	NULL
is	NULL
an	NULL
important	NULL
mechanism	NULL
for	NULL
regulating	NULL
functional	NULL
properties	NULL
of	NULL
NF-IL6	NULL
,	NULL
but	NULL
not	NULL
those	NULL
of	NULL
C/EBP	NULL
-	NULL
«	NULL
(	NULL
41	NULL
,	NULL
45	NULL
,	NULL
54	NULL
,	NULL
55	NULL
,	NULL
80	NULL
)	NULL
.	NULL

Our	NULL
preliminary	NULL
experiments	NULL
suggest	NULL
that	NULL
at	NULL
least	NULL
in	NULL
Kel22	NULL
H	NULL
oo	NULL
Z	NULL
o	NULL
o	NULL
b	NULL
o	NULL
Hom	NULL
N	NULL
A	NULL
M	NULL
®	NULL
3	NULL
©	NULL
Ad	NULL
d	NULL
Gr	NULL
H	NULL
G	NULL
st	NULL
Aim	NULL
-A	NULL
c	NULL
E	NULL
H	NULL
RW	NULL
A	NULL
m	NULL
0	NULL
0	NULL
A	NULL
9	NULL
M	NULL
#	NULL
®	NULL
0	NULL
D	NULL
2	NULL
&	NULL
0	NULL
M	NULL
t	NULL
B	NULL
R	NULL
M	NULL
Z	NULL
f	NULL
2	NULL
BD	NULL
MoM	NULL
hrd	NULL
ary	NULL
w	NULL
#	NULL
®	NULL
#	NULL
:	NULL
*	NULL
*	NULL
w	NULL
W	NULL
|	NULL
<	NULL
-CEBP	NULL
:	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Expression	NULL
of	NULL
C/EBP-s£	NULL
RNA	NULL
in	NULL
human	NULL
cell	NULL
lines	NULL
of	NULL
various	NULL
origins	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
20	NULL
ug	NULL
per	NULL
lane	NULL
)	NULL
was	NULL
separated	NULL
on	NULL
a	NULL
1.25	NULL
%	NULL
agarose	NULL
gel	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
formaldehyde	NULL
and	NULL
subjected	NULL
to	NULL
Northern	NULL
blotting	NULL
(	NULL
51	NULL
)	NULL
(	NULL
see	NULL
footnotes	NULL
to	NULL
Table	NULL
1	NULL
for	NULL
details	NULL
)	NULL
.	NULL

C/EBP	NULL
-£	NULL
expression	NULL
was	NULL
found	NULL
to	NULL
be	NULL
maximal	NULL
in	NULL
HL6O	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
of	NULL
Northern	NULL
blotting	NULL
of	NULL
the	NULL
RNA	NULL
preparations	NULL
are	NULL
shown	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
,	NULL
and	NULL
ethidium	NULL
bromide	NULL
(	NULL
EtBr	NULL
)	NULL
staining	NULL
of	NULL
the	NULL
preparations	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
confirms	NULL
approximately	NULL
equal	NULL
loading	NULL
of	NULL
RNA	NULL
in	NULL
all	NULL
lanes	NULL
.	NULL

cells	NULL
,	NULL
C/EBP	NULL
-£	NULL
exists	NULL
as	NULL
a	NULL
nuclear	NULL
phosphoprotein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
must	NULL
be	NULL
performed	NULL
to	NULL
address	NULL
the	NULL
importance	NULL
of	NULL
phosphorylation	NULL
for	NULL
the	NULL
functional	NULL
properties	NULL
of	NULL
C/EBP	NULL
-e.	NULL
In	NULL
myeloid	NULL
cells	NULL
,	NULL
differentiation	NULL
frequently	NULL
produces	NULL
mature	NULL
cells	NULL
with	NULL
very	NULL
limited	NULL
life	NULL
spans	NULL
;	NULL
for	NULL
example	NULL
,	NULL
normal	NULL
granu-locytes	NULL
,	NULL
which	NULL
exhibit	NULL
endogenous	NULL
C/EBP	NULL
-£	NULL
expression	NULL
,	NULL
have	NULL
a	NULL
half-life	NULL
of	NULL
only	NULL
6	NULL
h.	NULL
The	NULL
cDNA	NULL
sequence	NULL
of	NULL
C/EBP	NULL
-£	NULL
does	NULL
not	NULL
contain	NULL
any	NULL
sequences	NULL
implicated	NULL
in	NULL
mRNA	NULL
instability	NULL
,	NULL
and	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
the	NULL
half-life	NULL
of	NULL
the	NULL
C/EBP	NULL
-£	NULL
protein	NULL
is	NULL
short	NULL
,	NULL
between	NULL
1	NULL
and	NULL
1.5	NULL
h.	NULL
The	NULL
human	NULL
myeloid-cell-specific	NULL
C/EBP-£	NULL
protein	NULL
shares	NULL
a	NULL
DNA-binding	NULL
motif	NULL
with	NULL
other	NULL
C/EBP	NULL
proteins	NULL
.	NULL

We	NULL
were	NULL
interested	NULL
to	NULL
know	NULL
if	NULL
the	NULL
myeloid-cell-specific	NULL
member	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
of	NULL
transcriptional	NULL
regulators	NULL
had	NULL
DNA-binding	NULL
properties	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
other	NULL
known	NULL
homologs	NULL
.	NULL

Previous	NULL
experiments	NULL
have	NULL
not	NULL
demonstrated	NULL
a	NULL
clear	NULL
distinction	NULL
between	NULL
the	NULL
DNA-binding	NULL
preferences	NULL
of	NULL
various	NULL
members	NULL
of	NULL
this	NULL
family	NULL
.	NULL

In	NULL
vitro	NULL
,	NULL
all	NULL
known	NULL
C/EBP	NULL
proteins	NULL
exhibit	NULL
high	NULL
affinity	NULL
for	NULL
the	NULL
oligonucleotide	NULL
containing	NULL
an	NULL
optimal	NULL
C/EBP	NULL
sequence	NULL
(	NULL
73	NULL
,	NULL
83	NULL
)	NULL
.	NULL

We	NULL
have	NULL
studied	NULL
the	NULL
interaction	NULL
of	NULL
C/EBP	NULL
-£	NULL
with	NULL
this	NULL
palindromic	NULL
motif	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
number	NULL
of	NULL
other	NULL
sites	NULL
that	NULL
can	NULL
bind	NULL
C/EBP	NULL
and	NULL
C/EBP	NULL
-B	NULL
in	NULL
gel	NULL
retardation	NULL
(	NULL
EMSA	NULL
)	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

The	NULL
C/EBP	NULL
-£	NULL
was	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
consensus	NULL
CCAAT	NULL
palindromic	NULL
site	NULL
,	NULL
as	NULL
seen	NULL
in	NULL
lane	NULL
2	NULL
.	NULL

This	NULL
binding	NULL
was	NULL
abolished	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
10-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabelled	NULL
self	NULL
probe	NULL
but	NULL
not	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
10-fold	NULL
molar	NULL
excess	NULL
of	NULL
mutated	NULL
double-stranded	NULL
oligonucleotide	NULL
in	NULL
which	NULL
the	NULL
CCAAT	NULL
box	NULL
was	NULL
destroyed	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
anti-C/EBP-£	NULL
antibody	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
caused	NULL
a	NULL
su-pershift	NULL
of	NULL
the	NULL
specific	NULL
C/EBP-DNA	NULL
complex	NULL
,	NULL
while	NULL
addition	NULL
of	NULL
preimmune	NULL
rabbit	NULL
antiserum	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
detect	NULL
C/EBP	NULL
DNA	NULL
binding	NULL
in	NULL
myeloid	NULL
cell	NULL
lysates	NULL
,	NULL
we	NULL
used	NULL
consensus	NULL
C/EBP-binding	NULL
sites	NULL
,	NULL
as	NULL
well	NULL
as	NULL
CCAAT	NULL
box-containing	NULL
oligonucleotides	NULL
derived	NULL
from	NULL
the	NULL
M-CSF	NULL
receptor	NULL
promoter	NULL
(	NULL
89	NULL
)	NULL
.	NULL

The	NULL
NB4	NULL
cell	NULL
line	NULL
was	NULL
chosen	NULL
as	NULL
1380	NULL
CHUMAKOV	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
B	NULL
C	NULL
Immunoprecipitation	NULL
Western	NULL
C/EBP-E	NULL
C/EBPAS	NULL
MW	NULL
C_	NULL
N	NULL
Gens	NULL
.	NULL

€	NULL
43kD	NULL
--	NULL
0M	NULL
€	NULL
Actin	NULL
antiC/EBP-£	NULL
preimmune	NULL
-p	NULL
'	NULL
WAP	NULL
<	NULL
29kD	NULL
.	NULL

(	NULL
c/EBP—e	NULL
_	NULL
Pe	NULL
*	NULL
&	NULL
C/EBP-E-JP	NULL
»	NULL
KKB	NULL
<	NULL
14	NULL
.	NULL

3k0	NULL
1	NULL
2	NULL
3	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Specificity	NULL
of	NULL
anti-C/EBP-£	NULL
antiserum	NULL
.	NULL

Antiserum	NULL
raised	NULL
against	NULL
the	NULL
bacterially	NULL
expressed	NULL
GST-C/EBP	NULL
-£	NULL
fusion	NULL
protein	NULL
was	NULL
tested	NULL
by	NULL
immunoprecipitation	NULL
of	NULL
in	NULL
vitro-translated	NULL
[	NULL
*°S	NULL
)	NULL
methionine-labelled	NULL
C/EBP	NULL
-£	NULL
protein	NULL
.	NULL

Twenty	NULL
microliters	NULL
of	NULL
C/EBP	NULL
-£	NULL
RNA-programmed	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
was	NULL
mixed	NULL
with	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
reticulocyte	NULL
lysate	NULL
programmed	NULL
with	NULL
the	NULL
control	NULL
brome	NULL
mosaic	NULL
virus	NULL
RNA	NULL
,	NULL
diluted	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
PBSTDS	NULL
solution	NULL
(	NULL
10	NULL
mM	NULL
dibasic	NULL
sodium	NULL
phosphate	NULL
[	NULL
pH	NULL
7.2	NULL
]	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
0.5	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
,	NULL
0.1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
,	NULL
0.2	NULL
%	NULL
sodium	NULL
azide	NULL
,	NULL
0.004	NULL
%	NULL
sodium	NULL
fluoride	NULL
)	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
for	NULL
details	NULL
)	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
an	NULL
aliquot	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
of	NULL
anti-C/EBP-£	NULL
antiserum	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
preimmune	NULL
serum	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Following	NULL
SDS-12	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
the	NULL
gel	NULL
was	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
X-ray	NULL
film	NULL
overnight	NULL
to	NULL
detect	NULL
radiolabelled	NULL
C/EBP	NULL
-g.	NULL
(	NULL
B	NULL
)	NULL
Expression	NULL
of	NULL
the	NULL
32-kDa	NULL
C/EBP	NULL
-£	NULL
protein	NULL
in	NULL
transfected	NULL
COS-1	NULL
cells	NULL
.	NULL

COS-1	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
10	NULL
g	NULL
of	NULL
an	NULL
expression	NULL
plasmid	NULL
(	NULL
1.2-kb	NULL
C/EBP	NULL
-e	NULL
cDNA	NULL
cloned	NULL
into	NULL
the	NULL
CMV	NULL
promoter-containing	NULL
peDNAI	NULL
vector	NULL
(	NULL
Invitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
)	NULL
in	NULL
the	NULL
sense	NULL
(	NULL
C/EBP	NULL
-£	NULL
)	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
antisense	NULL
(	NULL
C/EBPAS	NULL
)	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
orientation	NULL
.	NULL

At	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
proteins	NULL
were	NULL
labelled	NULL
in	NULL
vivo	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
Ci	NULL
of	NULL
[	NULL
*S	NULL
methionine-	NULL
[	NULL
**	NULL
$	NULL
cysteine	NULL
labelling	NULL
mix	NULL
(	NULL
ICN	NULL
Corp.	NULL
)	NULL
per	NULL
ml	NULL
,	NULL
lysed	NULL
,	NULL
and	NULL
immunoprecipitated	NULL
in	NULL
PBSTDS	NULL
solution	NULL
with	NULL
rabbit	NULL
anti-C/EBP	NULL
-£	NULL
antiserum	NULL
.	NULL

Immunoprecipitated	NULL
proteins	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-12.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
and	NULL
autoradiography	NULL
.	NULL

Protein	NULL
molecular	NULL
mass	NULL
markers	NULL
(	NULL
MW	NULL
,	NULL
in	NULL
kilodaltons	NULL
)	NULL
are	NULL
shown	NULL
in	NULL
the	NULL
far-right	NULL
lane	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
subcellular	NULL
localization	NULL
of	NULL
C/EBP	NULL
-£	NULL
protein	NULL
in	NULL
Kel22	NULL
late	NULL
myeloblast	NULL
cells	NULL
.	NULL

Thirty-microgram	NULL
samples	NULL
of	NULL
nuclear	NULL
(	NULL
N	NULL
)	NULL
and	NULL
cytoplasmic	NULL
(	NULL
C	NULL
)	NULL
extracts	NULL
of	NULL
Kel22	NULL
cells	NULL
were	NULL
separated	NULL
by	NULL
SDS-12.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
and	NULL
transferred	NULL
onto	NULL
an	NULL
Immobilon-P	NULL
membrane	NULL
.	NULL

The	NULL
32-kDa	NULL
C/EBP	NULL
-£	NULL
protein	NULL
(	NULL
indicated	NULL
in	NULL
lane	NULL
2	NULL
by	NULL
the	NULL
larger	NULL
arrow	NULL
)	NULL
was	NULL
detected	NULL
by	NULL
using	NULL
an	NULL
ECL	NULL
kit	NULL
(	NULL
Amersham	NULL
)	NULL
following	NULL
incubation	NULL
of	NULL
the	NULL
blot	NULL
with	NULL
rabbit	NULL
anti-C/EBP-£	NULL
specific	NULL
antibody	NULL
(	NULL
18	NULL
pg/m1	NULL
)	NULL
.	NULL

the	NULL
source	NULL
of	NULL
the	NULL
nuclear	NULL
extract	NULL
,	NULL
since	NULL
these	NULL
cells	NULL
express	NULL
C/EBP	NULL
-£	NULL
but	NULL
not	NULL
any	NULL
other	NULL
C/EBP	NULL
-related	NULL
proteins	NULL
(	NULL
unpub-	NULL
moter	NULL
interacted	NULL
specifically	NULL
with	NULL
C/EBP	NULL
-g	NULL
derived	NULL
from	NULL
NB4	NULL
cells	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
11	NULL
)	NULL
,	NULL
although	NULL
complexes	NULL
were	NULL
visible	NULL
only	NULL
in	NULL
lished	NULL
data	NULL
)	NULL
and	NULL
thus	NULL
results	NULL
are	NULL
easier	NULL
to	NULL
interpret	NULL
.	NULL

In	NULL
NB4	NULL
cell	NULL
lysates	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
detect	NULL
effective	NULL
binding	NULL
of	NULL
C/EBP	NULL
-£	NULL
to	NULL
the	NULL
consensus	NULL
motif	NULL
either	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
anti-C/EBP-£	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
C/EBP-binding	NULL
site	NULL
derived	NULL
from	NULL
the	NULL
M-CSF	NULL
receptor	NULL
pro	NULL
0	NULL
lhr	NULL
2hr	NULL
3hr	NULL
4hr	NULL
Shr	NULL
6hr	NULL
yaap	NULL
:	NULL
seme	NULL
oe	NULL
eep	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

The	NULL
C/EBP	NULL
-s	NULL
protein	NULL
has	NULL
a	NULL
half-life	NULL
of	NULL
approximately	NULL
1.5	NULL
h	NULL
in	NULL
vivo	NULL
.	NULL

C/EBP	NULL
-g-expressing	NULL
Kel22	NULL
cells	NULL
were	NULL
pulse-labelled	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
[	NULL
**SJme-thionine-	NULL
[	NULL
*	NULL
``	NULL
$	NULL
Jcysteine	NULL
labelling	NULL
mix	NULL
(	NULL
ICN	NULL
Corp.	NULL
)	NULL
and	NULL
then	NULL
incubated	NULL
in	NULL
a	NULL
complete	NULL
medium	NULL
for	NULL
a	NULL
period	NULL
of	NULL
up	NULL
to	NULL
6	NULL
h.	NULL
Aliquots	NULL
were	NULL
taken	NULL
at	NULL
the	NULL
end	NULL
of	NULL
each	NULL
hour	NULL
,	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
C/EBP	NULL
-s	NULL
protein	NULL
was	NULL
determined	NULL
by	NULL
immunoprecipitation	NULL
with	NULL
specific	NULL
antibodies	NULL
.	NULL

The	NULL
intensities	NULL
of	NULL
the	NULL
C/EBP-e-specific	NULL
bands	NULL
were	NULL
compared	NULL
with	NULL
that	NULL
at	NULL
the	NULL
zero	NULL
time	NULL
point	NULL
by	NULL
densitometry	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
half-life	NULL
of	NULL
the	NULL
C/EBP	NULL
-g	NULL
protein	NULL
was	NULL
determined	NULL
to	NULL
be	NULL
approximately	NULL
1.5	NULL
h.	NULL
the	NULL
presence	NULL
of	NULL
anti-C/EBP-£	NULL
antibodies	NULL
.	NULL

Oligonucleotides	NULL
containing	NULL
a	NULL
mutated	NULL
M-CSF	NULL
receptor	NULL
CCAAT	NULL
site	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
and	NULL
control	NULL
preimmune	NULL
antiserum	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
did	NULL
not	NULL
produce	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
was	NULL
specific	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
lack	NULL
of	NULL
disruption	NULL
of	NULL
the	NULL
complex	NULL
by	NULL
addition	NULL
of	NULL
a	NULL
10-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
self	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutated	NULL
CCAAT	NULL
binding	NULL
site	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

The	NULL
mobility	NULL
of	NULL
DNA-protein	NULL
complexes	NULL
containing	NULL
C/EBP	NULL
-£	NULL
derived	NULL
from	NULL
NB4	NULL
cells	NULL
is	NULL
different	NULL
from	NULL
that	NULL
of	NULL
complexes	NULL
formed	NULL
by	NULL
in	NULL
vitro-translated	NULL
C/EBP	NULL
-g.	NULL
Our	NULL
preliminary	NULL
results	NULL
indicate	NULL
that	NULL
unlike	NULL
other	NULL
C/EBP	NULL
proteins	NULL
,	NULL
C/EBP	NULL
-£	NULL
is	NULL
very	NULL
inefficient	NULL
at	NULL
forming	NULL
homodimers	NULL
and	NULL
heterodimers	NULL
with	NULL
other	NULL
C/EBP	NULL
-like	NULL
proteins	NULL
in	NULL
vivo	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

An	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
AML-1	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
M-CSF	NULL
receptor	NULL
promoter	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
nearby	NULL
C/EBP	NULL
binding	NULL
site	NULL
was	NULL
able	NULL
to	NULL
form	NULL
a	NULL
C/EBP-g-specific	NULL
complex	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-C/	NULL
EBP	NULL
-g	NULL
(	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
the	NULL
C/EBP	NULL
-binding	NULL
site	NULL
found	NULL
in	NULL
the	NULL
NF-IL6	NULL
promoter	NULL
(	NULL
positions	NULL
163	NULL
to	NULL
139	NULL
)	NULL
was	NULL
able	NULL
to	NULL
bind	NULL
C/EBP	NULL
-£	NULL
(	NULL
lanes	NULL
12	NULL
and	NULL
13	NULL
)	NULL
.	NULL

C/EBP	NULL
-s	NULL
activates	NULL
transcription	NULL
from	NULL
the	NULL
myeloid-cell-specific	NULL
mim-1	NULL
hMPO	NULL
promoter	NULL
and	NULL
shows	NULL
no	NULL
cooperation	NULL
with	NULL
c-Myb	NULL
.	NULL

In	NULL
the	NULL
avian	NULL
system	NULL
,	NULL
c-mim	NULL
and	NULL
c-MGF	NULL
promoters	NULL
were	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
UIO	NULL
4	NULL
)	NULL
``	NULL
EE	NULL
wa'ﬂws	NULL
0	NULL
|	NULL
-	NULL
o	NULL
§	NULL
H	NULL
A_	NULL
U	NULL
=	NULL
=	NULL
4	NULL
M	NULL
-d	NULL
HoH	NULL
8	NULL
MoH	NULL
-~	NULL
0	NULL
-	NULL
g	NULL
o	NULL
o	NULL
90	NULL
UV	NULL
@	NULL
A	NULL
aA	NULL
wen	NULL
J	NULL
>	NULL
€	NULL
&	NULL
EBP-¢	NULL
+	NULL
6	NULL
C/	NULL
€	NULL
»	NULL
WBM	NULL
<	NULL
c/rBPp-s	NULL
&	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
analysis	NULL
of	NULL
binding	NULL
of	NULL
the	NULL
C/EBP	NULL
-£	NULL
protein	NULL
to	NULL
a	NULL
high-affinity	NULL
C/EBP-binding	NULL
site	NULL
.	NULL

The	NULL
C/EBP	NULL
consensus	NULL
oligonucleotide	NULL
probe	NULL
was	NULL
mixed	NULL
with	NULL
in	NULL
vitro-expressed	NULL
recombinant	NULL
C/EBP	NULL
-e	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
programmed	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
added	NULL
(	NULL
3	NULL
pl	NULL
)	NULL
was	NULL
identical	NULL
in	NULL
all	NULL
lanes	NULL
,	NULL
except	NULL
that	NULL
lane	NULL
1	NULL
contained	NULL
control	NULL
lysate	NULL
lacking	NULL
C/EBP-g	NULL
.	NULL

The	NULL
protein	NULL
was	NULL
used	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
anti-C/EBP-£	NULL
antibody	NULL
(	NULL
1	NULL
pl	NULL
)	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Approximately	NULL
1	NULL
ng	NULL
of	NULL
radiolabelled	NULL
double-stranded	NULL
oligonucleotide	NULL
was	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
programmed	NULL
lysate	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
pg	NULL
of	NULL
sonicated	NULL
salmon	NULL
sperm	NULL
DNA	NULL
.	NULL

Protein-DNA	NULL
complexes	NULL
were	NULL
resolved	NULL
by	NULL
4.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
in	NULL
0.5	NULL
%	NULL
Tris-borate-EDTA	NULL
buffer	NULL
at	NULL
190	NULL
V.	NULL
NOVEL	NULL
PROMYELOCYTE-SPECIFIC	NULL
C/EBP	NULL
FACTOR	NULL
-	NULL
1381	NULL
very	NULL
helpful	NULL
in	NULL
identification	NULL
of	NULL
the	NULL
promyelocyte-specific	NULL
NF-M	NULL
activity	NULL
and	NULL
eventual	NULL
cloning	NULL
of	NULL
c-NFM	NULL
(	NULL
a	NULL
C/EBP-B	NULL
homolog	NULL
)	NULL
(	NULL
41	NULL
)	NULL
.	NULL

The	NULL
e-mim	NULL
promoter	NULL
has	NULL
been	NULL
found	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
c-Myb	NULL
and	NULL
C/EBP	NULL
-like	NULL
proteins	NULL
and	NULL
to	NULL
be	NULL
functional	NULL
exclusively	NULL
in	NULL
promyelocytes	NULL
(	NULL
59	NULL
)	NULL
.	NULL

Our	NULL
preliminary	NULL
studies	NULL
indicated	NULL
that	NULL
in	NULL
human	NULL
cells	NULL
in	NULL
transient	NULL
transfection	NULL
experiments	NULL
,	NULL
the	NULL
c-nim	NULL
promoter	NULL
is	NULL
also	NULL
active	NULL
in	NULL
HL60	NULL
promyelocyte	NULL
cells	NULL
but	NULL
is	NULL
inactive	NULL
in	NULL
the	NULL
very	NULL
early	NULL
myeloblast-like	NULL
KG1	NULL
and	NULL
monocytic	NULL
U937	NULL
cells	NULL
.	NULL

In	NULL
transient	NULL
tranfection	NULL
experiments	NULL
in	NULL
C/EBP	NULL
HL6O0	NULL
cells	NULL
,	NULL
the	NULL
c-mim	NULL
promoter	NULL
provides	NULL
enough	NULL
background	NULL
to	NULL
study	NULL
the	NULL
effect	NULL
of	NULL
both	NULL
increased	NULL
and	NULL
decreased	NULL
expression	NULL
of	NULL
C/EBP	NULL
-£	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
the	NULL
mirm-CAT	NULL
reporter	NULL
construct	NULL
and	NULL
the	NULL
CMV	NULL
promoter-driven	NULL
C/EBP	NULL
-g	NULL
expression	NULL
plasmid	NULL
results	NULL
in	NULL
an	NULL
approximately	NULL
3.5-fold	NULL
upregulation	NULL
of	NULL
the	NULL
min	NULL
promoter	NULL
activity	NULL
,	NULL
while	NULL
the	NULL
antisense	NULL
C/EBP-£	NULL
construct	NULL
decreased	NULL
the	NULL
background	NULL
activity	NULL
of	NULL
the	NULL
mim	NULL
promoter	NULL
approximately	NULL
S-fold	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
cotransfected	NULL
c-Myb	NULL
expression	NULL
vector	NULL
alone	NULL
,	NULL
mim	NULL
promoter	NULL
activity	NULL
increased	NULL
approximately	NULL
4.3-fold	NULL
over	NULL
the	NULL
background	NULL
activity	NULL
while	NULL
the	NULL
cotransfected	NULL
dominant-negative	NULL
mutant	NULL
of	NULL
c-Myb	NULL
caused	NULL
a	NULL
3-fold	NULL
decrease	NULL
in	NULL
promoter	NULL
activity	NULL
.	NULL

Cotransfection	NULL
of	NULL
c-Myb	NULL
and	NULL
C/EBP	NULL
-£	NULL
expression	NULL
plasmids	NULL
did	NULL
not	NULL
cause	NULL
further	NULL
upregulation	NULL
of	NULL
the	NULL
mim	NULL
promoter	NULL
,	NULL
indicating	NULL
either	NULL
a	NULL
lack	NULL
of	NULL
cooperation	NULL
between	NULL
these	NULL
transcription	NULL
factors	NULL
or	NULL
perhaps	NULL
the	NULL
presence	NULL
of	NULL
some	NULL
other	NULL
limiting	NULL
factor	NULL
.	NULL

In	NULL
our	NULL
prior	NULL
studies	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
a	NULL
number	NULL
of	NULL
potential	NULL
binding	NULL
sites	NULL
for	NULL
members	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
upstream	NULL
of	NULL
the	NULL
hMPO	NULL
promoter	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Since	NULL
MPO	NULL
mRNA	NULL
expression	NULL
is	NULL
maximal	NULL
in	NULL
myeloid	NULL
cells	NULL
at	NULL
the	NULL
promyelocyte	NULL
stage	NULL
,	NULL
which	NULL
is	NULL
when	NULL
C/EBP	NULL
-£	NULL
is	NULL
also	NULL
expressed	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
C/EBP-g	NULL
to	NULL
transactivate	NULL
the	NULL
hMPO	NULL
promoter	NULL
in	NULL
CEM	NULL
T-lymphoblastic	NULL
cells	NULL
,	NULL
which	NULL
normally	NULL
lack	NULL
endogenous	NULL
C/EBP	NULL
-g	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

The	NULL
C/EBP	NULL
-£	NULL
expression	NULL
plasmid	NULL
caused	NULL
an	NULL
average	NULL
5.2-fold	NULL
upregulation	NULL
of	NULL
the	NULL
hMPO	NULL
promoter	NULL
,	NULL
while	NULL
no	NULL
change	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
C/EBP-e	NULL
antisense	NULL
expression	NULL
plasmid	NULL
.	NULL

Transfection	NULL
of	NULL
the	NULL
c-Myb	NULL
expression	NULL
vector	NULL
caused	NULL
a	NULL
sixfold	NULL
activation	NULL
of	NULL
the	NULL
hMPO	NULL
promoter	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
potential	NULL
Myb-binding	NULL
sites	NULL
upstream	NULL
of	NULL
the	NULL
MPO	NULL
RNA	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

The	NULL
role	NULL
of	NULL
endogenous	NULL
Myb	NULL
proteins	NULL
in	NULL
regulation	NULL
of	NULL
the	NULL
hMPO	NULL
The	NULL
arrows	NULL
indicate	NULL
the	NULL
position	NULL
of	NULL
a	NULL
single	NULL
major	NULL
C/EBP-s-DNA	NULL
complex	NULL
and	NULL
the	NULL
same	NULL
complex	NULL
supershifted	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-C/EBP-£	NULL
antibody	NULL
(	NULL
AB	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
binding	NULL
is	NULL
demonstrated	NULL
by	NULL
complete	NULL
inhibition	NULL
of	NULL
C/EBP-s-DNA	NULL
complex	NULL
formation	NULL
by	NULL
addition	NULL
of	NULL
a	NULL
10-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabelled	NULL
probe	NULL
(	NULL
``	NULL
self	NULL
``	NULL
)	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
and	NULL
by	NULL
the	NULL
lack	NULL
of	NULL
inhibition	NULL
of	NULL
the	NULL
C/EBP	NULL
-e-specific	NULL
band	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
10-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabelled	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutated	NULL
C/EBP-binding	NULL
motif	NULL
(	NULL
``	NULL
mutant	NULL
``	NULL
)	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
for	NULL
details	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
of	NULL
C/EBP	NULL
-e	NULL
derived	NULL
from	NULL
nuclear	NULL
extracts	NULL
of	NULL
NB4	NULL
cells	NULL
.	NULL

Gel	NULL
retardation	NULL
experiments	NULL
were	NULL
done	NULL
with	NULL
NB4	NULL
cell	NULL
nuclear	NULL
extracts	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
13	NULL
)	NULL
.	NULL

Consensus	NULL
CCAAT	NULL
box-containing	NULL
oligonucleotides	NULL
were	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
anti-C/EBP-£	NULL
antibodies	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Oligonucleotide	NULL
containing	NULL
the	NULL
C/EBP-binding	NULL
site	NULL
found	NULL
in	NULL
the	NULL
M-CSF	NULL
receptor	NULL
promoter	NULL
(	NULL
89	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
either	NULL
alone	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
in	NULL
combination	NULL
with	NULL
anti-C/EBP	NULL
-£	NULL
antibodies	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
or	NULL
with	NULL
control	NULL
preimmune	NULL
antibodies	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Specificity	NULL
of	NULL
binding	NULL
was	NULL
also	NULL
demonstrated	NULL
by	NULL
the	NULL
lack	NULL
of	NULL
C/EBP-z-containing	NULL
complexes	NULL
when	NULL
a	NULL
mutant	NULL
C/EBP	NULL
site	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-C/EBP-£	NULL
antibody	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

The	NULL
C/EBP-e-specific	NULL
band	NULL
(	NULL
right	NULL
arrow	NULL
)	NULL
was	NULL
suppressed	NULL
by	NULL
addition	NULL
of	NULL
a	NULL
10-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabelled	NULL
self	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
but	NULL
not	NULL
by	NULL
addition	NULL
of	NULL
the	NULL
unlabelled	NULL
mutated	NULL
C/EBP	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

The	NULL
larger	NULL
probe	NULL
,	NULL
containing	NULL
the	NULL
site	NULL
for	NULL
AML-1	NULL
as	NULL
well	NULL
as	NULL
the	NULL
CCAAT	NULL
site	NULL
,	NULL
derived	NULL
from	NULL
the	NULL
M-CSF	NULL
receptor	NULL
promoter	NULL
(	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
)	NULL
,	NULL
also	NULL
produced	NULL
a	NULL
C/EBP-e-specific	NULL
band	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
specific	NULL
antibody	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
.	NULL

The	NULL
C/EBP-binding	NULL
site	NULL
found	NULL
in	NULL
the	NULL
NF-IL6	NULL
promoter	NULL
(	NULL
positions	NULL
-163	NULL
to	NULL
-139	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
anti-C/EBP-£	NULL
antibody	NULL
(	NULL
lanes	NULL
12	NULL
and	NULL
13	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

The	NULL
left	NULL
arrow	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
the	NULL
DNA-protein	NULL
complex	NULL
containing	NULL
in	NULL
vitro-expressed	NULL
recombinant	NULL
C/EBP	NULL
-g	NULL
,	NULL
used	NULL
as	NULL
a	NULL
control	NULL
in	NULL
lane	NULL
1	NULL
.	NULL

1382	NULL
CHUMAKOV	NULL
ET	NULL
AL	NULL
.	NULL

n	NULL
w	NULL
w	NULL
®	NULL
®	NULL
o	NULL
o	NULL
lal	NULL
bl	NULL
®	NULL
HA	NULL
o	NULL
n	NULL
o	NULL
A	NULL
a	NULL
a	NULL
g	NULL
a	NULL
og	NULL
a	NULL
s	NULL
&	NULL
5	NULL
o	NULL
H	NULL
4	NULL
#	NULL
bal	NULL
4	NULL
4	NULL
hal	NULL
hal	NULL
4	NULL
+4	NULL
o	NULL
w	NULL
bu	NULL
o	NULL
o	NULL
&	NULL
®	NULL
®	NULL
o	NULL
w	NULL
)	NULL
lal	NULL
lal	NULL
®	NULL
o	NULL
Ll	NULL
al	NULL
o	NULL
<	NULL
o	NULL
Lal	NULL
bl	NULL
o	NULL
©0	NULL
s	NULL
a	NULL
oa	NULL
»	NULL
0	NULL
s	NULL
a	NULL
0	NULL
»	NULL
<	NULL
€	NULL
b	NULL
®	NULL
@	NULL
%	NULL
0	NULL
o	NULL
@	NULL
0	NULL
¢	NULL
@	NULL
@	NULL
eo	NULL
e	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
B	NULL
9	NULL
10	NULL
11	NULL
;	NULL
2	NULL
CMV	NULL
Expression	NULL
[	NULL
=	NULL
]	NULL
Vector	NULL
#	NULL
4	NULL
4	NULL
a	NULL
£	NULL
®	NULL
é	NULL
5	NULL
%	NULL
o	NULL
%	NULL
Ao	NULL
A	NULL
soz	NULL
i	NULL
g	NULL
|	NULL
$	NULL
|-	NULL
80	NULL
m	NULL
E	NULL
R	NULL
8	NULL
£	NULL
f	NULL
&	NULL
f	NULL
8	NULL
|	NULL
9	NULL
_p	NULL
0	NULL
&	NULL
%	NULL
#	NULL
m_	NULL
_u	NULL
U|	NULL
pMimCAT	NULL
bd	NULL
w	NULL
Pu	NULL
w	NULL
0	NULL
Ll	NULL
~	NULL
BJ	NULL
lal	NULL
o	NULL
bl	NULL
o	NULL
*	NULL
B	NULL
g	NULL
-	NULL
g	NULL
°	NULL
g	NULL
40	NULL
g	NULL
$	NULL
g	NULL
2	NULL
#	NULL
bal	NULL
#	NULL
bal	NULL
pal	NULL
+4	NULL
+4	NULL
w	NULL
o	NULL
bJ	NULL
L	NULL
~	NULL
0	NULL
=	NULL
]	NULL
[	NULL
al	NULL
lal	NULL
o	NULL
a	NULL
w	NULL
a	NULL
a	NULL
r	NULL
s	NULL
es	NULL
6	NULL
6	NULL
~	NULL
@	NULL
e	NULL
@	NULL
cEBPeAs	NULL
*	NULL
‘	NULL
©	NULL
*	NULL
~	NULL
C00	NULL
°	NULL
@	NULL
6	NULL
@	NULL
©	NULL
cmy	NULL
E	NULL
ion	NULL
&	NULL
&	NULL
a	NULL
cater	NULL
O00	NULL
:	NULL
§	NULL
50	NULL
Bo	NULL
$	NULL
0	NULL
f	NULL
2	NULL
Vector	NULL
0	NULL
5	NULL
]	NULL
£	NULL
g	NULL
2	NULL
|	NULL
1	NULL
p3	NULL
.	NULL

8MPO	NULL
pCATB	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Ability	NULL
of	NULL
human	NULL
C/EBP-e	NULL
to	NULL
activate	NULL
myeloid-cell-specific	NULL
promot-ers	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Relative	NULL
CAT	NULL
activities	NULL
detected	NULL
48	NULL
h	NULL
after	NULL
transient	NULL
transfection	NULL
of	NULL
the	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
containing	NULL
the	NULL
mim-1	NULL
promoter	NULL
in	NULL
HL60	NULL
cells	NULL
.	NULL

The	NULL
background	NULL
activity	NULL
of	NULL
the	NULL
pMimCAT	NULL
reporter	NULL
vector	NULL
was	NULL
taken	NULL
as	NULL
1.0	NULL
in	NULL
each	NULL
experiment	NULL
.	NULL

Relative	NULL
CAT	NULL
activities	NULL
from	NULL
three	NULL
independent	NULL
transient	NULL
transfection	NULL
experiments	NULL
are	NULL
presented	NULL
above	NULL
each	NULL
sample	NULL
.	NULL

Thirty	NULL
micrograms	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
was	NULL
cotransfected	NULL
by	NULL
electroporation	NULL
together	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
the	NULL
effector	NULL
expression	NULL
plasmids	NULL
for	NULL
C/EBP	NULL
-s	NULL
,	NULL
antisense	NULL
C/EBP	NULL
-e	NULL
c-Jun	NULL
,	NULL
CREB-1	NULL
,	NULL
c-Fos	NULL
,	NULL
c-Myb	NULL
,	NULL
dominant-negative	NULL
mutant	NULL
Myb	NULL
protein	NULL
(	NULL
MybDN	NULL
)	NULL
,	NULL
and	NULL
Ets-2	NULL
.	NULL

Lanes	NULL
10	NULL
and	NULL
11	NULL
show	NULL
experimental	NULL
data	NULL
obtained	NULL
by	NULL
cotransfection	NULL
of	NULL
two	NULL
effector	NULL
plasmids	NULL
(	NULL
10	NULL
g	NULL
each	NULL
)	NULL
with	NULL
pMimCAT	NULL
.	NULL

The	NULL
efficiency	NULL
of	NULL
transfection	NULL
was	NULL
monitored	NULL
by	NULL
cotransfection	NULL
of	NULL
2	NULL
g	NULL
of	NULL
CMV-luciferase	NULL
reporter	NULL
,	NULL
and	NULL
these	NULL
data	NULL
were	NULL
used	NULL
for	NULL
correction	NULL
of	NULL
the	NULL
amount	NULL
of	NULL
total	NULL
cellular	NULL
extract	NULL
used	NULL
in	NULL
the	NULL
CAT	NULL
assays	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Effect	NULL
of	NULL
C/EBP	NULL
-£	NULL
expression	NULL
on	NULL
activity	NULL
of	NULL
the	NULL
MPO	NULL
promoter	NULL
in	NULL
transiently	NULL
transfected	NULL
T-lymphoblast	NULL
CEM	NULL
cells	NULL
.	NULL

CEM	NULL
cells	NULL
lack	NULL
detectable	NULL
C/EBP	NULL
-s	NULL
protein	NULL
but	NULL
express	NULL
endogenous	NULL
c-Myb	NULL
.	NULL

A	NULL
reporter	NULL
construct	NULL
,	NULL
p3.8CAT	NULL
,	NULL
contained	NULL
a	NULL
3.8-kb	NULL
Pvull	NULL
fragment	NULL
of	NULL
the	NULL
hMPO	NULL
gene	NULL
,	NULL
including	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

Relative	NULL
CAT	NULL
activities	NULL
are	NULL
presented	NULL
at	NULL
the	NULL
top	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
p3.8CAT	NULL
promoter	NULL
transfected	NULL
alone	NULL
was	NULL
taken	NULL
as	NULL
1.0	NULL
and	NULL
was	NULL
used	NULL
as	NULL
a	NULL
reference	NULL
point	NULL
for	NULL
comparison	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
same	NULL
reporter	NULL
cotransfected	NULL
with	NULL
the	NULL
expression	NULL
vectors	NULL
for	NULL
C/EBP-s	NULL
,	NULL
antisense	NULL
C/EBP-£	NULL
(	NULL
C/	NULL
EBPeAS	NULL
)	NULL
,	NULL
c-Jun	NULL
,	NULL
CREB-1	NULL
,	NULL
c-Fos	NULL
,	NULL
c-Myb	NULL
,	NULL
and	NULL
dominant-negative	NULL
Myb	NULL
mutant	NULL
(	NULL
MybDN	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
promoterless	NULL
pCATBasic	NULL
reporter	NULL
(	NULL
pCATB	NULL
)	NULL
is	NULL
shown	NULL
in	NULL
lane	NULL
9.	NULL
promoter	NULL
is	NULL
further	NULL
emphasized	NULL
by	NULL
the	NULL
effect	NULL
of	NULL
cotransfected	NULL
dominant-negative	NULL
Myb	NULL
expression	NULL
construct	NULL
(	NULL
8	NULL
,	NULL
26	NULL
)	NULL
,	NULL
which	NULL
reduced	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
hMPO	NULL
promoter	NULL
in	NULL
CEM	NULL
cells	NULL
to	NULL
the	NULL
background	NULL
level	NULL
,	NULL
presumably	NULL
by	NULL
preventing	NULL
activation	NULL
by	NULL
the	NULL
endogenous	NULL
Myb	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

As	NULL
with	NULL
the	NULL
mim-CAT	NULL
promoter	NULL
construct	NULL
,	NULL
we	NULL
saw	NULL
no	NULL
synergistic	NULL
cooperation	NULL
effect	NULL
of	NULL
C/EBP	NULL
-£	NULL
and	NULL
c-Myb	NULL
on	NULL
the	NULL
hMPO	NULL
promoter	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
C/EBP	NULL
-g	NULL
has	NULL
a	NULL
dramatic	NULL
effect	NULL
on	NULL
the	NULL
proliferation	NULL
of	NULL
myeloid	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
transfection	NULL
of	NULL
the	NULL
antisense	NULL
C/EBP	NULL
-g	NULL
expression	NULL
plasmid	NULL
resulted	NULL
in	NULL
a	NULL
specific	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

cq	NULL
<	NULL
»	NULL
--	NULL
--	NULL
--	NULL
'	NULL
«	NULL
<	NULL
»	NULL
5	NULL
.	NULL

“	NULL
—	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5°	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
B	NULL
900	NULL
i	NULL
]	NULL
_	NULL
.	NULL

800	NULL
C	NULL
E	NULL
700	NULL
{	NULL
5	NULL
BR	NULL
nB4+CEBPs	NULL
sense	NULL
2	NULL
600	NULL
-	NULL
NB4+	NULL
CEBPs	NULL
antisense	NULL
6	NULL
38	NULL
500	NULL
7	NULL
R	NULL
1cF7+CEBPs	NULL
sense	NULL
MCF7+	NULL
j	NULL
“	NULL
g	NULL
400	NULL
7	NULL
m	NULL
CEBPs	NULL
antisense	NULL
o	NULL
4	NULL
3	NULL
,	NULL
300	NULL
B	NULL
200	NULL
9	NULL
°	NULL
400	NULL
{	NULL
o	NULL
Cell	NULL
lines	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Transfection	NULL
of	NULL
C/EBP	NULL
-£	NULL
antisense	NULL
expression	NULL
plasmid	NULL
caused	NULL
a	NULL
dose-dependent	NULL
suppression	NULL
of	NULL
C/EBP	NULL
-s	NULL
production	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
transiently	NULL
transfected	NULL
COS-1	NULL
cells	NULL
was	NULL
performed	NULL
with	NULL
anti-C/EBP-£	NULL
antibodies	NULL
.	NULL

Cells	NULL
were	NULL
cotransfected	NULL
either	NULL
with	NULL
C/EBP-£	NULL
antisense	NULL
expression	NULL
plasmid	NULL
(	NULL
pSRe-C/EBPAS	NULL
)	NULL
,	NULL
10	NULL
ug	NULL
per	NULL
10-cm-diameter	NULL
plate	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
and	NULL
10	NULL
)	NULL
,	NULL
or	NULL
with	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
empty	NULL
pSRaTkneo	NULL
vector	NULL
DNA	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
7	NULL
,	NULL
and	NULL
9	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
C/EBP	NULL
-£	NULL
expression	NULL
plasmid	NULL
(	NULL
pSRe-C/	NULL
EBPS	NULL
)	NULL
(	NULL
0.2	NULL
mg	NULL
per	NULL
plate	NULL
in	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
,	NULL
0.5	NULL
pg	NULL
per	NULL
plate	NULL
in	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
,	NULL
1	NULL
ug	NULL
per	NULL
plate	NULL
in	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
,	NULL
2	NULL
pg	NULL
per	NULL
plate	NULL
in	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
,	NULL
and	NULL
5	NULL
ug	NULL
per	NULL
plate	NULL
in	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
.	NULL

The	NULL
C/EBP	NULL
-e-specific	NULL
band	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

Very	NULL
little	NULL
C/EBP	NULL
-s	NULL
was	NULL
expressed	NULL
even	NULL
when	NULL
cells	NULL
were	NULL
cotransfected	NULL
at	NULL
either	NULL
a	NULL
2:1	NULL
or	NULL
5:1	NULL
antisense-to-sense	NULL
expression	NULL
plasmid	NULL
ratio	NULL
(	NULL
lanes	NULL
10	NULL
and	NULL
8	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
and	NULL
no	NULL
detectable	NULL
signal	NULL
was	NULL
observed	NULL
when	NULL
the	NULL
ratio	NULL
was	NULL
increased	NULL
to	NULL
10:1	NULL
,	NULL
20:1	NULL
,	NULL
and	NULL
50:1	NULL
(	NULL
lanes	NULL
6	NULL
,	NULL
4	NULL
,	NULL
and	NULL
2	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Expression	NULL
of	NULL
C/EBP-£	NULL
is	NULL
important	NULL
for	NULL
proliferation	NULL
of	NULL
myeloid	NULL
cells	NULL
.	NULL

The	NULL
C/EBP-g-expressing	NULL
NB4	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10	NULL
``	NULL
per	NULL
sample	NULL
)	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
(	NULL
250	NULL
V	NULL
,	NULL
950	NULL
wF	NULL
)	NULL
with	NULL
15	NULL
pg	NULL
of	NULL
the	NULL
murine	NULL
sarcoma	NULL
virus	NULL
promoter-driven	NULL
C/EBP-e	NULL
DNA	NULL
in	NULL
cither	NULL
the	NULL
sense	NULL
or	NULL
antisense	NULL
orientation	NULL
and	NULL
PSRaCEBPAS	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

MCF-7	NULL
breast	NULL
cancer	NULL
cells	NULL
,	NULL
which	NULL
lack	NULL
endogenous	NULL
C/EBP	NULL
-s	NULL
,	NULL
were	NULL
transfected	NULL
by	NULL
lipofection	NULL
with	NULL
3	NULL
mg	NULL
of	NULL
the	NULL
same	NULL
expression	NULL
plasmids	NULL
.	NULL

Clonogenic	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
G418	NULL
(	NULL
800	NULL
ug/ml	NULL
for	NULL
NB4	NULL
and	NULL
450	NULL
pg/ml	NULL
for	NULL
MCF-7	NULL
cells	NULL
)	NULL
added	NULL
to	NULL
the	NULL
bottom	NULL
level	NULL
of	NULL
the	NULL
two-layer	NULL
soft	NULL
agar	NULL
system	NULL
for	NULL
either	NULL
8	NULL
days	NULL
(	NULL
for	NULL
MCF-7	NULL
)	NULL
or	NULL
15	NULL
days	NULL
(	NULL
for	NULL
NB4	NULL
)	NULL
.	NULL

The	NULL
figure	NULL
represents	NULL
data	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

The	NULL
number	NULL
of	NULL
colonies	NULL
obtained	NULL
in	NULL
each	NULL
experiment	NULL
with	NULL
cells	NULL
transfected	NULL
by	NULL
an	NULL
empty	NULL
expression	NULL
vector	NULL
was	NULL
taken	NULL
as	NULL
100	NULL
%	NULL
.	NULL

and	NULL
dose-dependent	NULL
decrease	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
C/EBP	NULL
-£	NULL
pro-duced	NULL
.	NULL

Since	NULL
our	NULL
previous	NULL
studies	NULL
demonstrated	NULL
the	NULL
presence	NULL
of	NULL
endogenous	NULL
C/EBP	NULL
-£	NULL
in	NULL
several	NULL
leukemic	NULL
cell	NULL
lines	NULL
arrested	NULL
at	NULL
the	NULL
late	NULL
myeloblast-promyelocyte	NULL
stage	NULL
of	NULL
differentiation	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
consequences	NULL
of	NULL
overexpression	NULL
as	NULL
well	NULL
as	NULL
decreased	NULL
expression	NULL
of	NULL
C/EBP	NULL
-£	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

In	NULL
a	NULL
clonogenic	NULL
assay	NULL
,	NULL
NB4	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
sense	NULL
C/EBP	NULL
-£	NULL
expression	NULL
construct	NULL
showed	NULL
an	NULL
average	NULL
7-fold	NULL
increase	NULL
in	NULL
colony	NULL
numbers	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
the	NULL
C/EBP	NULL
-£	NULL
expression	NULL
construct	NULL
into	NULL
the	NULL
nonmyeloid	NULL
breast	NULL
cancer	NULL
cell	NULL
line	NULL
MCF7	NULL
,	NULL
which	NULL
lacks	NULL
endogenous	NULL
C/EBP	NULL
-g	NULL
,	NULL
caused	NULL
an	NULL
approximately	NULL
1.5-	NULL
to	NULL
2-fold	NULL
increase	NULL
in	NULL
colony	NULL
numbers	NULL
compared	NULL
to	NULL
cells	NULL
transfected	NULL
with	NULL
empty-vector	NULL
DNA	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
expression	NULL
of	NULL
C/EBP	NULL
-£	NULL
for	NULL
proliferation	NULL
of	NULL
myeloid	NULL
cells	NULL
is	NULL
further	NULL
emphasized	NULL
by	NULL
effects	NULL
of	NULL
a	NULL
transiently	NULL
transfected	NULL
antisense	NULL
C/EBP	NULL
-g	NULL
expression	NULL
construct	NULL
that	NULL
caused	NULL
a	NULL
fivefold	NULL
decrease	NULL
in	NULL
the	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
number	NULL
of	NULL
NB4	NULL
colonies	NULL
in	NULL
soft	NULL
agar	NULL
while	NULL
having	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
number	NULL
of	NULL
MCF7	NULL
colonies	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

Under	NULL
the	NULL
conditions	NULL
of	NULL
these	NULL
experiments	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
a	NULL
change	NULL
in	NULL
the	NULL
differentiation	NULL
pattern	NULL
of	NULL
NB4	NULL
cells	NULL
transfected	NULL
with	NULL
either	NULL
the	NULL
sense	NULL
or	NULL
antisense	NULL
C/EBP	NULL
-£	NULL
construct	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
have	NULL
reported	NULL
the	NULL
cloning	NULL
of	NULL
a	NULL
novel	NULL
human	NULL
member	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
of	NULL
transcriptional	NULL
activators	NULL
that	NULL
is	NULL
exclusively	NULL
expressed	NULL
in	NULL
late	NULL
myeloblast-promyelocyte-like	NULL
cells	NULL
.	NULL

All	NULL
C/EBP	NULL
family	NULL
members	NULL
contain	NULL
a	NULL
characteristic	NULL
basic	NULL
domain	NULL
,	NULL
important	NULL
for	NULL
DNA	NULL
binding	NULL
and	NULL
interaction	NULL
with	NULL
certain	NULL
other	NULL
proteins	NULL
,	NULL
and	NULL
a	NULL
dimerization	NULL
domain	NULL
that	NULL
contains	NULL
a	NULL
leucine	NULL
zipper	NULL
and	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
stable	NULL
,	NULL
covalently	NULL
linked	NULL
homo-	NULL
and	NULL
heterodimers	NULL
of	NULL
different	NULL
C/EBP-like	NULL
proteins	NULL
.	NULL

The	NULL
hypothesis	NULL
that	NULL
transcription	NULL
factors	NULL
are	NULL
key	NULL
regulators	NULL
in	NULL
the	NULL
development	NULL
of	NULL
differentiated	NULL
cells	NULL
from	NULL
multipotential	NULL
progenitors	NULL
has	NULL
led	NULL
to	NULL
the	NULL
identification	NULL
and	NULL
characterization	NULL
of	NULL
several	NULL
regulators	NULL
of	NULL
myelopoiesis	NULL
(	NULL
23	NULL
,	NULL
72	NULL
)	NULL
.	NULL

Numerous	NULL
members	NULL
of	NULL
the	NULL
major	NULL
transcription	NULL
factor	NULL
groups	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
regulation	NULL
of	NULL
various	NULL
stages	NULL
of	NULL
myelopoiesis	NULL
and/or	NULL
functional	NULL
activation	NULL
of	NULL
mature	NULL
myeloid	NULL
cells	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
these	NULL
include	NULL
an	NULL
AML1	NULL
transcription	NULL
factor	NULL
complex	NULL
(	NULL
57	NULL
,	NULL
76	NULL
,	NULL
78	NULL
)	NULL
,	NULL
several	NULL
members	NULL
of	NULL
the	NULL
Myb	NULL
(	NULL
24	NULL
,	NULL
30	NULL
,	NULL
32	NULL
,	NULL
79	NULL
)	NULL
and	NULL
Ets	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
PU.1	NULL
[	NULL
18	NULL
,	NULL
31	NULL
,	NULL
43	NULL
,	NULL
75	NULL
,	NULL
85	NULL
]	NULL
)	NULL
families	NULL
of	NULL
transcriptional	NULL
regulators	NULL
,	NULL
zinc	NULL
finger	NULL
proteins	NULL
,	NULL
(	NULL
12	NULL
,	NULL
34	NULL
)	NULL
and	NULL
helix-loop-helix	NULL
proteins	NULL
(	NULL
46	NULL
,	NULL
62	NULL
)	NULL
.	NULL

The	NULL
abundance	NULL
of	NULL
transcriptional	NULL
regulators	NULL
that	NULL
all	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
activation	NULL
and	NULL
repression	NULL
of	NULL
transcription	NULL
in	NULL
myeloid	NULL
cells	NULL
suggests	NULL
the	NULL
importance	NULL
of	NULL
interaction	NULL
between	NULL
the	NULL
various	NULL
coexpressed	NULL
proteins	NULL
and	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
that	NULL
regulate	NULL
them	NULL
in	NULL
cooperative	NULL
activation	NULL
of	NULL
particular	NULL
genes	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
identified	NULL
chicken	NULL
NF-M	NULL
,	NULL
which	NULL
is	NULL
homologous	NULL
to	NULL
mammalian	NULL
C/EBP	NULL
-B	NULL
(	NULL
33	NULL
,	NULL
74	NULL
)	NULL
.	NULL

It	NULL
,	NULL
together	NULL
with	NULL
Myb	NULL
,	NULL
can	NULL
function	NULL
as	NULL
a	NULL
combinatorial	NULL
master	NULL
switch	NULL
for	NULL
several	NULL
myeloid-cell-specific	NULL
genes	NULL
in	NULL
the	NULL
chicken	NULL
(	NULL
41	NULL
,	NULL
45	NULL
,	NULL
61	NULL
)	NULL
.	NULL

However	NULL
,	NULL
homology	NULL
between	NULL
avian	NULL
NF-M	NULL
and	NULL
mammalian	NULL
C/EBP-B	NULL
(	NULL
NF-IL6	NULL
)	NULL
does	NULL
not	NULL
extend	NULL
to	NULL
their	NULL
expression	NULL
pat-terns	NULL
;	NULL
while	NULL
avian	NULL
NF-M	NULL
is	NULL
exclusively	NULL
expressed	NULL
in	NULL
promyelocytes	NULL
,	NULL
mammalian	NULL
NF-IL6	NULL
is	NULL
ectopically	NULL
expressed	NULL
in	NULL
response	NULL
to	NULL
inflammatory	NULL
stimuli	NULL
and	NULL
appears	NULL
to	NULL
be	NULL
more	NULL
important	NULL
for	NULL
functional	NULL
activation	NULL
of	NULL
cells	NULL
of	NULL
many	NULL
lineages	NULL
rather	NULL
than	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
determination	NULL
of	NULL
the	NULL
differentiation	NULL
pathway	NULL
.	NULL

Mice	NULL
with	NULL
targeted	NULL
disruption	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
do	NULL
indeed	NULL
show	NULL
defects	NULL
in	NULL
activation	NULL
of	NULL
macrophages	NULL
,	NULL
but	NULL
production	NULL
and	NULL
differentiation	NULL
of	NULL
macrophages	NULL
are	NULL
not	NULL
blocked	NULL
(	NULL
71	NULL
,	NULL
77	NULL
)	NULL
.	NULL

Other	NULL
studies	NULL
have	NULL
observed	NULL
a	NULL
pattern	NULL
of	NULL
coordinated	NULL
regulation	NULL
of	NULL
three	NULL
different	NULL
C/EBP	NULL
-like	NULL
proteins	NULL
,	NULL
C/EBP-	NULL
«	NULL
,	NULL
C/EBP	NULL
-B	NULL
,	NULL
and	NULL
C/EBP-8	NULL
,	NULL
in	NULL
adipocytes	NULL
as	NULL
well	NULL
as	NULL
differentiating	NULL
myeloid	NULL
cells	NULL
(	NULL
15	NULL
,	NULL
59	NULL
,	NULL
70	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
C/EBP-	NULL
«	NULL
was	NULL
higher	NULL
in	NULL
less-differentiated	NULL
myeloid	NULL
cells	NULL
,	NULL
while	NULL
in	NULL
adipocytes	NULL
,	NULL
the	NULL
level	NULL
of	NULL
C/EBP	NULL
expression	NULL
paralleled	NULL
differentiation	NULL
and	NULL
was	NULL
important	NULL
for	NULL
the	NULL
progression	NULL
of	NULL
differentiation	NULL
(	NULL
27	NULL
,	NULL
81	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
C/EBP-B	NULL
(	NULL
NF-IL6	NULL
)	NULL
was	NULL
found	NULL
to	NULL
increase	NULL
gradually	NULL
as	NULL
myeloid	NULL
cells	NULL
differentiated	NULL
toward	NULL
macrophages	NULL
.	NULL

Another	NULL
C/EBP	NULL
-like	NULL
factor	NULL
,	NULL
C/EBP	NULL
-y	NULL
(	NULL
Ig-C/EBP	NULL
)	NULL
,	NULL
is	NULL
expressed	NULL
ubiquitously	NULL
(	NULL
67	NULL
)	NULL
.	NULL

Considering	NULL
that	NULL
any	NULL
of	NULL
the	NULL
C/EBP-like	NULL
factors	NULL
can	NULL
cooperate	NULL
in	NULL
the	NULL
avian	NULL
system	NULL
in	NULL
induction	NULL
of	NULL
myeloid-cell-specific	NULL
genes	NULL
in	NULL
nonmyeloid	NULL
cell	NULL
types	NULL
(	NULL
41	NULL
,	NULL
61	NULL
)	NULL
,	NULL
we	NULL
hypothesized	NULL
that	NULL
the	NULL
role	NULL
played	NULL
by	NULL
homology	NULL
of	NULL
the	NULL
amino	NULL
acid	NULL
sequences	NULL
of	NULL
a	NULL
C/EBP	NULL
protein	NULL
may	NULL
be	NULL
secondary	NULL
to	NULL
the	NULL
restricted	NULL
pattern	NULL
of	NULL
expression	NULL
and	NULL
regulation	NULL
of	NULL
expression	NULL
of	NULL
a	NULL
particular	NULL
C/EBP	NULL
isoform	NULL
.	NULL

Interestingly	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
homolog	NULL
of	NULL
the	NULL
NOVEL	NULL
PROMYELOCYTE-SPECIFIC	NULL
C/EBP	NULL
FACTOR	NULL
-	NULL
1383	NULL
chicken	NULL
myeloid-cell-specific	NULL
mim-1	NULL
(	NULL
c-mim	NULL
)	NULL
gene	NULL
was	NULL
not	NULL
restricted	NULL
to	NULL
cells	NULL
of	NULL
the	NULL
myeloid	NULL
lineage	NULL
,	NULL
while	NULL
the	NULL
tissue-specific	NULL
pattern	NULL
of	NULL
activity	NULL
of	NULL
the	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
c-mim	NULL
gene	NULL
was	NULL
similar	NULL
in	NULL
both	NULL
human	NULL
and	NULL
avian	NULL
cells	NULL
(	NULL
60	NULL
)	NULL
.	NULL

We	NULL
thus	NULL
undertook	NULL
the	NULL
task	NULL
of	NULL
cloning	NULL
a	NULL
putative	NULL
C/EBP	NULL
-like	NULL
factor	NULL
whose	NULL
expression	NULL
pattern	NULL
resembled	NULL
chicken	NULL
NF-M	NULL
in	NULL
being	NULL
restricted	NULL
to	NULL
promyelocyte-like	NULL
or	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

RT-PCR	NULL
with	NULL
C/EBP	NULL
-specific	NULL
primers	NULL
was	NULL
performed	NULL
on	NULL
RNA	NULL
from	NULL
the	NULL
HL60	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
a	NULL
cDNA	NULL
for	NULL
the	NULL
C/EBP	NULL
-£	NULL
transcription	NULL
factor	NULL
was	NULL
identified	NULL
by	NULL
Northern	NULL
blot	NULL
hybridization	NULL
of	NULL
candidate	NULL
PCR	NULL
products	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
Table	NULL
1	NULL
,	NULL
a	NULL
C/EBP-£	NULL
mRNA	NULL
of	NULL
approximately	NULL
1.2	NULL
kb	NULL
was	NULL
found	NULL
to	NULL
be	NULL
expressed	NULL
only	NULL
in	NULL
cells	NULL
arrested	NULL
at	NULL
or	NULL
close	NULL
to	NULL
the	NULL
late	NULL
myeloblast-promyelocyte	NULL
stage	NULL
of	NULL
myeloid	NULL
differentiation	NULL
(	NULL
HL60	NULL
,	NULL
PLB985	NULL
,	NULL
NB4	NULL
,	NULL
and	NULL
Kecl22	NULL
)	NULL
,	NULL
not	NULL
by	NULL
very-early-myeloblast-like	NULL
KG1	NULL
or	NULL
monocytic	NULL
U937	NULL
cells	NULL
.	NULL

No	NULL
expression	NULL
was	NULL
detected	NULL
in	NULL
B	NULL
and	NULL
T	NULL
lymphocytes	NULL
or	NULL
in	NULL
cells	NULL
of	NULL
mast	NULL
,	NULL
megakaryocyte	NULL
,	NULL
erythroid	NULL
,	NULL
fibroblast	NULL
,	NULL
or	NULL
epithelial	NULL
lineage	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Hybridization	NULL
of	NULL
a	NULL
C/EBP	NULL
-e-specific	NULL
probe	NULL
with	NULL
a	NULL
Northern	NULL
blot	NULL
containing	NULL
mRNA	NULL
from	NULL
multiple	NULL
normal	NULL
human	NULL
tissues	NULL
gave	NULL
only	NULL
a	NULL
weak	NULL
signal	NULL
with	NULL
peripheral	NULL
blood	NULL
leukocyte-derived	NULL
RNA	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Sequence	NULL
analysis	NULL
as	NULL
well	NULL
as	NULL
cloning	NULL
of	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
C/EBP	NULL
-g	NULL
genes	NULL
indicated	NULL
that	NULL
they	NULL
are	NULL
highly	NULL
homologous	NULL
to	NULL
rat	NULL
CRP1	NULL
sequences	NULL
and	NULL
likely	NULL
represent	NULL
its	NULL
human	NULL
and	NULL
murine	NULL
counterparts	NULL
(	NULL
84	NULL
)	NULL
.	NULL

The	NULL
rat	NULL
gene	NULL
for	NULL
CRP1	NULL
was	NULL
cloned	NULL
by	NULL
relaxed-stringency	NULL
hybridization	NULL
,	NULL
as	NULL
were	NULL
two	NULL
other	NULL
C/EBP-related	NULL
genes	NULL
,	NULL
CRP2	NULL
and	NULL
CRP3	NULL
,	NULL
which	NULL
were	NULL
later	NULL
identified	NULL
as	NULL
NF-IL6	NULL
and	NULL
NF-IL6-B	NULL
,	NULL
respectively	NULL
(	NULL
3	NULL
,	NULL
42	NULL
,	NULL
66	NULL
)	NULL
.	NULL

Although	NULL
no	NULL
transcripts	NULL
for	NULL
CRP1	NULL
have	NULL
been	NULL
found	NULL
in	NULL
any	NULL
cell	NULL
type	NULL
and	NULL
the	NULL
gene	NULL
had	NULL
the	NULL
least	NULL
homology	NULL
with	NULL
the	NULL
other	NULL
C/EBP	NULL
factors	NULL
,	NULL
it	NULL
appeared	NULL
to	NULL
be	NULL
a	NULL
functional	NULL
gene	NULL
rather	NULL
than	NULL
a	NULL
pseudogene	NULL
84	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
oth	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
C/EBP	NULL
-£	NULL
genes	NULL
,	NULL
like	NULL
their	NULL
rat	NULL
CRP1	NULL
counterpart	NULL
,	NULL
which	NULL
was	NULL
previously	NULL
identified	NULL
by	NULL
Williams	NULL
et	NULL
al	NULL
.	NULL

(	NULL
84	NULL
)	NULL
,	NULL
have	NULL
an	NULL
intron	NULL
sequence	NULL
separating	NULL
the	NULL
two	NULL
protein-coding	NULL
exons	NULL
.	NULL

Although	NULL
a	NULL
region	NULL
of	NULL
high	NULL
homology	NULL
extends	NULL
further	NULL
upstream	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
ATG	NULL
codon	NULL
immediately	NULL
followed	NULL
by	NULL
a	NULL
codon	NULL
for	NULL
cysteine	NULL
is	NULL
utilized	NULL
as	NULL
the	NULL
translational	NULL
start	NULL
site	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
the	NULL
apparent	NULL
molecular	NULL
weight	NULL
of	NULL
endogenous	NULL
C/EBP	NULL
-£	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
molecular	NULL
weight	NULL
of	NULL
C/EBP	NULL
-g	NULL
derived	NULL
from	NULL
cDNA	NULL
lacking	NULL
upstream	NULL
sequences	NULL
.	NULL

Primer	NULL
extention	NULL
analysis	NULL
has	NULL
identified	NULL
a	NULL
single	NULL
major	NULL
transcriptional	NULL
start	NULL
site	NULL
about	NULL
200	NULL
nucleotides	NULL
upstream	NULL
of	NULL
the	NULL
ATG	NULL
initiation	NULL
codon	NULL
.	NULL

The	NULL
C/EBP-£	NULL
promoter	NULL
is	NULL
similar	NULL
to	NULL
other	NULL
known	NULL
myeloid-cell-specific	NULL
promoters	NULL
in	NULL
that	NULL
it	NULL
lacks	NULL
the	NULL
TATAAA	NULL
box	NULL
and	NULL
contains	NULL
multiple	NULL
stretches	NULL
of	NULL
purine-rich	NULL
DNA	NULL
sequences	NULL
.	NULL

The	NULL
gene	NULL
for	NULL
human	NULL
C/EBP	NULL
-£	NULL
was	NULL
mapped	NULL
to	NULL
chromosome	NULL
14q11	NULL
,	NULL
in	NULL
the	NULL
immediate	NULL
proximity	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
delta	NULL
gene	NULL
complex	NULL
(	NULL
8	NULL
,	NULL
36	NULL
,	NULL
44	NULL
)	NULL
.	NULL

This	NULL
segment	NULL
of	NULL
chromosome	NULL
14	NULL
contains	NULL
several	NULL
important	NULL
groups	NULL
of	NULL
genes	NULL
,	NULL
all	NULL
of	NULL
which	NULL
are	NULL
expressed	NULL
predominantly	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
hematopoietic	NULL
lineage	NULL
.	NULL

The	NULL
high	NULL
degree	NULL
of	NULL
homology	NULL
between	NULL
the	NULL
murine	NULL
and	NULL
human	NULL
C/EBP-g	NULL
proteins	NULL
suggests	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
chicken	NULL
C/EBP	NULL
-£	NULL
(	NULL
CRP1	NULL
)	NULL
homolog	NULL
.	NULL

After	NULL
this	NULL
paper	NULL
had	NULL
been	NULL
submitted	NULL
,	NULL
Antonson	NULL
et	NULL
al	NULL
.	NULL

(	NULL
8	NULL
)	NULL
also	NULL
reported	NULL
the	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
counterpart	NULL
of	NULL
CRP1	NULL
,	NULL
C/EBP	NULL
-e.	NULL
C/EBP	NULL
-B	NULL
and	NULL
C/EBP-8	NULL
were	NULL
both	NULL
found	NULL
to	NULL
be	NULL
phosphopro-teins	NULL
that	NULL
translocate	NULL
into	NULL
the	NULL
nucleus	NULL
following	NULL
threonine	NULL
phosphorylation	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
site	NULL
(	NULL
PGTP	NULL
)	NULL
,	NULL
which	NULL
is	NULL
conserved	NULL
among	NULL
murine	NULL
,	NULL
chicken	NULL
,	NULL
and	NULL
human	NULL
homologs	NULL
of	NULL
these	NULL
proteins	NULL
.	NULL

No	NULL
such	NULL
site	NULL
is	NULL
found	NULL
in	NULL
C/EBP	NULL
-	NULL
«	NULL
(	NULL
47	NULL
,	NULL
64	NULL
)	NULL
.	NULL

We	NULL
have	NULL
noted	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
site	NULL
in	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
C/EBP	NULL
-g	NULL
protein	NULL
,	NULL
at	NULL
amino	NULL
acid	NULL
positions	NULL
41	NULL
to	NULL
44	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
°°P-labelled	NULL
C/EBP	NULL
-g	NULL
protein	NULL
was	NULL
readily	NULL
detectable	NULL
in	NULL
immunoprecipitates	NULL
with	NULL
anti-C/EBP-g	NULL
antiserum	NULL
,	NULL
indicating	NULL
that	NULL
it	NULL
is	NULL
a	NULL
phosphoprotein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

1384	NULL
CHUMAKOV	NULL
ET	NULL
AL	NULL
.	NULL

However	NULL
,	NULL
in	NULL
all	NULL
cells	NULL
that	NULL
were	NULL
found	NULL
to	NULL
express	NULL
C/EBP	NULL
-£	NULL
,	NULL
it	NULL
was	NULL
localized	NULL
exclusively	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
was	NULL
detected	NULL
as	NULL
a	NULL
single	NULL
band	NULL
of	NULL
about	NULL
32	NULL
kDa	NULL
on	NULL
Western	NULL
blotting	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
is	NULL
fully	NULL
phosphorylated	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
other	NULL
C/EBP	NULL
isoforms	NULL
,	NULL
C/EBP	NULL
-£	NULL
produced	NULL
in	NULL
vitro	NULL
was	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
optimal	NULL
C/EBP	NULL
-binding	NULL
site	NULL
(	NULL
73	NULL
,	NULL
83	NULL
)	NULL
,	NULL
and	NULL
the	NULL
complex	NULL
was	NULL
specifically	NULL
supershifted	NULL
by	NULL
anti-C/	NULL
EBP	NULL
-£	NULL
antiserum	NULL
,	NULL
suppressed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
unlabelled	NULL
self	NULL
competitor	NULL
,	NULL
and	NULL
unaffected	NULL
by	NULL
addition	NULL
of	NULL
a	NULL
10-fold	NULL
molar	NULL
excess	NULL
of	NULL
similar	NULL
oligonucleotides	NULL
which	NULL
had	NULL
a	NULL
mutated	NULL
CCAAT	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
detect	NULL
efficient	NULL
binding	NULL
of	NULL
the	NULL
optimal	NULL
C/EBP	NULL
motif	NULL
to	NULL
C/EBP	NULL
-£	NULL
derived	NULL
from	NULL
myeloid	NULL
cell	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Another	NULL
C/EBP	NULL
-binding	NULL
site	NULL
,	NULL
derived	NULL
from	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
M-CSF	NULL
receptor	NULL
,	NULL
can	NULL
form	NULL
C/EBP-g-containing	NULL
complexes	NULL
that	NULL
migrate	NULL
more	NULL
slowly	NULL
than	NULL
the	NULL
putative	NULL
C/EBP	NULL
-g	NULL
homodimer-con-taining	NULL
complexes	NULL
produced	NULL
by	NULL
in	NULL
vitro-translated	NULL
C/EBP	NULL
-e.	NULL
The	NULL
C/EBP	NULL
-like	NULL
transcription	NULL
factors	NULL
are	NULL
expressed	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
,	NULL
and	NULL
some	NULL
of	NULL
them	NULL
,	NULL
in	NULL
particular	NULL
NF-IL6	NULL
(	NULL
C/EBP	NULL
-B	NULL
)	NULL
,	NULL
were	NULL
reported	NULL
to	NULL
interact	NULL
physically	NULL
and	NULL
functionally	NULL
with	NULL
other	NULL
transcriptional	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
Myb	NULL
(	NULL
56	NULL
)	NULL
,	NULL
CREB	NULL
(	NULL
49	NULL
,	NULL
80	NULL
,	NULL
82	NULL
)	NULL
,	NULL
c-Jun	NULL
(	NULL
35	NULL
)	NULL
,	NULL
glucocorticoid	NULL
receptor	NULL
(	NULL
63	NULL
)	NULL
,	NULL
and	NULL
AML-1	NULL
(	NULL
89	NULL
)	NULL
.	NULL

In	NULL
some	NULL
cases	NULL
this	NULL
heterodimerization	NULL
changes	NULL
their	NULL
affinity	NULL
for	NULL
various	NULL
DNA	NULL
sequences	NULL
and	NULL
brings	NULL
together	NULL
different	NULL
regulatory	NULL
pathways	NULL
,	NULL
such	NULL
as	NULL
cyclic	NULL
AMP-dependent	NULL
signalling	NULL
or	NULL
those	NULL
induced	NULL
by	NULL
LPS	NULL
(	NULL
80	NULL
)	NULL
,	NULL
while	NULL
in	NULL
others	NULL
it	NULL
appears	NULL
to	NULL
be	NULL
important	NULL
for	NULL
activity	NULL
of	NULL
two	NULL
transcriptional	NULL
factors	NULL
bound	NULL
to	NULL
closely	NULL
spaced	NULL
DNA	NULL
sites	NULL
,	NULL
as	NULL
in	NULL
the	NULL
case	NULL
of	NULL
Myb	NULL
and	NULL
C/EBP-B	NULL
(	NULL
56	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
bacterially	NULL
expressed	NULL
rat	NULL
C/EBP	NULL
-a	NULL
,	NULL
C/EBP-B	NULL
,	NULL
C/EBP-8	NULL
,	NULL
and	NULL
CRP1	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
able	NULL
to	NULL
form	NULL
stable	NULL
homo-	NULL
and	NULL
heterodimers	NULL
covalently	NULL
linked	NULL
by	NULL
disulfide	NULL
bonds	NULL
(	NULL
84	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
bacterially	NULL
expressed	NULL
fragment	NULL
of	NULL
rat	NULL
CRP1	NULL
was	NULL
less	NULL
likely	NULL
to	NULL
heterodimerize	NULL
with	NULL
other	NULL
C/EBP	NULL
homologs	NULL
in	NULL
vitro	NULL
as	NULL
it	NULL
has	NULL
less	NULL
homology	NULL
in	NULL
the	NULL
dimerization	NULL
domain	NULL
(	NULL
84	NULL
)	NULL
.	NULL

Further	NULL
experiments	NULL
are	NULL
in	NULL
progress	NULL
to	NULL
identify	NULL
potential	NULL
in	NULL
vivo	NULL
dimerization	NULL
partners	NULL
for	NULL
C/EBP	NULL
-g	NULL
,	NULL
since	NULL
our	NULL
preliminary	NULL
experiments	NULL
suggest	NULL
that	NULL
it	NULL
does	NULL
not	NULL
form	NULL
homodimers	NULL
with	NULL
high	NULL
efficiency	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

We	NULL
have	NULL
also	NULL
tested	NULL
the	NULL
effects	NULL
of	NULL
increased	NULL
and	NULL
decreased	NULL
C/EBP-£	NULL
expression	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
two	NULL
myeloid-specific	NULL
promoters	NULL
,	NULL
mim-1	NULL
and	NULL
hMPO	NULL
.	NULL

An	NULL
antisense	NULL
C/EBP	NULL
-g	NULL
expression	NULL
plasmid	NULL
can	NULL
specifically	NULL
suppress	NULL
production	NULL
of	NULL
C/EBP	NULL
-E	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
both	NULL
promoters	NULL
were	NULL
significantly	NULL
upregulated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
cotransfected	NULL
C/EBP-g	NULL
expression	NULL
vector	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
mim-1	NULL
promoter	NULL
was	NULL
downregulated	NULL
when	NULL
cotransfected	NULL
with	NULL
the	NULL
antisense	NULL
C/EBP	NULL
-g	NULL
expression	NULL
construct	NULL
into	NULL
the	NULL
HL60	NULL
cell	NULL
line	NULL
that	NULL
expresses	NULL
endogenous	NULL
C/EBP	NULL
-£	NULL
.	NULL

However	NULL
,	NULL
the	NULL
precise	NULL
mechanism	NULL
of	NULL
this	NULL
regulation	NULL
remains	NULL
unclear	NULL
,	NULL
largely	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
other	NULL
C/EBP	NULL
homologs	NULL
that	NULL
are	NULL
coexpressed	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Surprisingly	NULL
,	NULL
we	NULL
saw	NULL
no	NULL
synergistic	NULL
activation	NULL
of	NULL
either	NULL
the	NULL
mim-1	NULL
or	NULL
MPO	NULL
promoter	NULL
by	NULL
C/EBP	NULL
-g	NULL
transfected	NULL
with	NULL
a	NULL
c-Myb	NULL
expression	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

This	NULL
may	NULL
represent	NULL
a	NULL
difference	NULL
in	NULL
properties	NULL
of	NULL
chicken	NULL
NF-M	NULL
and	NULL
human	NULL
C/EBP	NULL
-£	NULL
with	NULL
respect	NULL
to	NULL
their	NULL
interaction	NULL
with	NULL
c-Myb	NULL
,	NULL
although	NULL
in	NULL
the	NULL
avian	NULL
system	NULL
,	NULL
c-Myb	NULL
was	NULL
significantly	NULL
less	NULL
effective	NULL
in	NULL
cooperation	NULL
with	NULL
the	NULL
c-NFM	NULL
than	NULL
was	NULL
mutated	NULL
v-Myb	NULL
(	NULL
14	NULL
,	NULL
61	NULL
)	NULL
.	NULL

We	NULL
can	NULL
speculate	NULL
that	NULL
perhaps	NULL
Myb	NULL
is	NULL
not	NULL
a	NULL
rate-limiting	NULL
factor	NULL
in	NULL
these	NULL
cells	NULL
or	NULL
that	NULL
C/EBP	NULL
-g	NULL
may	NULL
have	NULL
a	NULL
different	NULL
dimerization	NULL
partner	NULL
in	NULL
human	NULL
myeloid	NULL
cells	NULL
and	NULL
may	NULL
be	NULL
unable	NULL
to	NULL
interact	NULL
directly	NULL
with	NULL
Myb	NULL
,	NULL
as	NULL
does	NULL
chicken	NULL
NF-M	NULL
.	NULL

Since	NULL
the	NULL
ability	NULL
of	NULL
NF-M	NULL
to	NULL
synergize	NULL
with	NULL
Myb	NULL
in	NULL
the	NULL
chicken	NULL
system	NULL
is	NULL
dependent	NULL
on	NULL
a	NULL
physical	NULL
interaction	NULL
between	NULL
the	NULL
two	NULL
proteins	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
in	NULL
the	NULL
human	NULL
system	NULL
,	NULL
these	NULL
factors	NULL
do	NULL
activate	NULL
the	NULL
same	NULL
promoter	NULL
but	NULL
fail	NULL
to	NULL
interact	NULL
with	NULL
each	NULL
other	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
C/EBP	NULL
-g	NULL
has	NULL
a	NULL
remarkable	NULL
effect	NULL
on	NULL
cell	NULL
proliferation	NULL
.	NULL

Transfection	NULL
of	NULL
a	NULL
C/EBP-g	NULL
expression	NULL
construct	NULL
caused	NULL
a	NULL
sevenfold	NULL
increase	NULL
in	NULL
the	NULL
number	NULL
of	NULL
colonies	NULL
formed	NULL
by	NULL
the	NULL
NB4	NULL
promyelocytic	NULL
cell	NULL
line	NULL
in	NULL
soft	NULL
agar	NULL
.	NULL

A	NULL
modest	NULL
but	NULL
significant	NULL
and	NULL
consistent	NULL
growth-stimulatory	NULL
effect	NULL
was	NULL
also	NULL
noted	NULL
in	NULL
nonmyeloid	NULL
MCF-7	NULL
breast	NULL
cancer	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
C/EBP	NULL
-£	NULL
expression	NULL
vector	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

Since	NULL
C/EBP-£	NULL
expression	NULL
gradually	NULL
decreased	NULL
to	NULL
zero	NULL
as	NULL
myeloid	NULL
cells	NULL
differentiated	NULL
to	NULL
become	NULL
nondividing	NULL
monocytes	NULL
and	NULL
macrophages	NULL
,	NULL
the	NULL
continuing	NULL
cellular	NULL
proliferation	NULL
prior	NULL
to	NULL
commitment	NULL
to	NULL
terminal	NULL
differentiation	NULL
of	NULL
the	NULL
myeloid	NULL
cells	NULL
may	NULL
be	NULL
important	NULL
.	NULL

Proliferation	NULL
of	NULL
NB4	NULL
cells	NULL
was	NULL
significantly	NULL
decreased	NULL
upon	NULL
transfection	NULL
of	NULL
the	NULL
C/EBP	NULL
-£	NULL
antisense	NULL
expression	NULL
vector	NULL
.	NULL

However	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
the	NULL
antisense	NULL
expression	NULL
vector	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
cells	NULL
(	NULL
MCF-7	NULL
)	NULL
lacking	NULL
C/EBP-£	NULL
expression	NULL
.	NULL

C/EBP	NULL
-a	NULL
was	NULL
recently	NULL
shown	NULL
to	NULL
have	NULL
a	NULL
growth-inhibitory	NULL
effect	NULL
on	NULL
proliferation	NULL
of	NULL
many	NULL
cells	NULL
types	NULL
,	NULL
and	NULL
our	NULL
finding	NULL
of	NULL
a	NULL
growth-stimulatory	NULL
myeloid-cell-specific	NULL
homolog	NULL
of	NULL
C/EBP	NULL
may	NULL
suggest	NULL
the	NULL
coexistence	NULL
of	NULL
a	NULL
homeostatic	NULL
mechanism	NULL
of	NULL
positive	NULL
and	NULL
negative	NULL
regulatory	NULL
signals	NULL
in	NULL
the	NULL
same	NULL
cells	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
of	NULL
transcriptional	NULL
regulators	NULL
are	NULL
indeed	NULL
well	NULL
suited	NULL
for	NULL
this	NULL
role	NULL
,	NULL
as	NULL
they	NULL
are	NULL
able	NULL
to	NULL
form	NULL
complexes	NULL
with	NULL
a	NULL
number	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
c-Jun	NULL
,	NULL
CREB	NULL
,	NULL
and	NULL
NF-IL6	NULL
,	NULL
which	NULL
are	NULL
at	NULL
the	NULL
end	NULL
of	NULL
the	NULL
specialized	NULL
signal	NULL
transduction	NULL
pathways	NULL
that	NULL
are	NULL
important	NULL
in	NULL
regulation	NULL
of	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
.	NULL

Further	NULL
study	NULL
of	NULL
C/EBP	NULL
-£	NULL
and	NULL
its	NULL
partners	NULL
may	NULL
yield	NULL
important	NULL
new	NULL
information	NULL
about	NULL
the	NULL
regulatory	NULL
mechanism	NULL
that	NULL
couples	NULL
the	NULL
simultaneous	NULL
processes	NULL
of	NULL
proliferation	NULL
and	NULL
myeloid-cell	NULL
differentiation	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
M.	NULL
Lanotte	NULL
for	NULL
kindly	NULL
providing	NULL
NB4	NULL
cells	NULL
,	NULL
Richard	NULL
Gaynor	NULL
(	NULL
Dallas	NULL
,	NULL
Tex	NULL
.	NULL
)	NULL

for	NULL
his	NULL
generous	NULL
provision	NULL
of	NULL
c-jun	NULL
,	NULL
CREB	NULL
,	NULL
and	NULL
c-fos	NULL
expression	NULL
plasmids	NULL
,	NULL
and	NULL
Linda	NULL
Shapiro	NULL
for	NULL
her	NULL
gift	NULL
of	NULL
c-Myb	NULL
and	NULL
dominant-negative	NULL
Myb	NULL
mutant	NULL
clones	NULL
.	NULL

We	NULL
are	NULL
indebted	NULL
to	NULL
Fritz	NULL
A.	NULL
Gombart	NULL
and	NULL
Dorothy	NULL
Park	NULL
for	NULL
useful	NULL
suggestions	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
NIH	NULL
grants	NULL
DK41936	NULL
,	NULL
CA42710	NULL
,	NULL
and	NULL
DK42792	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
Parker	NULL
Hughes	NULL
Fund	NULL
and	NULL
the	NULL
Concern	NULL
Foundation	NULL
.	NULL

H.P.K	NULL
.	NULL

holds	NULL
the	NULL
Mark	NULL
Goodson	NULL
Chair	NULL
of	NULL
Oncology	NULL
Re-search	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Isshiki	NULL
,	NULL
T.	NULL
Suguita	NULL
,	NULL
O.	NULL
Tanabe	NULL
,	NULL
S.	NULL
Kinoshita	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
T.	NULL
Hirano	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
nuclear	NULL
factor	NULL
for	NULL
IL-6	NULL
expression	NULL
(	NULL
NF-IL6	NULL
)	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
C/EBP	NULL
family	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:1897-1906	NULL
.	NULL

2	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1992	NULL
.	NULL

IL-6	NULL
and	NULL
NF-IL6	NULL
in	NULL
acute-phase	NULL
response	NULL
and	NULL
viral	NULL
infection	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

127:25-50	NULL
.	NULL

3	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Isshiki	NULL
,	NULL
T.	NULL
Nakajima	NULL
,	NULL
S.	NULL
Kinoshita	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
T.	NULL
Hashimoto	NULL
,	NULL
S.	NULL
Natsuka	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
nuclear	NULL
factor	NULL
for	NULL
the	NULL
IL-6	NULL
gene	NULL
(	NULL
NF-IL6	NULL
)	NULL
.	NULL

Chem	NULL
.	NULL

Immunol	NULL
.	NULL

51:299-322	NULL
.	NULL

4	NULL
.	NULL

Alam	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
R.	NULL
An	NULL
,	NULL
and	NULL
J.	NULL
Papaconstantinou	NULL
.	NULL

1992	NULL
.	NULL

Differential	NULL
expression	NULL
of	NULL
three	NULL
C/EBP	NULL
isoforms	NULL
in	NULL
multiple	NULL
tissues	NULL
during	NULL
the	NULL
acute	NULL
phase	NULL
response	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:5021-5024	NULL
.	NULL

5	NULL
.	NULL

Alam	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
R.	NULL
An	NULL
,	NULL
R.	NULL
C.	NULL
Mifflin	NULL
,	NULL
C.	NULL
C.	NULL
Hsieh	NULL
,	NULL
X.	NULL
Ge	NULL
,	NULL
and	NULL
J.	NULL
Papaconstantinou	NULL
.	NULL

1993.	NULL
trens-Activation	NULL
of	NULL
the	NULL
alpha	NULL
1-acid	NULL
glycoprotein	NULL
gene	NULL
acute	NULL
phase	NULL
responsive	NULL
element	NULL
by	NULL
multiple	NULL
isoforms	NULL
of	NULL
C/EBP	NULL
and	NULL
glucocorticoid	NULL
receptor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:15681-15688	NULL
.	NULL

6	NULL
.	NULL

Altschul	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
W.	NULL
Gish	NULL
,	NULL
W.	NULL
Miller	NULL
,	NULL
E.	NULL
W.	NULL
Myers	NULL
,	NULL
and	NULL
D.	NULL
J.	NULL
Lipman	NULL
.	NULL

1990	NULL
.	NULL

Basic	NULL
local	NULL
alignment	NULL
search	NULL
tool	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

215:403-410	NULL
.	NULL

7	NULL
.	NULL

An	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
C.-C.	NULL
Hsieh	NULL
,	NULL
P.	NULL
D.	NULL
Reisner	NULL
,	NULL
J.	NULL
P.	NULL
Rabek	NULL
,	NULL
S.	NULL
G.	NULL
Scott	NULL
,	NULL
D.	NULL
T.	NULL
Kuninger	NULL
,	NULL
and	NULL
J.	NULL
Papaconstantinou	NULL
.	NULL

1996	NULL
.	NULL

Evidence	NULL
for	NULL
posttranscriptional	NULL
regulation	NULL
of	NULL
C/EBP	NULL
«	NULL
and	NULL
C/EBPB	NULL
isoform	NULL
expression	NULL
during	NULL
the	NULL
lipopo-lysaccharide-mediated	NULL
acute-phase	NULL
response	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:2295-2306	NULL
.	NULL

8	NULL
.	NULL

Ant	NULL
,	NULL
P.	NULL
,	NULL
P.	NULL
Stellon	NULL
,	NULL
R.	NULL
Y	NULL
ka	NULL
,	NULL
and	NULL
K.	NULL
G.	NULL
Xanthopoulos	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
novel	NULL
human	NULL
CCAAT/enhancer	NULL
binding	NULL
protein	NULL
gene	NULL
,	NULL
C/EBP	NULL
-s	NULL
,	NULL
is	NULL
expressed	NULL
in	NULL
cells	NULL
of	NULL
lymphoid	NULL
and	NULL
myeloid	NULL
lineages	NULL
and	NULL
is	NULL
localized	NULL
on	NULL
chromosome	NULL
14q11.2	NULL
close	NULL
to	NULL
the	NULL
T-cell	NULL
receptor	NULL
a/d	NULL
locus	NULL
.	NULL

Genomics	NULL
35:30-38	NULL
.	NULL

9	NULL
.	NULL

Badiani	NULL
,	NULL
P.	NULL
,	NULL
P.	NULL
Corbella	NULL
,	NULL
D.	NULL
Kioussis	NULL
,	NULL
J.	NULL
Marvel	NULL
,	NULL
and	NULL
K.	NULL
Weston	NULL
.	NULL

1994	NULL
.	NULL

Dominant	NULL
interfering	NULL
alleles	NULL
define	NULL
a	NULL
role	NULL
for	NULL
c-Myb	NULL
in	NULL
T-cell	NULL
development	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:770-782	NULL
.	NULL

10	NULL
.	NULL

Baumann	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
K.	NULL
Morella	NULL
,	NULL
S.	NULL
P.	NULL
Campos	NULL
,	NULL
Z.	NULL
Cao	NULL
,	NULL
and	NULL
G.	NULL
P.	NULL
Jahreis	NULL
.	NULL

1992	NULL
.	NULL

Role	NULL
of	NULL
CAAT-enhancer	NULL
binding	NULL
protein	NULL
isoforms	NULL
in	NULL
the	NULL
cytokine	NULL
regulation	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25.	NULL
of	NULL
acute-phase	NULL
plasma	NULL
protein	NULL
genes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:19744-19751	NULL
.	NULL

Baumann	NULL
,	NULL
H.	NULL
,	NULL
G.	NULL
P.	NULL
Jahreis	NULL
,	NULL
K.	NULL
K.	NULL
Morella	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

Won	NULL
,	NULL
S.	NULL
C.	NULL
Pruitt	NULL
,	NULL
V.	NULL
E.	NULL
Jones	NULL
,	NULL
and	NULL
K.	NULL
R.	NULL
Prowse	NULL
.	NULL

1991	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
through	NULL
cytokine	NULL
and	NULL
glucocorticoid	NULL
response	NULL
elements	NULL
of	NULL
rat	NULL
acute	NULL
phase	NULL
plasma	NULL
protein	NULL
genes	NULL
by	NULL
C/EBP	NULL
and	NULL
JunB	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:20390-20399	NULL
.	NULL

Bavisotto	NULL
,	NULL
L.	NULL
,	NULL
K.	NULL
Kaushansky	NULL
,	NULL
N.	NULL
Lin	NULL
,	NULL
and	NULL
R.	NULL
Hromas	NULL
.	NULL

1991	NULL
.	NULL

Antisense	NULL
oligonucleotides	NULL
from	NULL
the	NULL
stage-specific	NULL
myeloid	NULL
zinc	NULL
finger/gene	NULL
MZF-1	NULL
inhibit	NULL
granulopoiesis	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174:1097-1101	NULL
.	NULL

Birkenmeier	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
B.	NULL
Gwynn	NULL
,	NULL
S.	NULL
Howard	NULL
,	NULL
J.	NULL
Jerry	NULL
,	NULL
J.	NULL
I.	NULL
Gordon	NULL
,	NULL
W.	NULL
H.	NULL
Landschulz	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1989	NULL
.	NULL

Tissue-specific	NULL
expression	NULL
,	NULL
developmental	NULL
regulation	NULL
,	NULL
and	NULL
genetic	NULL
mapping	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
CCAAT/	NULL
enhancer	NULL
binding	NULL
protein	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1146-1156	NULL
.	NULL

Burk	NULL
,	NULL
O.	NULL
,	NULL
S.	NULL
Mink	NULL
,	NULL
M.	NULL
Ringwald	NULL
,	NULL
and	NULL
K.	NULL
H.	NULL
Klempnauer	NULL
.	NULL

1993	NULL
.	NULL

Synergistic	NULL
activation	NULL
of	NULL
the	NULL
chicken	NULL
mim-1	NULL
gene	NULL
by	NULL
v-myb	NULL
and	NULL
C/EBP	NULL
transcription	NULL
factors	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:2027-2038	NULL
.	NULL

Cao	NULL
,	NULL
Z.	NULL
,	NULL
R.	NULL
M.	NULL
Umek	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1991	NULL
.	NULL

Regulated	NULL
expression	NULL
of	NULL
three	NULL
C/EBP	NULL
isoforms	NULL
during	NULL
adipose	NULL
conversion	NULL
of	NULL
3T3-L1	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

51538-1552	NULL
.	NULL

Carter	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
S.	NULL
Bryan	NULL
,	NULL
P.	NULL
Gadson	NULL
,	NULL
and	NULL
J.	NULL
Papaconstantinou	NULL
.	NULL

1989	NULL
.	NULL

Dead-enylation	NULL
of	NULL
alpha	NULL
1-acid	NULL
glycoprotein	NULL
mRNA	NULL
in	NULL
cultured	NULL
hepatic	NULL
cells	NULL
during	NULL
stimulation	NULL
by	NULL
dexamethasone	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264:4112-4119	NULL
.	NULL

Chang	NULL
,	NULL
C.-J	NULL
.	NULL

,	NULL
T.~T	NULL
.	NULL

Chen	NULL
,	NULL
H.-Y	NULL
.	NULL

Lei	NULL
,	NULL
D.-S.	NULL
Chen	NULL
,	NULL
and	NULL
S.-C.	NULL
Lee	NULL
.	NULL

1990	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
,	NULL
AGP/EBP	NULL
,	NULL
that	NULL
belongs	NULL
to	NULL
members	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:6442-6653	NULL
.	NULL

Chen	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
P.	NULL
Zhang	NULL
,	NULL
M.	NULL
T.	NULL
Voso	NULL
,	NULL
S.	NULL
Hohaus	NULL
,	NULL
D.	NULL
A.	NULL
Gonzalez	NULL
,	NULL
C.	NULL
K.	NULL
Glass	NULL
,	NULL
D.	NULL
E.	NULL
Zhang	NULL
,	NULL
and	NULL
D.	NULL
G.	NULL
Tenen	NULL
.	NULL

1995	NULL
.	NULL

Neutrophils	NULL
and	NULL
monocytes	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
PU.1	NULL
(	NULL
Spi-1	NULL
)	NULL
but	NULL
not	NULL
Spi-B	NULL
.	NULL

Blood	NULL
85:2918-2928	NULL
.	NULL

Christy	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
V.	NULL
W.	NULL
Yang	NULL
,	NULL
J.	NULL
M.	NULL
Ntambi	NULL
,	NULL
D.	NULL
E.	NULL
Geiman	NULL
,	NULL
W.	NULL
H.	NULL
Landschulz	NULL
,	NULL
A.	NULL
D.	NULL
Friedman	NULL
,	NULL
Y.	NULL
Nakabeppu	NULL
,	NULL
T.	NULL
J.	NULL
Kelly	NULL
,	NULL
and	NULL
M.	NULL
D.	NULL
Lane	NULL
.	NULL

1989	NULL
.	NULL

Differ-entiation-induced	NULL
gene	NULL
expression	NULL
in	NULL
3T3-L1	NULL
preadipocytes	NULL
:	NULL
CCAAT/enhancer	NULL
binding	NULL
protein	NULL
interacts	NULL
with	NULL
and	NULL
activates	NULL
the	NULL
promoters	NULL
of	NULL
two	NULL
adipocyte-specific	NULL
genes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1323-1335	NULL
.	NULL

Chumakov	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
E.	NULL
A.	NULL
Chumakova	NULL
,	NULL
and	NULL
H.	NULL
P.	NULL
Koeffler	NULL
.	NULL

Molecular	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
myeloperoxidase	NULL
promoter	NULL
region	NULL
.	NULL

Submitted	NULL
for	NULL
publication	NULL
.	NULL

Chumakov	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
H.	NULL
P.	NULL
Koeffler	NULL
.	NULL

1993	NULL
.	NULL

Specific	NULL
interaction	NULL
between	NULL
adenoviral	NULL
55-kDa	NULL
E1B	NULL
protein	NULL
and	NULL
in	NULL
vivo	NULL
produced	NULL
p53	NULL
fusion	NULL
proteins	NULL
.	NULL

Gene	NULL
131:231-236	NULL
.	NULL

Chumakov	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
C.	NULL
W.	NULL
Miller	NULL
,	NULL
D.	NULL
L.	NULL
Chen	NULL
,	NULL
and	NULL
H.	NULL
P.	NULL
Koeffler	NULL
.	NULL

1993	NULL
.	NULL

Analysis	NULL
of	NULL
p53	NULL
transactivation	NULL
through	NULL
high-affinity	NULL
binding	NULL
sites	NULL
.	NULL

Oncogene	NULL
8:3005-3011	NULL
.	NULL

Clark	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
and	NULL
K.	NULL
Docherty	NULL
.	NULL

1993	NULL
.	NULL

Negative	NULL
regulation	NULL
of	NULL
transcription	NULL
in	NULL
eukaryotes	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

296:521-541	NULL
.	NULL

Clarke	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
J.	NULL
F.	NULL
Kukowska-Latallo	NULL
,	NULL
E.	NULL
Westin	NULL
,	NULL
M.	NULL
Smith	NULL
,	NULL
and	NULL
E.	NULL
V.	NULL
Prochownik	NULL
.	NULL

1988	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
a	NULL
c-myb	NULL
cDNA	NULL
blocks	NULL
Friend	NULL
murine	NULL
erythroleukemia	NULL
cell	NULL
differentiation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:884-892	NULL
.	NULL

D	NULL
bes	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Chojkier	NULL
,	NULL
S.	NULL
Lichsteiner	NULL
,	NULL
E.	NULL
Falvey	NULL
,	NULL
and	NULL
V.	NULL
Schibler	NULL
.	NULL

1990	NULL
.	NULL

LAP	NULL
,	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
C/EBP	NULL
gene	NULL
family	NULL
,	NULL
encodes	NULL
a	NULL
liver-enriched	NULL
transcriptional	NULL
activator	NULL
protein	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

41541-1551	NULL
.	NULL

25a.de	NULL
Wet	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
K.	NULL
V.	NULL
Wood	NULL
,	NULL
M.	NULL
DeLuca	NULL
,	NULL
D.	NULL
R.	NULL
Helinski	NULL
,	NULL
and	NULL
S.	NULL
Subramani	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

1987	NULL
.	NULL

Firefly	NULL
luciferase	NULL
gene	NULL
:	NULL
structure	NULL
and	NULL
expression	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:725-737	NULL
.	NULL

Dudek	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
V.	NULL
Tantravahi	NULL
,	NULL
V.	NULL
N.	NULL
Rao	NULL
,	NULL
E.	NULL
S.	NULL
Reddy	NULL
,	NULL
and	NULL
E.	NULL
P.	NULL
Reddy	NULL
.	NULL

1992	NULL
.	NULL

Myb	NULL
and	NULL
Ets	NULL
proteins	NULL
cooperate	NULL
in	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
mim-1	NULL
promoter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:1291-1295	NULL
.	NULL

Freytag	NULL
,	NULL
S.	NULL
O.	NULL
,	NULL
and	NULL
T.	NULL
J.	NULL
Geddes	NULL
.	NULL

1992	NULL
.	NULL

Reciprocal	NULL
regulation	NULL
of	NULL
adipogenesis	NULL
by	NULL
Myc	NULL
and	NULL
C/EBP	NULL
alpha	NULL
.	NULL

Science	NULL
256:379-382	NULL
.	NULL

Friedman	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
W.	NULL
N.	NULL
Landschulz	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1989	NULL
.	NULL

CCAAT/	NULL
enhancer	NULL
binding	NULL
protein	NULL
activates	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
serum	NULL
albumin	NULL
gene	NULL
in	NULL
cultured	NULL
hepatoma	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1314-1322	NULL
.	NULL

Genetics	NULL
Computer	NULL
Group	NULL
.	NULL

1991	NULL
.	NULL

Program	NULL
manual	NULL
for	NULL
the	NULL
GCG	NULL
package	NULL
,	NULL
version	NULL
7	NULL
,	NULL
April	NULL
1991	NULL
.	NULL

Genetics	NULL
Computer	NULL
Group	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
Gewirtz	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
B.	NULL
Calabretta	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
c-myb	NULL
antisense	NULL
oligodeoxynucle-otide	NULL
inhibits	NULL
normal	NULL
human	NULL
hematopoiesis	NULL
in	NULL
vitro	NULL
.	NULL

Science	NULL
242:1303-1306	NULL
.	NULL

Giese	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
Kingsley	NULL
,	NULL
J.	NULL
R.	NULL
Kirshner	NULL
,	NULL
and	NULL
R.	NULL
GrosschedI	NULL
.	NULL

1995	NULL
.	NULL

Assembly	NULL
and	NULL
function	NULL
of	NULL
a	NULL
TCR	NULL
alpha	NULL
enhancer	NULL
complex	NULL
is	NULL
dependent	NULL
on	NULL
LEF-1-induced	NULL
DNA	NULL
bending	NULL
and	NULL
multiple	NULL
protein-protein	NULL
interactions	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:995-1008	NULL
.	NULL

Graf	NULL
,	NULL
T.	NULL
1992	NULL
.	NULL

Myb	NULL
:	NULL
a	NULL
transcriptional	NULL
activator	NULL
linking	NULL
proliferation	NULL
and	NULL
differentiation	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

2:249-255	NULL
.	NULL

Haas	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
M.	NULL
Strobel	NULL
,	NULL
A.	NULL
Leutz	NULL
,	NULL
P.	NULL
Wendelgass	NULL
,	NULL
C.	NULL
Muller	NULL
,	NULL
E.	NULL
Sterneck	NULL
,	NULL
G.	NULL
Riethmuller	NULL
,	NULL
and	NULL
H.	NULL
W.	NULL
Ziegler-Heitbrock	NULL
.	NULL

1992	NULL
.	NULL

Constitutive	NULL
monocyte-restricted	NULL
activity	NULL
of	NULL
NF-M	NULL
,	NULL
a	NULL
nuclear	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
a	NULL
C/EBP	NULL
motif	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:237-243	NULL
.	NULL

Hromas	NULL
,	NULL
R.	NULL
,	NULL
S.	NULL
J.	NULL
Collins	NULL
,	NULL
D.	NULL
Hickstein	NULL
,	NULL
W.	NULL
Raskind	NULL
,	NULL
L.	NULL
L.	NULL
Deaven	NULL
,	NULL
P.	NULL
O'Hara	NULL
,	NULL
F.	NULL
S.	NULL
Hagen	NULL
,	NULL
and	NULL
K.	NULL
Kaushansky	NULL
,	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
retinoic	NULL
acid-responsive	NULL
human	NULL
zinc	NULL
finger	NULL
gene	NULL
,	NULL
MZF-1	NULL
,	NULL
preferentially	NULL
expressed	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:14183-14187	NULL
.	NULL

Hsu	NULL
,	NULL
W.	NULL
,	NULL
T.	NULL
K.	NULL
Kerppola	NULL
,	NULL
P.-L.	NULL
Chen	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
S.	NULL
Chen-Kiang	NULL
.	NULL

1994	NULL
.	NULL

Fos	NULL
and	NULL
Jun	NULL
repress	NULL
transcription	NULL
activation	NULL
by	NULL
NF-IL6	NULL
through	NULL
association	NULL
at	NULL
the	NULL
basic	NULL
zipper	NULL
region	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:268-276	NULL
.	NULL

Jenkins	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
D.	NULL
J.	NULL
Gilbert	NULL
,	NULL
B.	NULL
C.	NULL
Cho	NULL
,	NULL
M.	NULL
C.	NULL
Strobel	NULL
,	NULL
S.	NULL
C.	NULL
Williams	NULL
,	NULL
N.	NULL
G.	NULL
Copeland	NULL
,	NULL
and	NULL
P.	NULL
F.	NULL
Johnson	NULL
.	NULL

1995	NULL
.	NULL

Mouse	NULL
chromosomal	NULL
location	NULL
of	NULL
the	NULL
NOVEL	NULL
PROMYELOCYTE-SPECIFIC	NULL
C/EBP	NULL
FACTOR	NULL
37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

1385	NULL
CAAT/enhancer	NULL
binding	NULL
proteins	NULL
C/EBP	NULL
beta	NULL
(	NULL
Cebp	NULL
)	NULL
,	NULL
C/EBP	NULL
delta	NULL
(	NULL
Cebpd	NULL
)	NULL
,	NULL
and	NULL
CRP1	NULL
(	NULL
Cebpe	NULL
)	NULL
.	NULL

Genomics	NULL
28:333-336	NULL
.	NULL

Johnson	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
W.	NULL
M.	NULL
Nauseef	NULL
,	NULL
A	NULL
.	NULL

Care	NULL
,	NULL
M.	NULL
J.	NULL
Wheelock	NULL
,	NULL
S.	NULL
Shane	NULL
,	NULL
S.	NULL
Hudson	NULL
,	NULL
H.	NULL
P.	NULL
Koeffler	NULL
,	NULL
M.	NULL
Selsted	NULL
,	NULL
C.	NULL
W.	NULL
Miller	NULL
,	NULL
and	NULL
G.	NULL
Rovera	NULL
.	NULL

1987	NULL
.	NULL

Characterization	NULL
of	NULL
cDNA	NULL
clones	NULL
for	NULL
human	NULL
myeloperoxidase	NULL
:	NULL
predicted	NULL
amino	NULL
acid	NULL
sequence	NULL
and	NULL
evidence	NULL
for	NULL
multiple	NULL
mRNA	NULL
species	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15:2013-2028	NULL
.	NULL

Johnson	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
W.	NULL
H.	NULL
Landschulz	NULL
,	NULL
B.	NULL
J.	NULL
Graves	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1987	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
rat	NULL
liver	NULL
nuclear	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
enhancer	NULL
core	NULL
element	NULL
of	NULL
three	NULL
animal	NULL
viruses	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

1:133-146	NULL
.	NULL

Juan	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
D.	NULL
R.	NULL
Wilson	NULL
,	NULL
M.	NULL
D.	NULL
Wilde	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Darlington	NULL
.	NULL

1993	NULL
.	NULL

Participation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
C/EBP	NULL
delta	NULL
in	NULL
the	NULL
acute-phase	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
gene	NULL
for	NULL
complement	NULL
component	NULL
C3	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2584-2588	NULL
.	NULL

Kaestner	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
R.	NULL
J.	NULL
Christy	NULL
,	NULL
and	NULL
M.	NULL
D.	NULL
Lane	NULL
.	NULL

1990	NULL
.	NULL

Mouse	NULL
insulin-responsive	NULL
glucose	NULL
transporter	NULL
gene	NULL
:	NULL
characterization	NULL
of	NULL
the	NULL
gene	NULL
and	NULL
transactivation	NULL
by	NULL
the	NULL
CCAAT/enhancer	NULL
binding	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:251-255	NULL
.	NULL

Katz	NULL
,	NULL
S.	NULL
,	NULL
E.	NULL
Kowenz-Leutz	NULL
,	NULL
C.	NULL
Muller	NULL
,	NULL
K.	NULL
Meese	NULL
,	NULL
S.	NULL
A.	NULL
Ness	NULL
,	NULL
and	NULL
A.	NULL
Leutz	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
NF-M	NULL
transcription	NULL
factor	NULL
is	NULL
related	NULL
to	NULL
C/EBP	NULL
beta	NULL
and	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
signal	NULL
transduction	NULL
,	NULL
differentiation	NULL
and	NULL
leukemogenesis	NULL
of	NULL
avian	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:1321-1332	NULL
.	NULL

Kinoshita	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
member	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
,	NULL
NF-IL6	NULL
beta	NULL
,	NULL
forms	NULL
a	NULL
heterodimer	NULL
and	NULL
transcriptionally	NULL
synergizes	NULL
with	NULL
NF-IL6	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:1473-1476	NULL
.	NULL

Klemsz	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
S.	NULL
R.	NULL
McKercher	NULL
,	NULL
A.	NULL
Celada	NULL
,	NULL
C.	NULL
Van	NULL
Beveren	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Maki	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
macrophage	NULL
and	NULL
B	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
PU.1	NULL
is	NULL
related	NULL
to	NULL
the	NULL
ets	NULL
oncogene	NULL
.	NULL

Cell	NULL
61:113-124	NULL
.	NULL

Koike	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
M.	NULL
Chumakov	NULL
,	NULL
S.	NULL
Takeuchi	NULL
,	NULL
R.	NULL
Yang	NULL
,	NULL
and	NULL
H.	NULL
P.	NULL
Koeffler	NULL
.	NULL

Mutational	NULL
analysis	NULL
and	NULL
chromosomal	NULL
localization	NULL
of	NULL
the	NULL
promyelocyte-specific	NULL
hMEF	NULL
gene	NULL
.	NULL

Submitted	NULL
for	NULL
publication	NULL
.	NULL

Kowenz-Leutz	NULL
,	NULL
E.	NULL
,	NULL
G.	NULL
Twamley	NULL
,	NULL
S.	NULL
Ansieau	NULL
,	NULL
and	NULL
A.	NULL
Leutz	NULL
.	NULL

1994	NULL
.	NULL

Novel	NULL
mechanism	NULL
of	NULL
C/EBPB	NULL
(	NULL
NF-M	NULL
)	NULL
transcriptional	NULL
control	NULL
:	NULL
activation	NULL
through	NULL
dere-pression	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:2781-2791	NULL
.	NULL

Kreider	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
G.	NULL
Benezra	NULL
,	NULL
G.	NULL
Rovera	NULL
,	NULL
and	NULL
T.	NULL
Kadesch	NULL
.	NULL

1992	NULL
.	NULL

Inhibition	NULL
of	NULL
myeloid	NULL
differentiation	NULL
by	NULL
the	NULL
helix-loop-helix	NULL
protein	NULL
Id	NULL
.	NULL

Science	NULL
255:1700-1702	NULL
.	NULL

Landschulz	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
P.	NULL
F.	NULL
Johnson	NULL
,	NULL
E.	NULL
Y.	NULL
Adashi	NULL
,	NULL
B.	NULL
J.	NULL
Graves	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1988	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
recombinant	NULL
copy	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
C/EBP	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2786-800	NULL
.	NULL

Lassar	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
R.	NULL
L.	NULL
Davis	NULL
,	NULL
W.	NULL
E.	NULL
Wright	NULL
,	NULL
T.	NULL
Kadesch	NULL
,	NULL
C.	NULL
Murre	NULL
,	NULL
A.	NULL
Voronova	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1991	NULL
.	NULL

Functional	NULL
activity	NULL
of	NULL
myogenic	NULL
HLH	NULL
proteins	NULL
requires	NULL
hetero-oligomerization	NULL
with	NULL
E12/E47-like	NULL
proteins	NULL
in	NULL
vivo	NULL
.	NULL

Cell	NULL
66:305-315	NULL
.	NULL

LeClair	NULL
,	NULL
K.	NULL
P.	NULL
,	NULL
M.	NULL
A.	NULL
Blanar	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
p50	NULL
subunit	NULL
of	NULL
NF-kappa	NULL
B	NULL
associates	NULL
with	NULL
the	NULL
NF-IL6	NULL
transcription	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:8145-8149	NULL
.	NULL

Lin	NULL
,	NULL
F.	NULL
T.	NULL
,	NULL
and	NULL
M.	NULL
D.	NULL
Lane	NULL
.	NULL

1994	NULL
.	NULL

CCAAT/enhancer	NULL
binding	NULL
protein	NULL
alpha	NULL
is	NULL
sufficient	NULL
to	NULL
initiate	NULL
the	NULL
3T3-L1	NULL
adipocyte	NULL
differentiation	NULL
program	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:8757-8761	NULL
.	NULL

Lin	NULL
,	NULL
F.	NULL
T.	NULL
,	NULL
and	NULL
M.	NULL
D.	NULL
Lane	NULL
.	NULL

1992	NULL
.	NULL

Antisense	NULL
CCAAT/enhancer-binding	NULL
protein	NULL
RNA	NULL
suppresses	NULL
coordinate	NULL
gene	NULL
expression	NULL
and	NULL
triglyceride	NULL
accumulation	NULL
during	NULL
differentiation	NULL
of	NULL
3T3-L1	NULL
preadipocytes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:533-544	NULL
.	NULL

Luckow	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
G.	NULL
Schutz	NULL
.	NULL

1987	NULL
.	NULL

CAT	NULL
constructions	NULL
with	NULL
multiple	NULL
unique	NULL
restriction	NULL
sites	NULL
for	NULL
the	NULL
functional	NULL
analysis	NULL
of	NULL
eukaryotic	NULL
promoters	NULL
and	NULL
regulatory	NULL
elements	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:1919	NULL
.	NULL

Maniatis	NULL
,	NULL
T.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
J.	NULL
Sambrook	NULL
.	NULL

1982	NULL
.	NULL

Molecular	NULL
cloning	NULL
:	NULL
a	NULL
laboratory	NULL
manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Har-bor	NULL
,	NULL
N.Y.	NULL
Metz	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
E.	NULL
Ziff	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
helix-loop-helix	NULL
protein	NULL
rE12	NULL
and	NULL
the	NULL
C/EBP	NULL
-related	NULL
factor	NULL
rNFIL-6	NULL
bind	NULL
to	NULL
neighboring	NULL
sites	NULL
within	NULL
the	NULL
c-fos	NULL
serum	NULL
response	NULL
clement	NULL
.	NULL

Oncogene	NULL
6:2165-2178	NULL
.	NULL

Metz	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
E.	NULL
Ziff	NULL
.	NULL

1991.	NULL
cAMP	NULL
stimulates	NULL
the	NULL
C/EBP-related	NULL
transcription	NULL
factor	NULL
rNFIL-6	NULL
to	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
induce	NULL
c-fos	NULL
transcription	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:1754-1766	NULL
.	NULL

Mink	NULL
,	NULL
S.	NULL
,	NULL
U.	NULL
Kerber	NULL
,	NULL
and	NULL
K.-H.	NULL
Klempnauer	NULL
.	NULL

1996	NULL
.	NULL

Interaction	NULL
of	NULL
C/EBPB	NULL
and	NULL
v-Myb	NULL
is	NULL
required	NULL
for	NULL
synergistic	NULL
activation	NULL
of	NULL
the	NULL
mim-1	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:1316-1325	NULL
.	NULL

Miyoshi	NULL
,	NULL
H.	NULL
,	NULL
M	NULL
.	NULL

Obira	NULL
.	NULL

,	NULL
K.	NULL
Shimizu	NULL
,	NULL
K.	NULL
Mitani	NULL
,	NULL
H.	NULL
Hirai	NULL
,	NULL
T.	NULL
Imai	NULL
,	NULL
K.	NULL
Yokoyama	NULL
,	NULL
E.	NULL
Soeda	NULL
,	NULL
and	NULL
M.	NULL
Ohki	NULL
.	NULL

1995	NULL
.	NULL

Alternative	NULL
splicing	NULL
and	NULL
genomic	NULL
structure	NULL
of	NULL
the	NULL
AML1	NULL
gene	NULL
involved	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

23:2762-2769	NULL
.	NULL

Munker	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
W.	NULL
Norman	NULL
,	NULL
and	NULL
H.	NULL
P.	NULL
Koeffler	NULL
.	NULL

1986	NULL
.	NULL

Vitamin	NULL
D	NULL
compounds	NULL
:	NULL
effects	NULL
on	NULL
clonal	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
human	NULL
myeloid	NULL
cells	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

87:424-430	NULL
.	NULL

Natsuka	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
S.	NULL
Hashimoto	NULL
,	NULL
T.	NULL
Sugita	NULL
,	NULL
H.	NULL
Isshiki	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1992	NULL
.	NULL

Macrophage	NULL
differentiation-specific	NULL
expression	NULL
of	NULL
NF-IL6	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
for	NULL
interleukin-6	NULL
.	NULL

Blood	NULL
79:460-466	NULL
.	NULL

Ness	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
A.	NULL
Marknell	NULL
,	NULL
and	NULL
T.	NULL
Graf	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
v-myb	NULL
oncogene	NULL
product	NULL
binds	NULL
to	NULL
and	NULL
activates	NULL
the	NULL
promyelocyte-specific	NULL
mim-1	NULL
gene	NULL
.	NULL

Cell	NULL
59:1115-1125	NULL
.	NULL

1386	NULL
61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

CHUMAKOV	NULL
ET	NULL
AL	NULL
.	NULL

Ness	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
E.	NULL
Kowenz-Leutz	NULL
,	NULL
T.	NULL
Casini	NULL
,	NULL
T.	NULL
Graf	NULL
,	NULL
and	NULL
A.	NULL
Leutz	NULL
.	NULL

1993	NULL
.	NULL

Myb	NULL
and	NULL
NF-M	NULL
:	NULL
combinatorial	NULL
activators	NULL
of	NULL
myeloid	NULL
genes	NULL
in	NULL
heterologous	NULL
cell	NULL
types	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:749-759	NULL
.	NULL

Nguyen	NULL
,	NULL
H.	NULL
Q.	NULL
,	NULL
B.	NULL
Hoffman-Liebermann	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Liebermann	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
zinc	NULL
finger	NULL
transcription	NULL
factor	NULL
Egr-1	NULL
is	NULL
essential	NULL
for	NULL
and	NULL
restricts	NULL
differentiation	NULL
along	NULL
the	NULL
macrophage	NULL
lineage	NULL
.	NULL

Cell	NULL
72:197-209	NULL
.	NULL

Nishio	NULL
,	NULL
Y.	NULL
,	NULL
H.	NULL
Isshiki	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
nuclear	NULL
factor	NULL
for	NULL
interleukin-6	NULL
expression	NULL
(	NULL
NF-IL6	NULL
)	NULL
and	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
synergistically	NULL
activate	NULL
transcription	NULL
of	NULL
the	NULL
rat	NULL
el-acid	NULL
glycoprotein	NULL
gene	NULL
via	NULL
direct	NULL
protein-protein	NULL
interaction	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1854-1862	NULL
.	NULL

Pahl	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
T.	NULL
C.	NULL
Burn	NULL
,	NULL
and	NULL
D.	NULL
G.	NULL
Tenen	NULL
.	NULL

1991	NULL
.	NULL

Optimization	NULL
of	NULL
transient	NULL
transfection	NULL
into	NULL
human	NULL
myeloid	NULL
cell	NULL
lines	NULL
using	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

Exp	NULL
.	NULL

Hematol	NULL
.	NULL

19:1038-1041	NULL
.	NULL

Park	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
W.	NULL
J.	NULL
Roesler	NULL
,	NULL
J.	NULL
Liu	NULL
,	NULL
D.	NULL
J.	NULL
Klemm	NULL
,	NULL
A.	NULL
L.	NULL
Gurney	NULL
,	NULL
J.	NULL
D.	NULL
Thatcher	NULL
,	NULL
J.	NULL
Shuman	NULL
,	NULL
A.	NULL
Friedman	NULL
,	NULL
and	NULL
R.	NULL
W.	NULL
Hanson	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
role	NULL
of	NULL
CAAT	NULL
enhancer-binding	NULL
protein	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
gene	NULL
for	NULL
phosphoenolpyruvate	NULL
carboxykinase	NULL
(	NULL
GTP	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:6264-6274	NULL
.	NULL

Poli	NULL
,	NULL
V.	NULL
,	NULL
F.	NULL
P.	NULL
Mancini	NULL
,	NULL
and	NULL
R.	NULL
Cortese	NULL
.	NULL

1990	NULL
.	NULL

IL-6DBP	NULL
,	NULL
a	NULL
nuclear	NULL
protein	NULL
involved	NULL
in	NULL
interleukin-6	NULL
signal	NULL
transduction	NULL
,	NULL
defines	NULL
a	NULL
new	NULL
family	NULL
of	NULL
leucine	NULL
zipper	NULL
proteins	NULL
related	NULL
to	NULL
C/EBP	NULL
.	NULL

Cell	NULL
63:643-653	NULL
.	NULL

Roman	NULL
,	NULL
C.	NULL
,	NULL
J.	NULL
S.	NULL
Platero	NULL
,	NULL
J.	NULL
D.	NULL
Shuman	NULL
,	NULL
and	NULL
K.	NULL
Calame	NULL
.	NULL

1990	NULL
.	NULL

Ig/EBP-1	NULL
:	NULL
a	NULL
ubiquitously	NULL
expressed	NULL
immunoglobulin	NULL
enhancer	NULL
binding	NULL
protein	NULL
that	NULL
is	NULL
similar	NULL
to	NULL
C/EBP	NULL
and	NULL
heterodimerizes	NULL
with	NULL
C/EBP	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1404-1415	NULL
.	NULL

Ron	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Habener	NULL
.	NULL

1992	NULL
.	NULL

CHOP	NULL
,	NULL
a	NULL
novel	NULL
developmentally	NULL
regulated	NULL
nuclear	NULL
protein	NULL
that	NULL
dimerizes	NULL
with	NULL
transcription	NULL
factors	NULL
C/EBP	NULL
and	NULL
LAP	NULL
and	NULL
functions	NULL
as	NULL
a	NULL
dominant-negative	NULL
inhibitor	NULL
of	NULL
gene	NULL
transcription	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6439-453	NULL
.	NULL

Samuelsson	NULL
,	NULL
L.	NULL
,	NULL
K.	NULL
Stromberg	NULL
,	NULL
K.	NULL
Vikman	NULL
,	NULL
G.	NULL
Bjursell	NULL
,	NULL
and	NULL
S.	NULL
Enerback	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
CCAAT/enhancer	NULL
binding	NULL
protein	NULL
and	NULL
its	NULL
role	NULL
in	NULL
adipocyte	NULL
dif-ferentiation	NULL
:	NULL
evidence	NULL
for	NULL
direct	NULL
involvement	NULL
in	NULL
terminal	NULL
adipocyte	NULL
development	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:3787-3793	NULL
.	NULL

Scott	NULL
,	NULL
L	NULL
,	NULL
M.	NULL
,	NULL
C.	NULL
I.	NULL
Civin	NULL
,	NULL
P.	NULL
Rorth	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Friedman	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
temporal	NULL
expression	NULL
pattern	NULL
of	NULL
three	NULL
C/EBP	NULL
family	NULL
members	NULL
in	NULL
differentiating	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

Blood	NULL
80:1725-1735	NULL
.	NULL

Screpanti	NULL
,	NULL
T.	NULL
,	NULL
L.	NULL
Romani	NULL
,	NULL
P.	NULL
Musiani	NULL
,	NULL
A.	NULL
Modesti	NULL
,	NULL
E.	NULL
Fattori	NULL
,	NULL
D.	NULL
Lazzaro	NULL
,	NULL
C.	NULL
Sellitto	NULL
,	NULL
S.	NULL
Scarpa	NULL
,	NULL
D.	NULL
Bellavia	NULL
,	NULL
and	NULL
G.	NULL
Lattanzio	NULL
.	NULL

1995	NULL
.	NULL

Lymphoproliferative	NULL
disorder	NULL
and	NULL
imbalanced	NULL
T-helper	NULL
response	NULL
in	NULL
C/EBP	NULL
beta-deficient	NULL
mice	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:1932-1941	NULL
.	NULL

Shivdasani	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Orkin	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
transcriptional	NULL
control	NULL
of	NULL
hematopoiesis	NULL
.	NULL

Blood	NULL
87:4025-4039	NULL
.	NULL

Shuman	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
C.	NULL
R.	NULL
Vinson	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1990	NULL
.	NULL

Evidence	NULL
of	NULL
changes	NULL
in	NULL
protease	NULL
sensitivity	NULL
and	NULL
subunit	NULL
exchange	NULL
rate	NULL
on	NULL
DNA	NULL
binding	NULL
by	NULL
C/EBP	NULL
.	NULL

Science	NULL
249:771-774	NULL
.	NULL

Sterneck	NULL
,	NULL
E.	NULL
,	NULL
C.	NULL
Muller	NULL
,	NULL
S.	NULL
Katz	NULL
,	NULL
and	NULL
A.	NULL
Leutz	NULL
.	NULL

1992	NULL
.	NULL

Autocrine	NULL
growth	NULL
induced	NULL
by	NULL
kinase	NULL
type	NULL
oncogenes	NULL
in	NULL
myeloid	NULL
cells	NULL
requires	NULL
AP-1	NULL
and	NULL
NF-M	NULL
,	NULL
a	NULL
myeloid	NULL
specific	NULL
,	NULL
C/EBP-like	NULL
factor	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:115-126	NULL
.	NULL

Sun	NULL
,	NULL
W.	NULL
,	NULL
B.	NULL
J.	NULL
Graves	NULL
,	NULL
and	NULL
N.	NULL
A.	NULL
Speck	NULL
.	NULL

1995	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
and	NULL
T-cell	NULL
receptor	NULL
B-chain	NULL
enhancers	NULL
by	NULL
cbf	NULL
and	NULL
ets	NULL
requires	NULL
intact	NULL
binding	NULL
sites	NULL
for	NULL
both	NULL
proteins	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:4941-4949	NULL
.	NULL

Takahashi	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Satake	NULL
,	NULL
Y.	NULL
Yamaguchi-Iwai	NULL
,	NULL
S.	NULL
C.	NULL
Bae	NULL
,	NULL
J.	NULL
Lu	NULL
,	NULL
M.	NULL
Ma	NULL
77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

83	NULL
.	NULL

84	NULL
.	NULL

85	NULL
.	NULL

86	NULL
.	NULL

87	NULL
.	NULL

88	NULL
.	NULL

89	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

ruyama	NULL
,	NULL
Y.	NULL
W.	NULL
Zhang	NULL
,	NULL
H.	NULL
Oka	NULL
,	NULL
N.	NULL
Arai	NULL
,	NULL
and	NULL
K.	NULL
Arai	NULL
.	NULL

1995	NULL
.	NULL

Positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
activity	NULL
by	NULL
AML1-related	NULL
transcription	NULL
factor	NULL
,	NULL
PEBP2	NULL
.	NULL

Blood	NULL
86	NULL
:	NULL
607-616	NULL
.	NULL

Tanaka	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
K.	NULL
Yoshida	NULL
,	NULL
M.	NULL
Umemoto	NULL
,	NULL
Y.	NULL
Yoneda	NULL
,	NULL
N.	NULL
Shirafuji	NULL
,	NULL
H.	NULL
Fujiwara	NULL
,	NULL
S.	NULL
S	NULL
tsu	NULL
,	NULL
K.	NULL
Yoshida	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1995	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
discloses	NULL
its	NULL
essential	NULL
role	NULL
in	NULL
bacteria	NULL
killing	NULL
and	NULL
tumor	NULL
cytotoxicity	NULL
by	NULL
macrophages	NULL
.	NULL

Cell	NULL
80:353-361	NULL
.	NULL

Tanaka	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Tanaka	NULL
,	NULL
S.	NULL
Ogawa	NULL
,	NULL
M.	NULL
Kurokawa	NULL
,	NULL
K.	NULL
Mitani	NULL
,	NULL
J.	NULL
Nishida	NULL
,	NULL
Y.	NULL
Shibata	NULL
,	NULL
Y.	NULL
Yazaki	NULL
,	NULL
and	NULL
H.	NULL
Hirai	NULL
.	NULL

1995	NULL
.	NULL

An	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
gene	NULL
,	NULL
AML1	NULL
,	NULL
regulates	NULL
hemopoietic	NULL
myeloid	NULL
cell	NULL
differentiation	NULL
and	NULL
transcriptional	NULL
activation	NULL
antagonistically	NULL
by	NULL
two	NULL
alternative	NULL
spliced	NULL
forms	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:341-350	NULL
.	NULL

Todokoro	NULL
,	NULL
K.	NULL
,	NULL
R.	NULL
J.	NULL
Watson	NULL
,	NULL
H.	NULL
Higo	NULL
,	NULL
H.	NULL
Amanuma	NULL
,	NULL
S.	NULL
Kuramochi	NULL
,	NULL
H.	NULL
Yanagisawa	NULL
,	NULL
and	NULL
Y.	NULL
Ikawa	NULL
.	NULL

1988	NULL
.	NULL

Down-regulation	NULL
of	NULL
c-myb	NULL
gene	NULL
expression	NULL
is	NULL
a	NULL
prerequisite	NULL
for	NULL
erythropoictin-induced	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:8900-8904	NULL
.	NULL

Tsukada	NULL
,	NULL
J.	NULL
,	NULL
K.	NULL
Saito	NULL
,	NULL
W.	NULL
R.	NULL
Waterman	NULL
,	NULL
A.	NULL
C.	NULL
Webb	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Auron	NULL
.	NULL

1994	NULL
.	NULL

Transcription	NULL
factors	NULL
NF-IL6	NULL
and	NULL
CREB	NULL
recognize	NULL
a	NULL
common	NULL
essential	NULL
site	NULL
in	NULL
the	NULL
human	NULL
prointerleukin	NULL
18	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:7285-7297	NULL
.	NULL

Umek	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
A.	NULL
D.	NULL
Friedman	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1991	NULL
.	NULL

CCAAT-enhancer	NULL
binding	NULL
protein	NULL
:	NULL
a	NULL
component	NULL
of	NULL
a	NULL
differentiation	NULL
switch	NULL
.	NULL

Science	NULL
251:288-292	NULL
.	NULL

Vallejo	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
Ron	NULL
,	NULL
C.	NULL
P.	NULL
Miller	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Habener	NULL
.	NULL

1993	NULL
.	NULL

C/ATF	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
activating	NULL
transcription	NULL
factor	NULL
family	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
,	NULL
dimerizes	NULL
with	NULL
CAAT/enhancer-binding	NULL
proteins	NULL
and	NULL
directs	NULL
their	NULL
binding	NULL
to	NULL
cAMP	NULL
response	NULL
elements	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:4679-4683	NULL
.	NULL

Vinson	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
P.	NULL
B.	NULL
Sigler	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1989	NULL
.	NULL

Scissors-grip	NULL
model	NULL
for	NULL
DNA	NULL
recognition	NULL
by	NULL
a	NULL
family	NULL
of	NULL
leucine	NULL
zipper	NULL
proteins	NULL
.	NULL

Science	NULL
246:911-916	NULL
.	NULL

Williams	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
C.	NULL
A.	NULL
Cantwell	NULL
,	NULL
and	NULL
P.	NULL
F.	NULL
Johnson	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
family	NULL
of	NULL
C/EBP	NULL
related	NULL
proteins	NULL
capable	NULL
of	NULL
forming	NULL
covalently	NULL
linked	NULL
leucine	NULL
zipper	NULL
dimers	NULL
in	NULL
vitro	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

51553-1567	NULL
.	NULL

Wotton	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Ghysdael	NULL
,	NULL
S.	NULL
Wang	NULL
,	NULL
N.	NULL
A.	NULL
Speck	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Owen	NULL
.	NULL

1994	NULL
.	NULL

Cooperative	NULL
binding	NULL
of	NULL
Ets-1	NULL
and	NULL
core	NULL
binding	NULL
factor	NULL
to	NULL
DNA	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:840-850	NULL
.	NULL

Xu	NULL
,	NULL
L.	NULL
X.	NULL
,	NULL
D.	NULL
F.	NULL
Wan	NULL
,	NULL
Y.	NULL
F.	NULL
Liu	NULL
,	NULL
H.	NULL
N.	NULL
Li	NULL
,	NULL
P.	NULL
P.	NULL
Zhang	NULL
,	NULL
Y.	NULL
F.	NULL
Sui	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Gu	NULL
.	NULL

1995	NULL
.	NULL

HS8	NULL
:	NULL
the	NULL
partial	NULL
cDNA	NULL
clone	NULL
of	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
C/EBP	NULL
gene	NULL
family	NULL
.	NULL

GenBank	NULL
accession	NULL
number	NULL
X87248	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

Yiangou	NULL
,	NULL
M.	NULL
,	NULL
X.	NULL
Ge	NULL
,	NULL
K.	NULL
C.	NULL
Carter	NULL
,	NULL
and	NULL
J.	NULL
Papaconstantinou	NULL
.	NULL

1991	NULL
.	NULL

Induction	NULL
of	NULL
several	NULL
acute-phase	NULL
protein	NULL
genes	NULL
by	NULL
heavy	NULL
metals	NULL
:	NULL
a	NULL
new	NULL
class	NULL
of	NULL
metal-responsive	NULL
genes	NULL
.	NULL

Biochemistry	NULL
30:3798-3806	NULL
.	NULL

Yiangou	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
J.	NULL
Papaconstantinou	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
differential	NULL
induction	NULL
of	NULL
alpha	NULL
l-acid	NULL
glycoprotein	NULL
and	NULL
serum	NULL
amyloid	NULL
A	NULL
genes	NULL
by	NULL
heavy	NULL
metals	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1174:123-132	NULL
.	NULL

Zhang	NULL
,	NULL
D.-E.	NULL
,	NULL
C.	NULL
J.	NULL
Hetherington	NULL
,	NULL
S.	NULL
Meyers	NULL
,	NULL
K.	NULL
L.	NULL
Rhoades	NULL
,	NULL
C.	NULL
J.	NULL
Larson	NULL
,	NULL
H.-M.	NULL
Chen	NULL
,	NULL
S.	NULL
W.	NULL
Hiebert	NULL
,	NULL
and	NULL
D.	NULL
G.	NULL
Tenen	NULL
.	NULL

1996	NULL
.	NULL

CCAAT	NULL
enhancer-binding	NULL
protein	NULL
(	NULL
C/EBP	NULL
)	NULL
and	NULL
AML1	NULL
(	NULL
CBFa2	NULL
)	NULL
synergistically	NULL
activate	NULL
the	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
receptor	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:1231-1240	NULL
.	NULL

